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INTRODUCTION
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Introduction
The mammalian brain controls many body functions and is essential for emotions 
and cognitive behavior, such as learning. Networks of nerve cells (neurons), which 
are the basic entities of the brain, process the information received from internal and 
external environments and coordinate physiological responses to these signals. The 
communication between neurons in the network occurs predominantly via the release 
of signaling molecules at specialized contact places, the synapses. Long extensions 
(axons and dendrites, together called neurites) make it possible to communicate 
between neurons. One of the major goals in neurobiology is to understand how 
neuronal networks develop and how these networks mature to form the adult brain.
During early stages of brain development the outgrowing neurites are already capable 
of releasing neurotransmitters. Several studies indicate that this developmental release 
has a role in network formation. After synapses have formed, these connections remain 
plastic; they can be strengthened or weakened as a result of previous experiences. 
This process is called synaptic plasticity. Synapse formation and synaptic plasticity 
may have several features in common. For instance, synaptic activity has a similar role 
in network formation and synaptic plasticity. As will be discussed below in greater 
detail, during synaptic plasticity and synapse formation gene expression is essential 
for sustained effects of synaptic activity. This activity-dependent gene expression may 
be essential for functional and morphological changes, both in development and in 
synaptic plasticity. The relation between synaptic activity and gene expression has 
been studied in vitro and in vivo. 
This introduction will mainly focus on our current knowledge of the role of synaptic 
activity in neural development. Particularly, we will discuss the induction of gene 
expression by synaptic activity. 
1 - Development of the nervous system
Three stages can be distinguished in the development of the nervous system: 
neurogenesis, synaptogenesis and maturation. During neurogenesis neurons 
proliferate and migrate to their correct positions and start to form dendrites and 
axons. Filopodial enlargements, called growth cones, at the end of outgrowing 
axons are guided by guidance cues from other cells. When the target is reached 
the formation of the synapse (synaptogenesis) starts. Synapses can then be either 
eliminated or stabilized and remain, this stage is called maturation.
For this thesis mainly the synapse formation and maturation is of importance, 
therefore these processes will be discussed in the next chapters in more detail.
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1.1 Synaptogenesis
Communication between neurons is primarily restricted to the place where two 
cells contact each other (i.e., the synapse). The synapse consists of three elements: 
the presynaptic terminal, the postsynaptic target membrane and the synaptic cleft. 
In the presynaptic terminal, neurotransmitters are stored in vesicles. When an action 
potential reaches the terminal, neurotransmitter is released into the synaptic cleft, 
where it can diffuse to the postsynaptic target cell. In the postsynaptic cell membrane, 
neurotransmitter receptors are present to detect the released neurotransmitter. This 
triggers depolarization of the postsynaptic cell or activation of postsynaptic second 
messenger pathways.
Communication between growth cones and possible targets can initiate synapse 
formation. Some neurons form an overabundance of synapses, of which later in 
development several will be eliminated. Competition between neurons for target-
derived factors is thought to be a central part in this elimination process (Vicario-
Abejón, et al., 1998). Pre- and post-synapse are considered to recognize each other 
by cell-speciﬁc surface proteins (like cell adhesion molecules) (see for review Bolz et 
al., 1996). Their contact triggers intracellular signals, like calcium, that causes the pre-
existing synaptic machinery to assemble (see for review Haydon and Drapeau, 1995; 
Marzban et al., 2003). Incorporation of 80 nm dense-core vesicles in the presynapse 
delivers structural and functional components necessary for synaptic activity. The 
content of these vesicles inﬂuences the differentiation of the post-synapse (see for 
review Garner et al., 2000). Time-lapse studies show that ﬁrst functional presynaptic 
sites are formed (within 30 min after contact) and then postsynaptic receptor clusters 
are formed (after approximately 1 to 2 hours after initial contact; Friedman et al., 2000). 
During synaptogenesis the pre- and postsynaptic terminal are thought to 
communicate with each other via the release of compounds or by interaction of 
molecules on the cell membrane. Synaptic release, for instance, can regulate ﬁlopodial 
motility and dendritic arbor growth and thus alter the number and stability of initial 
contacts (Cline, 2001; Lendvai et al., 2000). In the TrkB and TrkC null mutant the number 
of synaptic contacts is lower, indicating that the release of neurotrophins is involved 
in the formation of synapses (Martinez et al., 1998). Finally, the large diversity of cell 
adhesion molecules is most likely important for the formation of synapses (see for 
review Washbourne et al., 2004). Especially the classical cell adhesion molecules, like 
cadherins and neuroligin-neurexin complexes are known to be involved in the initial 
synapse formation (see review Garner et al., 2002). 
1.2 Maturation of synapses
After initial synapse formation, synapses are modiﬁed both morphologically and 
functionally. We will deﬁne these adjustments of the synapse after initial synaptic 
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assembly as synaptic maturation (see also Zhang and Poo, 2001). For instance, 
myelination of axons is part of this maturation (see Itoh et al., 1997). Myelination 
was used for a long time as criterion for maturation, as it is a clear morphological 
deﬁned step in development. However, now it is known that most axons in the CNS 
are unmyelinated, and myelination is only one of the many steps in maturation 
(Pfrieger, 2002). During maturation of synapses the synaptic strength increases, 
which is probably caused by the recruitment of pre- and postsynaptic compounds. 
Other important aspects that can be distinguished at this point are the change 
in subunit composition of the neurotransmitter receptors, the increase in the 
number of receptors, and the recruitment of several scaffolding molecules, together 
strengthening the synapse. In addition, at this stage of development the postsynaptic 
side forms dendritic spines (Fiala et al., 1998). Presynaptically, the number of synaptic 
vesicles increases during maturation (Mohrmann et al., 2003) and the neurotransmitter 
that is released from the synapse can be changed (Nabekura et al., 2004). 
Communication between the pre- and postsynapse is important for synaptic 
maturation. For instance, the incorporation of certain subunits of NMDA and AMPA 
receptors in the post-synaptic membrane involves several activity-dependent 
pathways (Sheng and Kim, 2002; Crump et al., 2001). In addition, in cultured rat 
neocortical neurons and in BDNF null mutant brain slices neurotrophins increase the 
protein levels of AMPA (Itami et al., 2000; Narisawa-Saito, 1999). In addition, in the TrkB 
and TrkC null mutant the number of vesicles in the presynapse and the RNA levels 
of proteins involved in synaptic activity are lower. This indicates that presynaptic 
maturation is inﬂuenced by neurotrophins (Martinez et al., 1998). 
Moreover, cell adhesion molecules are important for the maturation of synapses. 
For instance, integrins are required for the functional maturation of synapses in the 
hippocampus (Chavis and Westbrook, 2001). Second, NCAM is necessary for the 
recruitment of the naturally occurring NMDA receptor switch in heterogenotypic 
cocultures of NCAM-deﬁcient and wild-type neurons (Sytnyk et al., 2002). Third, ephrin’s 
and their receptors (EphB receptors) have been shown to promote the clustering of 
NMDA receptors (Dalva et al., 2000). Finally, the expression of glycoproteins changes 
during the maturation of synapses and may play a role in cell adhesion (see for review 
Yamaguchi, 2002). 
2 - Signaling in the nervous system
The preceding sections show that communication between the pre- and postsynaptic 
terminal is involved in several aspects of brain development. The next paragraphs will 
discuss the most important ways of communication between neurons in the nervous 
system. 
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2.1 Small clear cored vesicle release
Communication between neurons occurs in the adult brain mainly via fast 
chemical synapses. This method of communication is accomplished by release of 
neurotransmitter-ﬁlled synaptic vesicles (exocytosis) in response to calcium inﬂux. 
Membrane fusion between vesicle and cell membrane during synaptic vesicle release 
involves many highly coordinated steps that result in a fast and spatially restricted 
process. 
These efﬁcient membrane fusion reactions require a conserved family of proteins 
called SNAREs (soluble N-ethylmaleimide-sensitive fusion protein (NSF)-attachment 
protein (SNAP) receptors). For fusion of membranes both a t-SNARE (at the target 
membrane) and a v-SNARE (on the vesicle) is needed. The synaptic vesicle protein 
Synaptobrevin2 (also known as VAMP2) and the plasma membrane-associated 
proteins Syntaxin-1 and SNAP-25 (Sollner and Rothman, 1996) are involved in synaptic 
release. These three proteins form a complex (the SNARE or core complex) (Sollner et 
al., 1993), which is thought to facilitate the mixing of membrane lipids of the synaptic 
vesicle with the cell membrane (Chen et al., 1999; McNew et al., 2000). Other proteins 
are involved in the process of membrane fusion. For instance, members of the Sec1/
Munc18 family (SM proteins) are essential for membrane fusion. Genetic deletion of 
the SM protein munc18-1 results in a complete blockade of synaptic vesicle release 
(Verhage et al., 2000). There has been no report of other protein deletions with such 
a drastic effect; even the deletion of some members of the SNARE complex does not 
result in a complete block of vesicle fusion (Schoch et al., 2001; Washbourne et al., 
2002). In development, neurotransmitter release during outgrowth was thought to 
have two functions: ﬁrst to add membrane to make elongation of axons possible and 
second to guide the outgrowth. In the munc18-1 mutant, however, ﬁbers pathways are 
found. Thus, synaptic vesicle release may have other functions in brain development, 
such as maturation of synaptic contacts.
2.2 Large dense cored vesicle release
Besides the release of classical neurotransmitters, synapses are capable of releasing 
other compounds like neuropeptides and neurotrophins. Neuropeptides and 
neurotrophins are stored in large dense core vesicles (LDCV) and co-released with 
neurotransmitters (Berg et al., 2000; Wang et al., 2002). The release of neurotrophins 
from axon terminals is increased by depolarization, calcium inﬂux via N-type calcium 
channels and mobilization of calcium from intracellular stores (Wang et al., 2002). 
Several of the proteins involved in the release of synaptic vesicles are shown to be 
involved in the release of LDCV as well. For instance, the calcium sensor synaptotagmin 
I is required for rapid, highly Ca2+-sensitive release of both synaptic and LDCV vesicles. 
In addition, Munc18-1 is involved in both forms of release (Verhage et al., 2000; Voets 
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et al., 2001). Tetanus toxin inhibits NT-3 release, suggesting that intact Synaptobrevin 
or Synaptobrevin-like molecules are required for LDCV release (Wang et al., 2003). In 
PC12 cells Rabphilin and Noc2 were shown to be involved in LDCV release (Arribas et 
al., 1997; Haynes et al., 2001) and are probably recruited to dense-core vesicles through 
speciﬁc interaction with Rab27A (Fukuda et al., 2004). 
2.3 Retrograde signaling
Several studies indicate that, in addition to signals from pre- to postsynapse in so 
called anterograde signaling, the postsynapse can also signal to the presynapse. 
Retrograde messengers are hypothesized, because the postsynapse can affect 
presynaptic strength. These messengers may be soluble and released from vesicles in 
the postsynapse or may be membrane permeable and cross the post- and presynaptic 
membrane to exert its function. This signaling is thought to occur in response to 
activation of the presynapse.
For example, neurotrophins are hypothesized to act as retrograde messengers, as they 
can increase synaptic efﬁcacy (see for review Schmidt, 2004). Several studies examined 
the activity-dependent release of neurotrophins from neurons. Most likely, the release 
of neurotrophins is induced by calcium that originates from internal calcium stores. 
For instance, NGF is released when hippocampal slices or cultured cells are activated 
by potassium-ions, carbachol (an acetylcholine receptor agonist) or veratridine 
(see for review Bonhoeffer, 1996). In addition, glutamate or depolarization with high 
concentrations of potassium activates the release of NGF and BDNF in hippocampal 
slices and primary hippocampal neuronal cultures. Neurotrophin secretion is 
blocked by the intracellular, high-afﬁnity calcium chelator BAPTA and by blockade or 
depletion of intracellular calcium stores by dantrolene or thapsigargin (see Canossa 
et al., 1997). The calcium stores are probably opened by activation of the inositol-
triphophate pathway by neurotransmitter receptors in the membrane. Neurotrophins 
may originate from the postsynapse, since BDNF-GFP fusion protein is released upon 
high-frequency stimulation from postsynaptic structures of glutamatergic synapses 
in hippocampal neurons (Hartmann et al., 2001), However, the neurons may also 
have axonal BDNF-GFP expression, because axons often grow along a dendrite and 
the axonal localization of BDNF-GFP may be undetected. Therefore, the effects of 
neurotrophins on the presynaptic cell may still be an effect of presynaptic release of 
these compounds. 
Anterograde release of neurotrophins has been shown to be essential for presynaptic 
forms of long-term potentiation. For instance, restricted genetic deletion of BDNF in 
speciﬁc areas of the hippocampus showed that presynaptic derived BDNF is required 
for the induction of presynaptic potentiation (Zakharenko et al., 2003). 
In addition to neurotrophins, the membrane-permeable compounds nitric oxide, 
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endocannabinoids and arachidonic acid are thought to function as retrograde 
messengers as well. Nitric oxide (NO) can inﬂuence the presynaptic vesicle cycle and 
enhance neurotransmitter release (Micheva et al., 2003; see for review Medina and 
Izquierdo, 1996). Nitric oxide synthase (NOS), the NO producing enzyme, has been 
shown to be located postsynaptically (Burette et al., 2002). Furthermore, injecting 
NOS inhibitor in postsynaptic cells inhibits presynaptic LTP (see for review Medina 
and Izquierdo, 1996). Therefore, NO is a possible candidate to function as a retrograde 
messenger. 
Arachidonic acid can inﬂuence neurotransmitter release, but the postsynaptic origin of 
this compound has not yet been shown (see for review Medina and Izquierdo, 1996). 
Therefore, arachidonic acid is not yet proven to function as a retrograde signal. 
In addition, endocannabinoids may act as retrograde messenger. Endocannabinoid 
receptors are located presynaptically and agonists of endocannabinoids can 
induce presynaptic depression (Wilson and Nicoll, 2002; see for review Alger, 2002). 
Immunocytochemistry showed expression of FAAH, an enzyme, which produces 
an endocannabinoid in the cell bodies of Purkinje cells. Besides, CB1, a cannabinoid 
receptor, was expressed in the axons of granule cells and basket cells, neurons that are 
located presynaptically to Purkinje cells (Egertova et al., 1998). 
In conclusion, some compounds that inﬂuence presynaptic strength may originate 
from the postsynapse, however only for NO the function as retrograde messenger is 
proven. Retrograde signaling is most likely important for the regulation of synaptic 
strength, but which pathways are involved is still a matter of debate. 
3 - Activity dependent adjustments of synapses
Synapses are plastic subcellular structures, of which both function and morphology 
can be inﬂuenced by activity. The effects of synaptic activity on synapse function and 
structures are mainly studied in adult neurons during synaptic plasticity. However, 
similar mechanisms have been shown to be important during the development of 
synapses as well. For two reasons it is difﬁcult to study the effects of acvitity on the 
synase in great detail. First, functional and morphological changes can not always 
be separated, as functional changes can be accomplished by changes in synapse 
morphology and vise versa. Second, only the general effect of activity in the network 
on synapses can be studied, since action potential propagation leads to synaptic 
release. The synaptic release will in turn activate postsynaptic receptors. For that 
reason,  affecting either one of these sequential events will also affect the activity of 
the others. 
Several model systems, for instance the neuromuscular junction and the neocortex, 
have been exploited to analyze the activity-dependent changes in synapse function 
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and morphology. Most of them were either chosen for their accessibility or because 
their activity is easily blocked. Activity is often adjusted using pharmacological agents 
or by making lesions in certain brain areas.
3.1 Activity dependent functional changes
Synapses can be strengthened or weakened depending on the pattern of activity 
they experience. If the postsynaptic cell is activated just a few milliseconds after 
activation of the presynaptic cell, the synapse is often made stronger. Long-lasting 
enhancements of synaptic connections are called long-term potentiation (LTP). This 
process is important for the remodeling of neuronal circuits during development 
and for synaptic plasticity. Numerous studies show the relation between activity and 
synaptic strength during synaptic plasticity. However, less information is available 
about this relation during synapse development.
Some studies show an activity-dependent upregulation or change in the identity of 
receptors in the postsynaptic membrane during synapse development. For instance, 
some newly formed glutamatergic synapses only contain NMDA receptors. During 
maturation, AMPA receptors can be recruited to the synapse (Liao et al., 2001). This 
insertion of AMPA receptors in the post-synaptic membrane probably depends on 
protein kinase A (Watson et al., 2006). In addition, the subunit composition of the 
NMDA-receptor changes during synapse development depends on activity (Williams 
et al., 1993). 
In the presynapse, activity can change the neurotransmitter type that is released. 
For instance, in the rat, lateral superior olive neurons change from predominantly 
releasing GABA to predominantly releasing glycine (Nabekura et al., 2004). Moreover, 
NMDA receptor activity modulates the maturation of GABAergic transmission in the 
colliculus by regulating the expression of the GABA synthesizing enzyme glutamate 
decarboxylase. During development potentiation of synapses is quickly reversed, 
which suggests long periods of activation are needed for effective induction of 
stable synapses (Zhou et al., 2003). This indicates that synaptic adjustments can 
be made both in immature and mature synapses. However, the relation between 
synaptic activity and synaptic strength changes with time. For example, activation of 
Xenopus nerve-muscle cultures by brief bursts of action potentials only induced LTP 
in immature synapses with a low synaptic strength and not in mature synapses (Wan 
and Poo, 1999). 
3.2 Activity dependent morphological changes
In addition to functional effects on the synapse, activity can also affect the shape 
of synapses, especially the postsynaptic spine and the number of terminals of the 
presynapse. For instance, during embryonic development each muscle ﬁber is 
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innervated by multiple motor axons and each motor axon innervates multiple muscle 
ﬁbers. However during maturation of the neuromuscular junction the surplus of the 
synapses is eliminated and eventually only one synapse innervates one muscle ﬁber. 
For this process synaptic activity is essential (see for review Lichtman et al., 2000). 
In the central nervous system synaptic activity is important for the regulation of 
innervation as well. Neurons in the visual cortex are organized in columns that respond 
mainly to one of the eyes (ocular dominance columns). These columns are formed 
before birth and only remain intact when synaptic activity is present (see for review 
Cohen-Cory, 2002). A similar rewiring of synapses is seen in the lateral geniculate 
nucleus (LGN). Blocking electrical activity by TTX or synaptic activity using glutamate 
receptor blockers in projections of the LGN prevents the segregation of eye-input 
(Shatz, 1996). In addition, the axons project primarily to the sub-plate of cortical areas, 
which is normally bypassed, rather than projecting to the visual cortex (Catalano and 
Shatz, 1998). Furthermore, synaptic transmission is involved in the formation of the 
barrel map in the primary somatosensory cortex (Lu et al., 2006). Besides rewiring 
of synapses the presynaptic site of the synapse can also change morphology itself. 
Blocking activity by TTX changes the morphological development of retinogeniculate 
axon endings in the retinogeniculate pathway of the cat. The synaptic junctions in 
TTX treated animals were much larger than in the non-treated animals (Kalil et al., 
1986). Moreover, induction of activity using theta burst stimulation in hippocampal 
organotypic cultures increased the number of presynaptic protrusions (Nikonenko, 
2003).
At the postsynaptic site the shape and the motility of the spine is inﬂuenced by 
the amount of synaptic activity as well. Deprivation of sensory input reduces the 
motility of protrusions of the developing barrel cortex (Lendvai et al., 2000). However, 
activation of postsynaptic receptors in hippocampal cell cultures reduces the motility 
of spines (Fischer et al, 2000). From these contradictory data it is uncertain whether 
activity can increase or decrease spine motility. However, the morphology of spines is 
inﬂuenced by synaptic activity. 
Moreover, active axons can inﬂuence their own myelination. Action potential ﬁring 
of the axons can activate astrocytes, which in turn stimulate the oligodendrocytes to 
myelinate the axons (Ishibashi et al., 2006).
In conclusion, activity can change the wiring of the brain and the morphology of 
synapses. How this activity dependent morphology is accomplished at the cellular and 
molecular level is yet unclear. For long-term morphological effects gene expression is 
most likely involved. 
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4 - Activity dependent gene expression 
For consolidation of activity-dependent changes, induction of gene expression is 
needed (see for review Lynch, 2004). For instance, induction of LTP in several brain 
areas has been shown to induce expression of several early-response genes (especially 
transcription factors) and late response genes (like receptors; see for review: Lynch, 
2004). This gene expression is probably important to produce proper connectivity and 
may be necessary to induce the levels of proteins involved in synapse function and 
structure. Moreover, this activity-dependent gene expression seems to be important 
for consolidation of the synapse (Bozon et al., 2002; van Kesteren et al., 2001). In this 
way activity-dependent gene expression may be essential for the formation of 
the adult brain. The transcription of some genes involved in synapse function and 
structure has been shown to be inﬂuenced by activity, especially the expression of 
NGF, BDNF and some neurotransmitter-receptors has been studied. 
4.1 Neurotrophins
The relationship between activity and transcript levels is thoroughly studied for 
the neurotrophins. Their levels were found adjusted in several model systems using 
different ways to alter activity.
Neurotrophin levels in the visual system and the hippocampus increase upon 
stimulation, in vivo and in vitro. For instance, the RNA levels of NGF and BDNF are 
regulated by subtle light input (Castrén et al., 1992). Maintaining rats in darkness 
reduced the BDNF levels in the cortex to about half of the control level, but NGF mRNA 
levels were unaffected (Lindholm et al., 1994; Cellerino and Maffei, 1996). Intraocular 
injection of TTX, which blocks the electrical activity of retinal ganglion cells, also 
reduces BDNF transcript levels (Cellerino and Maffei, 1996). In the hippocampus 
of adult rats NGF and BDNF transcript levels increase a little when rats are kept in a 
stimulus-rich environment (Falkenberg et al., 1992). Electrolytic lesions, that cause 
limbic seizures, increase NGF and BDNF mRNA levels in the hippocampal hilus of 
adult rats (Gall and Isackson, 1989). In cultured hippocampal neurons depolarization 
produced by an increase in potassium concentration or by veratridine (a sodium-
channel inactivation inhibitor) increases NGF and BDNF mRNA levels (Zafra et 
al., 1994). Blocking activity using kainate acid, an agonist of the non-NMDA-type 
glutamate receptors increases the transcript levels for NGF and BDNF in several brain 
areas in vivo (Zafra et al., 1990). In addition, the activity-dependent increase during 
development and subcellular localization of BNDF transcripts have been shown to be 
isoform dependent (Pattabiraman et al., 2005)
These studies show, that BDNF and NGF mRNA levels in the visual cortex and 
hippocampus are regulated by activity. The regulation of NGF and BDNF expression 
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is thought to be mediated through voltage-gated calcium channels, NMDA and non-
NMDA receptors. This leads to an increase in intracellular calcium-concentration, which 
regulates gene expression via the calcium-response factor (CaRF), a transcription 
factor (Tao et al., 2002). Moreover, calmodulin inhibitors block the activity-dependent 
increase in BDNF mRNA, which suggests that the activity-dependent effects are 
mediated by calcium-calmodulin-dependent protein kinases. However, in calcium-
calmodulin-dependent protein kinase II alpha null mutants, activity-dependent 
induction of BDNF mRNA levels is not impaired. This indicates that other calmodulin-
dependent mechanisms may be involved in regulating the BDNF mRNA levels 
(Lindholm et al., 1994). 
Only a few studies have examined the relation between synaptic activity and the 
expression of the neurotrophin receptors. One study shows that activity is not involved 
in the expression of Trk receptors; TrkB receptor levels increase during development, 
but dark-reared animals show the same protein level and pattern of TrkB RNA level 
induction compared to age-matched, normally reared controls (Tropea and Domenici, 
2001). 
4.2 Neurotransmitter-receptors
Not only the expression of neurotrophins is affected by activity. Several studies 
describe an effect of activity on the expression of neurotransmitter-receptors, 
especially for NMDA, acetylcholine (AChR), and GABA receptor subunits. 
For instance, the levels of the NR1 and NR2B transcript (which code for NMDA-
receptor subunits) in the rat superior colliculus change dramatically during the ﬁrst 
postnatal weeks. When AP-5, a blocker of the NMDA receptor, is chronically applied 
to the colliculi, this increase in NR1 transcript levels fails to occur. This suggests that 
activity dependent upregulation of NR1 normally takes place in this system (see for 
review Scheetz and Constantine-Paton, 1994). NR2A mRNA levels in neocortical 
cultures are increased by activity, as blocking the postsynaptic glutamate receptors 
in these cultures resulted in a lower of NR2A transcript levels. In contrast, NR2B RNA 
levels were not inﬂuenced by this treatment. Moreover, as shown pharmacologically, 
the regulation of NR2A mRNA levels was mediated by postsynaptic Ca2+ inﬂux through 
both NMDA receptors and L-type Ca2+ channels (Hoffmann et al., 2000). Activity is also 
important for the synaptic targeting of NMDA, via the activity-dependent increase 
in Drebrin A (Takahashi at al., 2006). In summary, these studies demonstrate that 
activity is a key factor in the regulation of NMDA receptor subunit composition during 
neocortical development. 
During development, the levels of AChR protein and transcript increase in avian 
neurons. This increase coincides with the time when pre- and post-synaptic 
connections are formed. The normal 10- to 15-fold increase in the β2-subunit mRNA 
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levels does not occur in chick optic neurons deprived of innervation. It was shown 
that mRNA levels of the α3, α4 and α5-subunits are reduced to 60 % of the control 
situation in absence of innervation or by input-deprivation (see for review Schwartz et 
al., 1995). Also the levels of extrasynaptic α7-nAChR-subunit are regulated by activity 
(Brumwell et al., 2002). This suggests a role for activity in the regulation of AChR 
subunit-composition and levels. For the induction of nAChR transcript levels calcium/
calmodulin-activated protein kinase II is probably necessary (Macpherson et al., 2002). 
Besides upregulation of excitatory neurotransmitter-receptors, also the GABA 
receptors are upregulated by synaptic activity. Evoked seizures increases GABAB-
mediated responses and GABAB receptor binding in thalamus of the adult rat. Blocking 
the input from one eye, using TTX, reduced the RNA levels of GABAB receptors in the 
dorsal lateral geniculate nucleus (LGN). A similar decrease was shown for the α1, α2, 
α4, α5, β1, γ2 subunits of the GABAA receptor in response to monocular deprivation 
(Muñoz et al., 1998). These results indicate that activity induces both the inhibitory and 
the excitatory system. 
In conclusion, these investigations imply that activity regulates the amount of mRNA 
of receptors in the postsynaptic cell. Inﬂux of calcium is probably the main second 
messenger that regulates the expression of receptors. However, whether all receptors 
are regulated by the same magnitude of inﬂux of calcium is unknown.
4.3 Proteins of the nerve terminal
In the presynapse, activity inﬂuences the expression of neuropeptides, and 
neurotransmitter producing enzymes. This effect can be caused by three processes, 
by retrograde signaling from the postsynaptic cell, by depolarization of the cell 
itself or via a feedback in the network. For example, making lesions in the cortex 
decreases the RNA levels of VGF, a secretory-peptide precursor, in the ipsilateral cortex 
(Snyder, et al., 1998) and increases the RNA levels of glutamate decarboxylase (GAD), 
cholecystokinin, neuropeptide Y, and somatostatin in the homolateral cortex (Jacobs, 
et al., 1994). Neuronal stimulation with the depolarizing agent veratridine increases 
the RNA and protein levels of somatostatin in cortical cultures (Tolon, et al., 1996). 
Furthermore, blocking activity in the dorsal lateral geniculate nucleus by intraocular 
tetrodotoxin injection rapidly decreases the transcript levels of VGF (Snyder, et al., 
1998). Blocking GABA-ergic inhibition in hippocampal slice cell cultures of 7-day old 
rats increases the number of Somatostatin and Neuropeptide Y immunoreactive 
cells, whereas blocking the glutamatergic excitatory activity decreases the amount 
of immunoreactive cells (Marty and Onteniente, 1997). When activity is blocked in the 
primary visual cortex of a monkey by monocular deprivation the RNA levels of GABA 
and glutamic acid decarboxylase (GAD) are profoundly decreased. This decrease in 
immunoreactivity is restricted to the ocular dominance columns that had previously 
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received input from the removed eye. Similar effects were observed after monocular 
injection of TTX (Benson et al., 1994). When the striatum is denervated the mRNA 
levels of preproenkephalin are increased by at least 55 % (Campbell and Bjorklund, 
1994). During development, regulation of neuropeptide levels by activity has also 
been shown (see chapter 4).
In addition to genes coding for secreted compounds, also genes coding for proteins 
that are involved in vesicle release are regulated by activity. Blocking synapses of the 
chick ciliary ganglion by preventing reuptake of choline, increased the mRNA levels of 
the synaptic vesicle protein synaptophysin II, but not of synaptotagmin I (Plunkett et 
al., 1998). Increasing the calcium inﬂux by expression of the P/Q-type calcium channel 
or adding an ionophore to HEK293 cells increases the transcript levels of syntaxin-1A 
(Sutton et al., 1999). When activity is induced by electrical stimulation (0.6 Hz) in the 
hippocampal dentate gyrus the mRNA levels of the synaptic vesicle proteins, syntaxin 
1B and synapsin I, are upregulated (Hicks et al., 1997).
Thus, activity modulates the mRNA levels of synaptic vesicle proteins, neuropeptides, 
and neurotransmitter producing enzymes. This upregulation of presynaptic 
compounds may increase synaptic transmission during development, and have a role 
in induction of LTP. 
4.4 Other proteins
The expression of several other proteins has been shown to be regulated by activity, 
including cytoskeleton-associated proteins, and cell adhesion molecules, which will be 
described in the next section. Inﬂuencing the expression of these structural proteins 
may be responsible for the morphological effects of synaptic activity. 
During development the mRNA level of the cell adhesion molecule N-cadherin in 
myotubules is decreased. This normal decrease in N-cadherin can be prevented by 
blocking activity with d-tubocurare in cell culture (see Itoh et al., 1997). Several other 
cell adhesion molecules are regulated by activity, however their induction is cell type 
and frequency dependent. For instance, the transcript levels of L1 are downregulated 
by speciﬁc frequencies of electrical impulses in mouse DRG neurons in vitro. 
Stimulation of dorsal root ganglia with 0.1 Hz, but not with 0.3 or 1 Hz gave a 13-fold 
downregulation of the L1 mRNA. The levels of NCAM mRNA were not signiﬁcantly 
altered by any of the frequencies, whereas all frequencies of stimulation decreased 
N-cadherin mRNA levels (Itoh et al., 1997). Thus, different cell-adhesion molecules are 
targets for activity-dependent regulation, but their regulation depends on cell type 
and stimulus. Activity may regulate target selection in this way. 
An unanswered question remains: How does the cell make a distinction between 
different stimulation frequencies in its gene expression? It is possible that a critical 
calcium concentration is needed for the activation of gene expression. This critical 
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calcium concentration may be different for various proteins, for instance by activating 
distinct calcium-dependent pathways that have different calcium sensitivities (see for 
review Bito, 1998).
Several other structural proteins are upregulated by activity. For instance, the mRNA 
levels of neuritin, a GPI-anchored protein, which is expressed on the surface of neurons 
and promotes neurite outgrowth, are induced by activation of kainate glutamate-
receptors. When hippocampal and cortical cultures were treated with NMDA, AMPA or 
depolarizing concentrations of KCl the mRNA of neuritin was increased 5-fold. In the 
visual cortex physiological light-induced neuronal activity increases neuritin mRNA 
levels (Naeve et al., 1997). 
The transcript levels of the cytoskeleton-associated protein Arc are increased in the 
hippocampus of high frequency stimulated rats. The same raise in Arc mRNA levels 
was found in cultured PC12 cells (Lyford et al., 1995). AMPA receptors have recently 
been shown to be involved in the regulation of Arc transcription (Rao et al., 2006). 
In addition, Arc can be induced by cAMP and calcium (Waltereit et al., 2001), this 
induction requires the activity of protein kinase A and mitogen-activated protein 
kinase (Waltereit et al., 2001). Because lowering the expression of structural proteins 
will inﬂuence synaptic strength, morphological changes induced by synaptic activity 
and induction of LTP may be intermingled. 
Expression of alivin, a protein that promotes survival of neurons, is regulated by KCl 
and/or NMDA concentrations in cultured cerebellar granule neurons. Alivin mRNA 
levels are regulated by the Ca2+ inﬂux through voltage-dependent L-type Ca2+ 
channels. Levels of alivin mRNA in cultured cortical neurons were lower when their 
electrical activity was blocked by tetrodotoxin (Ono et al., 2003). How alivin regulates 
survival of neurons cannot be deduced from these data, but it shows that the survival 
of neurons depends on synaptic activity.
A few studies examined activity-dependent changes in gene expression of large 
groups of genes. For instance, using microarray hybridization a speciﬁc increase in the 
RNA levels of proteins involved in intracellular structure and vesicular trafﬁcking by 
activation of NMDA-receptors was shown (Hong et al., 2004). Changes in RNA levels 
induced by seizures in area CA1 were studied using cDNA microarrays containing 9000 
genes. Fourteen transcripts were more then 1.8 times regulated. One of them was 
coding for the orphan nuclear receptor, Nur77, which had 12 times higher trancript 
levels in the dentate gyrus after seizures as was shown by in situ hybridization (French 
et al., 2001). Kainate, an agonist of non-NMDA-glutamate receptors, increases the 
mRNA levels of 52 genes in the hippocampal dentate gyrus. Several of these genes 
encoded transcription factors, or vesicle- and synapse related proteins (Nedivi et al., 
1993). In Drosophila seizure mutants, the increased activity leads to a changed mRNA 
level of 250 trancripts, including transcripts coding for cell adhesion molecules, 
membrane excitability and cellular signaling proteins (Guan et al., 2005)
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Summarizing, several molecules have been identiﬁed that are regulated by activity, 
including: cytoskeleton-associated proteins, cell adhesion molecules, neuropeptides, 
neurotrophins, transcription factors, and receptors. These effects may result in 
physiology and morphology changes of the synapse. These changes may be 
responsible for the activity-dependent modulation of synaptic efﬁcacy in neural circuit 
development and experience-dependent plasticity. The structural and physiological 
effects are most likely not separate effects, since both effects may change the strength 
of a synapse. 
Several second messenger pathways are involved in the activity-dependent regulation 
of gene expression. Especially, the inﬂux of calcium-ions through NMDA, non-NMDA 
and voltage gated calcium channels is thought to have a role in this regulation. 
In addition, the CAMKII-pathway and the MAPK-pathway are involved in activity-
dependent gene expression (Brosenitsch et al., 2001; Wu et al., 2001).
5 - Short-term versus long-term effects of activity
Some of the effects of activity on the synaptic strength are mediated within minutes 
and are probably a consequence of posttranslational modiﬁcations, because gene 
expression takes hours to have an effect. For instance, the activity-induced cell surface 
expression of PSA (a regulator of cell surface interaction that is bound to NCAM) and 
NCAM is restored within 1 hour when the pre-existing PSA is enzymatically removed. 
This restoration is too quick to be explained by induction of gene expression (Kiss et 
al., 1994). 
In addition, BDNF application to microcultures of postnatal rat hippocampal neurons, 
enhanced the synaptic transmission by 143 %. This increase in synaptic transmission 
is an acute effect, because BDNF was applied during the recordings (Leßmann and 
Heumann, 1998). The enhancement of the synaptic transmission is accompanied by 
a 3-fold increase in the NMDA receptor open probability, which was abolished by the 
Trk-receptor blocker k252A indicating that Trk-receptors are involved in this process 
(Levine et al., 1998). 
NGF has been shown to modulate calcium current in PC12 cells within minutes, which 
indicates that NGF may have local effects (Jia et al., 1999). Local effects of NGF may be 
exerted by NO, because NGF can reduce the NOS activity to 61% of the baseline levels 
(Lam, et al., 1998).
In conclusion, some of the structural and physiological changes of synapses during 
development are rapid and transient, these effects will be induced in other ways than 
gene expression. Possibly, posttranslational modiﬁcations are involved in these short-
term effects.
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6 - Retrograde regulation of presynaptic gene expression
The activity-dependent modulation of neurons could either require the activation 
of the presynaptic neurons themselves, or activation of their target cells (Marty et al., 
1997). 
Especially neurotrophins are thought to act as retrograde messengers and they have 
been shown to regulate the expression of several presynaptic genes. Neurotrophins 
can inﬂuence the neurotransmitter phenotype of neurons in the central nervous 
system by modulating the expression of neuropeptides and neurotransmitter 
synthesizing enzymes (see Cellerino and Maffei, 1996). In particular, BDNF can regulate 
the expression of several neuropeptides in distinct neurons. For example, BDNF 
regulates the neuropeptide expression in cortical and hippocampal interneurons 
in vivo. At postnatal day 15, BDNF deﬁcient mice show reduced RNA levels of NPY in 
the neocortex and hippocampal formation, while the number of cells remain normal 
(see for review Marty et al., 1997). When cultures of immature hippocampal neurons 
are stimulated by BDNF, the NPY transcript levels in the GABA-containing neurons are 
increased (Marty et al., 1997). In addition, an increase in GAD and proenkephalin mRNA 
levels and a decrease in preprotachykinin caused by denervation of the rat striatum is 
counteracted by BDNF and NT-4/5 (Sauer et al., 1995). 
Besides BDNF, NGF and NT-3 are both also able to change gene expression. For 
instance, NGF can signal retrogradely to induce RNA levels of both tyrosine 
hydroxylase and p75 neurotrophin receptor (Toma et al., 1997). In addition, in 
hippocampal neurons NT-3 stimulates the increase in neuropeptides transcripts in 
GABA-containing neurons. All these effects can be blocked by k252A, a tyrosine-kinase 
inhibitor, with a preference for Trks (see for review Thoenen, 1995). 
Not only the expression of neuropeptides, neurotransmitter synthesizing enzymes, 
and receptors are regulated by neurotrophins. Also the mRNA levels of other 
proteins, which are involved in synapse morphology and transmission, are affected 
by neurotrophins, like neuritin and calbindin. Neuritin message can be induced by 
an intraventricular injection of BDNF into neonatal rat pups in the hippocampus and 
cortex. Inhibition of TrkB with k252A blocked the induction of neuritin mRNA by BDNF 
(Naeve et al., 1997). Calbindin (which binds Ca2+) protein levels are induced by NT-3 in 
hippocampal neurons in vitro (see for review Marty et al., 1997). 
Another way of investigating the relation between neurotrophins and gene 
expression is to compare the transcript levels in neurotrophin receptor (Trk) mutant 
mice with normal mice. In TrkB null mutant mice the synaptic vesicle proteins levels 
were examined by immunocytochemistry. Especially the synaptic proteins: Synapsin 
I (38-71 %), Synaptophysin (38-71 %), Synaptotagmin I (31-56 %), Syntaxin I (60-68 
%), SNAP-25 (40-56 %), and Rab3a (53-63 %) were reduced in the TrkB null mutant 
(Martínez et al., 1998). 
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These studies show that neurotrophin-signaling is responsible for some of the 
activity-dependent effects on the expression of presynapse proteins. However, 
because the postsynaptic origin of neurotrophins has not been proven, the effect may 
also be a feedback mechanism of the presynapse. The effects of neurotrophins on the 
presynaptic cell may be mediated by the tyrosine kinase receptors (Trk) or the p75-
receptor. Activated receptors are retrogradely transported from the nerve terminal to 
the cell body (see Lam, et al., 1998), where they may change expression. 
7 - Aim of this thesis
The aim of this thesis is to analyze the relation between the usage and strength of 
synapses and the expression of synaptic genes. We hypothesize that especially 
genes involved in synapse function and structure are regulated by activity. This gene 
expression may be important for the maturation of synapses, because an increase in 
synapse structure and function genes may increase the synaptic strength.
To study the role of synaptic activity in development we used the munc18-1 null 
mutant. This mutant lacks both evoked and spontaneous secretion and the secretion 
of large dense core vesicles that contain neuromodulatory substances, is severely 
impaired. To our knowledge, the munc18-1 mutant is the ﬁrst model defective in all 
these aspects of presynaptic signaling. Munc18-1 null mutant embryos are completely 
paralyzed. The mutants are unable to breathe and therefore die shortly after birth. 
As a consequence, for all measurements embryonic day 18 animals (E18) were used, 
just before birth (Verhage et al., 2000). Electrophysiological recordings of GABA-
ergic neocortical and cholinergic neuromuscular junction synapses at E18 revealed 
an absolute lack of neurotransmitter release. However, the cells responded normally 
to exogenously applied neurotransmitter, indicating that post-synaptic receptors 
were functional. Besides neurotransmitter release, measurements in chromafﬁn 
cells and the pituitary showed also a severely reduced release from large dense core 
vesicles (Voets et al., 2001; Korteweg N. et al., 2005). Electron microscopic analysis of 
the marginal zone of the cortex of E18 munc18-1 null indicated that the formation of 
morphologically deﬁned synapses does not require synaptic activity. Initially all brain 
structures developed normally but degenerated in order of appearance (i.e., brain 
structures that developed ﬁrst also showed degeneration ﬁrst). However, the cortex 
was still intact and did not show any signs of degeneration just before birth. Therefore, 
in this study we analyzed the neocortex of this mutant. 
In several other studies lesions or pharmacological agents were used to study the 
effects of activity on the brain. We now use a novel approach by studying a mutant 
that lacks activity. Because the environment of neurons in the munc18-1 null mutant 
is not affected except for synaptic activity, this mutant is a powerful model to study 
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effects of synaptic activity on synapse development. In addition, many model systems 
do not block spontaneous secretion, which is the main form of synaptic activity during 
synapse development. 
Therefore, the analysis of these mice allowed us to answer two important questions 
concerning the role of synaptic activity in brain development in vivo. First, how 
synaptic activity inﬂuences initial brain development and synapse formation. And 
second, which genes are regulated by synaptic activity during synapse development. 
8 - Outline of this thesis
The studies described in this thesis aim to address the role of synaptic activity in 
synapse formation and developmental gene expression. The munc18-1 mouse model, 
which lacks synaptic release, is mainly used to answer these questions.
Chapter 2 aims to unravel the role of activity in synapse development in vivo. In this 
chapter we studied the morphology and number of synapses and localization of 
synaptic proteins in the munc18-1 null mutant brain. The ultra-structure of mutant 
synapses was compared to control animals. 
Synaptic usage may be coupled to the expression of synaptic proteins. To examine 
this, we analyzed transcript levels in the munc18-1 null mutant and compared it to wild 
type littermates. In chapter 3 we exploited microarray technology and quantitative 
PCR to study RNA levels in general. We hypothesized a feedback mechanism of 
synaptic activity on the expression of genes involved in this process. For instance, an 
increase in synaptic activity may induce the expression of synaptic genes. Chapter 
4 studies the expression of genes that are important for synaptic signaling, like 
neuropeptides, neurotransmitter producing enzymes and their receptors speciﬁcally. 
Munc18-1 is binding to several molecules in the presynaptic terminal. Protein levels 
of these binding partners were shown earlier to be reduced in mutant whole brains. 
This reduction may be caused by a reduction of gene expression. Chapter 5 addresses 
the question whether all differential gene expression in the munc18-1 null mutant 
depends on activity, or whether Munc18-1 itself is able to regulate gene expression 
directly. This chapter describes the relation between the RNA levels of the SNARE 
complex member, Syntaxin1 and the proteins levels of Munc18-1.
Finally, chapter 6 summarizes the main ﬁndings, attempts to generate a model for the 
role of synaptic activity in the development of synapses and suggests directions for 
future experiments.
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QUANTIFICATION OF SYNAPSE FORMATION 
AND -MAINTENANCE IN VIVO 
IN THE ABSENCE OF SYNAPTIC RELEASE

ABSTRACT
Outgrowing axons in the developing nervous system secrete neurotransmitters 
and neuromodulatory substances, which is considered to stimulate synaptogenesis. 
However, some synapses develop independent of presynaptic secretion. To investigate 
the role of secretion in synapse formation and –maintenance in vivo, we quantiﬁed 
synapses and their morphology in the neocortical marginal zone of munc18-1 
deﬁcient mice which lack both evoked and spontaneous secretion (Verhage et al., 
2000). Histochemical analyses at embryonic day 18 (E18) showed that the overall 
organization of the neocortex and the number of cells were similar in mutants and 
controls. Western blot analysis revealed equal concentrations of pre- and post-synaptic 
marker proteins in mutants and controls and immunocytochemical analyses indicated 
that these markers were targeted to the neuropil of the synaptic layer in the mutant 
neocortex. Electron microscopy revealed that at E16 immature synapses had formed 
both in mutants and controls. These synapses had a similar synapse diameter, active 
zone length and contained similar amounts of synaptic vesicles, which were immuno-
positive for two synaptic vesicle markers. However, these synapses were 3 times less 
abundant in the mutant. Two days later, E18, synapses in the controls had more total 
and docked vesicles, but not in the mutant. Furthermore, synapses were now 5 times 
less abundant in the mutant. In both mutant and controls, synapse-like structures 
were observed with irregular shaped vesicles on both sides of the synaptic cleft. These 
’multivesicular structures’, were immuno-positive for synaptic vesicle markers and 
were 4 times more abundant in the mutant. 
We conclude that in the absence of presynaptic secretion immature synapses with a 
normal morphology form, but fewer in number. These secretion-deﬁcient synapses 
may fail to mature and instead give rise to multivesicular structures. These two 
observations suggest that secretion of neurotransmitters and neuromodulatory 
substances is required for synapse maintenance, not for synaptogenesis. Multivesicular 
structures may develop out of unstable synapses.
INTRODUCTION
In the developing nervous system, outgrowing axons secrete neurotransmitters, such 
as acetylcholine and GABA, from their growth cones in a quantal manner (Xie and 
Poo 1986; Sun and Poo, 1987; Gao and Van Den Pol, 2000). Blocking or promoting 
this quantal secretion was reported to inhibit axon outgrowth and promote 
synaptogenesis, respectively (Han et al., 1991; Osen-Sand et al., 1993; Kabayama et 
al., 1999). On the other hand, a variety of studies in vitro and in vivo suggested that 
presynaptic neurotransmitter release is not necessary for the formation of normal 
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synaptic networks. For instance, blocking receptors or the propagation of action 
potentials does not block the formation of normal synaptic networks in cultured 
neurons (see for instance Van Huizen et al., 1985, Verderio et al., 1994, but note 
Nakagami et al., 1997), and eliminating impulse activity in amphibians does not 
disturb retinotectal projection development (Harris, 1980). Also, neuromuscular 
junctions form correctly in the absence of postsynaptic neurotransmitter receptors 
in ﬁsh (Westerﬁeld et al., 1990) and develop without synaptic transmission in the ﬂy 
(Featherstone et al., 2002, Saitoe et al., 2001). In C. elegans synaptic connectivity is 
established, and receptors cluster normally in the absence of one of its most abundant 
neurotransmitters; GABA (Jin et al., 1999; Gally and Bessereau, 2003), Finally, we 
recently showed that the mouse brain is assembled correctly, including the formation 
of synapses, in the absence of quantal secretion (Verhage et al., 2000; see also 
Varoqueaux, 2002).
Nevertheless, synaptic secretion plays a role in establishing mature neuronal networks. 
When transmission is blocked, in vitro networks mature slower (Van Huizen et al., 
1985), massive cell death has been observed in vivo (Fawcett et al., 1984; Ikonomidou 
et al., 1999, Verhage et al., 2000) and in the absence of acetylcholine the mouse 
neuromuscular junction develops aberrant nerve branching and receptor clustering 
(Brandon et al., 2003). Furthermore, synaptic activity is important for reshaping 
of multiple innervation in the neuromuscular junction and the visual system (see 
Lichtman and Colman, 2000: Chapman et al., 1986; Goodman and Shatz, 1993). Hence, 
while the initial steps in synapse formation may not always require synaptic activity, 
the subsequent phases of synapse maturation probably do.
In addition to (evoked) synaptic transmission, nerve terminals continuously secrete 
transmitters by spontaneous fusion of vesicles with a low incidence. The signiﬁcance 
of this spontaneous release for synapse development remains elusive. In Drosophila 
neuromuscular junction spontaneous release was suggested to be necessary for 
receptor clustering (Saitoe et al. 2001). However, another study using similar mutant 
ﬂies did observe clustering in the absence of spontaneous release (Featherstone et al., 
2002). Thus, the role of spontaneous activity remains unclear.
In addition to neurotransmitters, other presynaptically delivered factors, like 
neuropeptides, neurotrophins and other neuromodulatory substances, are known to 
be important for synapse formation. In C. elegans the presence of the presynaptic cell, 
but not its main transmitter, GABA, is essential for correct receptor clustering (Gally 
and Bessereau, 2003) and presynaptic genes like agrin and NARP are essential for 
synaptogenesis (O’Brien, 2002; see for review Bezakova and Ruegg, 2003).
The munc18-1 null mutant mouse is a vertebrate model in which both evoked and 
spontaneous secretion of synaptic vesicles is completely blocked (Verhage et al, 2000), 
and also the secretion of large dense core vesicles that contain neuromodulatory 
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substances is severely impaired (Voets et al., 2001; Korteweg et al., 2005). To our 
knowledge, the munc18-1 mutant is the ﬁrst model defective in all these aspects of 
presynaptic signaling.
To study the role of presynaptic signaling on synapse formation and -maintenance in 
the developing brain in vivo, the munc18-1 mutant was analyzed in two ways. First, we 
analyzed the protein levels of pre- and post-synaptic marker proteins by Western blot 
and their location by immuno-histochemistry. Second, we quantiﬁed the number of 
synapses and analyzed their morphology using electron microscopy at different time 
points in development.
EXPERIMENTAL PROCEDURES
Animals
Generation of germ line-transmitting munc18-1-deﬁcient mice and PCR genotyping 
was described previously (Verhage et al., 2000). Exons 2 to 5 of the munc18-1 gene 
were replaced with a neomycin-resistance gene using homologous recombination. The 
mouse colony was maintained by breeding of heterozygous animals. Heterozygous 
males were mated with synchronized heterozygous females for one night. If the 
following morning a vaginal plug was detected, this was considered embryonic day 
(E) zero. Embryos were harvested from mothers rapidly sacriﬁced after timed matings 
at E16 and E18. Embryo heads were used for electron microscopy and a posterior paw 
was sampled for genotype analysis. Experimental procedures were carried out with 
local regulatory approval for animal experimentation, according to the Dutch law for 
animal welfare. All efforts were made to minimize the number of animals used and 
their suffering.
Immuno blotting
Mouse brains were obtained at E18 by caesarean section from heterozygous matings. 
Brains were solubilized with a tissue homogenizer and were then sonicated on ice 
(3 x 10 sec) in 10 mM Hepes with proteinase inhibitors. Then NaCl and Triton-X100 
were added (ﬁnal concentration: 150 mM and 1%, respectively) and the samples 
were rotated at 4°C for 1 h. Homogenates were centrifuged for 5 min at 16,100g. 
Solubilized proteins in the supernatant were quantiﬁed using a BCA protein assay 
(Pierce, Rockford, Illinois, USA) and equal amounts (approximately 50 µg) were loaded 
on a gradient SDS-PAGE (6 to 15%). Three mutant and three control homogenates 
were loaded on one gel. Proteins were transferred to a PVDF membrane (Biorad, 
Hercules, California, USA). Blots were preblocked using 5% blocking agent (Amersham, 
Buckinghamshire, UK) and immunostained with various antisera. Data were corrected 
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using Tau (Microtubulin associated protein) as internal standard, which is an abundant 
protein present in most neurons and not in glial cells and is expressed from early 
development onwards.
The following monoclonal antibodies were used: munc18-1 (BD Biosciences, Palo Alto, 
California, USA), syntaxin1 (Sigma, Saint Louis, Missouri, USA, HPC-1) SynaptobrevinII 
(Synaptic systems, Göttingen, Germany, Cl69.1), SNAP25 (BD Biosciences, Palo Alto, 
California, USA, SMI81), Tau (Chemicon, Hofheim, Germany, MAB361). The following 
polyclonals antisera were used: PSD95 (L667), Synapsin I (P610), GDI (D633), 
Synaptotagmin (W855), Rabphilin3A (I734), Doc2B (13.2). 
Immunohistochemistry
E18 mouse were decapitated and the heads were rapidly frozen in liquid nitrogen 
vapor. Coronal sections of 14 µm were cut with a cryostat (Leica, Jung CM3000) and 
stored at –20˚ C. Sections were thawed for 30-45 seconds at room temperature, 
immersed in a solution of 0.1 % paraformaldehyde in 0.1 M PBS (pH 7.4) and 
immediately irradiated in a microwave oven (30 seconds at 700 W). Then, they were 
then transferred into 0.01 M PBS (pH 7.4) and processed for immunoﬂuorescence 
staining.
Brieﬂy, sections were blocked with 10 % NGS/0.05 % Triton X-100 in PBS for 30 min, 
and incubated overnight at room temperature with primary antibodies diluted in 
3% NGS/0.05% Triton X-100 in PBS. We used a mouse monoclonal antibody against 
synaptobrevin/VAMP-2 (Synaptic System, Göttingen, Germany, clone 69.1; 1:1000) and 
a rabbit polyclonal antibody against AMPA (GluR2/3; Chemicon, Temecula, California, 
USA; 1:100). Secondary antibodies were goat-anti-mouse IgG-Alexa Fluor 488 
(Molecular Probes, Eugene, Oregon, USA) and goat anti–rabbit-Cy3 conjugate (Jackson 
ImmunoResearch). 
Fluorescent images were captured with a Zeiss (Heidelberg, Germany) AxioCam Hrc 
camera (using AxioVision 3.0 software) mounted on Nikon (Tokyo, Japan) eclipse E800 
microscope with a Nikon Plan Fluor lenses. Images were prepared for printing using 
Adobe Photoshop. Controls omitting the ﬁrst antibodies were all negative.
Electron microscopy preparation
E16 and E18 mouse embryos were decapitated. In order to give fast access to the 
brain for the ﬁxative a few drops of Karnovsky’s ﬁxative (Karnovsky, 1965) (4% 
paraformaldehyde, 5% glutaraldehyde, 5 mM CaCl2, 10 mM MgCl2, 0.1 M Na-cacodylate 
pH 7.4) or tri-aldehyde ﬁxative (2.5% DMSO, 3% glutaraldehyde, 2% paraformaldehyde, 
1% acrolein in 0.1 M Na-cacodylate pH 7.4) were poured onto the heads, and the skin 
and skull were peeled off. Brains were severed sagittally between the two hemispheres. 
The heads were then put in tri-aldehyde ﬁxative for 1h at room temperature, and then 
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overnight at 4o C. The next day, further dissection was carried out, as indicated in Fig. 
1. Afterwards, we followed a protocol described elsewhere (Gorgels, 1991). Brieﬂy, the 
area of interest was post-ﬁxed for 2h at room temperature in 2% OsO4 and 4% KRuCN6 
in Na-cacodylate buffer (0.4 M, pH 7.4). After dehydration, the area was embedded 
in EPON. For a consistent sampling of the same brain area, semi-thin sections were 
examined after toluidine blue staining. Ultrathin sections were mounted on non-
coated grids and contrasted with uranyl acetate/lead citrate. Four animals per group at 
each sample point were used and at least three non-consecutive sections per animal 
were examined, representing more than 5000 µm2 in total. 
Immunogold labeling
E18 mouse embryos were decapitated. We followed the same procedure as described 
above except that the ﬁxative consisted of 2% paraformaldehyde/0.2% glutaraldehyde 
in 0.1 M phosphate buffer (Slot et al., 1991). Dissected brains were incubated in the 
ﬁxative for 2h at room temperature and then overnight at 4o C. The area of interest 
was dissected into small blocks and washed in PBS with 0.02 M glycine. Blocks were 
embedded in 12% gelatin in PBS and solidiﬁed on ice. After inﬁltration with 2.3 M 
sucrose at 4˚ C, blocks were mounted on aluminum pins and frozen in liquid nitrogen. 
Ultrathin sections were picked up in a 1:1 mixture of 2% methylcellulose and 2.3 M 
sucrose for improved ultra-structural preservation (Liou et al., 1996).  Immuno-labeling 
Fig. 1: Scheme showing the dissection procedure used for a consistent sampling of the neocortical 
marginal zone (layer I) (A) Sagittal view of the brain. Double arrows indicate the planes of sectioning 
resulting in the thick slice visible in B. (B) Coronal view of the brain slice obtained. Double arrows indicate 
the area where quantiﬁcation in ultrathin sections occurred. Dark squares indicate the small areas taken for 
immunogold labeling (see Experimental Procedures).
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according to the protein A gold method was carried out as previously described (Slot 
et al., 1991)
Mouse monoclonal antibodies against VAMP/synaptobrevin (Cl69.1; (Edelmann et al., 
1995) and Rab3 (Cl42.1, Matteoli et al., 1991) were obtained from Synaptic Systems 
(Göttingen, Germany). As a bridging antibody for protein A conjugated 10 nm gold we 
used rabbit-anti-mouse IgG (DAKO, Denmark).
Data collection and statistical analysis 
The synaptic parameters chosen (see Results) were quantiﬁed directly from the 
microscope’s calibrated scale. The total areas scanned during these quantiﬁcations 
were also measured directly from the electron microscope. Low magniﬁcation 
micrographs (x1,200) of the cortical marginal zone were taken and used for the 
extracellular space and cell number measurements. A cell soma was counted only 
when the cell nucleus was visible. Extracellular space measurement was done 
following the stereology method (Steer, 1981). Raw data were log-transformed and 
tested using the 2-sided Student’s t-test (α=5 %). Values are given as mean ± standard 
error of the mean (SEM).
RESULTS
The synaptic layer of the mutant neocortex has a normal overall 
morphology
To investigate synaptogenesis, we choose the marginal zone of the neocortex. Some 
brain areas in the munc18-1 mutant mouse showed signs of degeneration, especially 
in the rhombencephalon. However, the entire cortex of the mutant and control were 
alike until birth, although the total size of the brain and the cortex were slightly lower 
in the mutant, but there was no conspicuous cell degeneration, and the number of 
cells and the layering were similar in mutant and wild type (Verhage et al., 2000). 
Furthermore, the synapses in the marginal zone originate largely from cortical plate 
neurons, with little extra-cortical input (some ﬁbers from midbrain catecholamine 
systems and thalamic input are present at this developmental stage; see Marin-Padilla, 
1998; Miyashita-Lin et al., 1999). Thus, marginal zone synapses are largely formed by 
two cortical neurons and the quantiﬁcation of synapse formation will not be disturbed 
by the fact that some lower brain areas start to degenerate in the mutant. 
First, we quantiﬁed the protein levels and their distribution in the whole neocortex, to 
test whether pre- and post-synaptic proteins are present and at the correct location 
to form functional synapses. We compared, with Western blotting, the protein levels 
of pre- and post-synaptic markers in control and mutant littermates (Fig. 2). As an 
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internal standard we used the ubiquitous protein Tau. The protein levels of the 
synaptic vesicle protein Synaptotagmin1 were unchanged, as were the levels of the 
post-synaptic anchoring protein, PSD-95. The levels of valosin-containing protein, a 
protein involved in membrane trafﬁcking, were similar in mutant and wild type. Also, 
the expression of the SNARE-complex members that do not interact with Munc18-
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Fig. 2: Quantiﬁcation of protein levels in the cortex of the munc18-1 mutant and wild type. A: Immunoblots 
were loaded with 50µg total protein from littermates of wild type and mutant mice. B: Quantiﬁcation of the 
western data. Indicated is the average of 3 animals standardized to the staining of tau on the same blot (black 
bars: wild type animals and grey bars: mutant animals).
1, namely SNAP25 and VAMP, were unaffected. The presynaptic Munc18-1 binding 
partners Syntaxin1 and DOC2 were present but at lower levels in the mutant. The 
protein levels of the two isoforms of Syntaxin1, Syntaxin1A and Syntaxin1B, which are 
expressed in neurons, were both 70% lower in the mutant, and the Munc18-1 binding 
partners DOC2A and DOC2B were 40% lower. We previously showed that the staining 
patterns for B50/GAP43, Synapsin1 and VAMP/Synaptobrevin are similar in whole 
brain at a low magniﬁcation (Verhage et al., 2000). Here, we studied the localization 
of a post-synaptic AMPA receptor (GluR2/3) and a presynaptic protein (VAMP2) in 
wild type and mutant slices of the cortex at a higher magniﬁcation; the staining 
patterns of VAMP2 and AMPA were equal in wild type and mutant (Fig. 3, color ﬁgure 
see pag. 92). Punctate immuno-ﬂuorescence was observed in all cortical layers and in 
particular in the marginal zone. Bright clusters of postsynaptic staining were present 
(Fig. 3B, E, color ﬁgure see pag. 92).  Because the marginal zone contains very few cell 
bodies and because the staining pattern was punctuate, the data suggest that the 
antigens were present in the neuropil and, therefore, the antigens were targeted from 
their site of synthesis (soma) to their correct location (axons/dendrites). However, we 
cannot exclude that at the synaptic level, the distribution of synaptic markers may be 
different. 
We used light and electron microscopy to study to the cortex structure in the mutant. 
No difference in the layering of the cortex in the mutant compared to wild type was 
observed using light microscopy, indicating that the migration of cells is normal in 
the mutant (Fig. 4A,B). In line with this observation, we observed no differences in the 
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Fig. 3: Localization of pre- and postsynaptic proteins in neurons. Immunostaining for AMPA-receptor 
GluR2/3 shows receptors are targeted similar in wild type (B) and mutant (E). Staining for VAMP2 indicates 
that the localization of presynaptic proteins is unaffected in mutant (D) compared to wild type(A). The overlay 
of these two stainings (C,F) shows adjacent staining for the pre- and postsynaptic marker. The scheme to 
the side (Uylings et al., 1990) showed what part of the cortex is represented in the pictures. Abbreviations: V, 
ventricular zone; SV, subventricular zone; IZ, intermediate zone; SP, subplate; CP, cortical plate; MZ, marginal 
zone.
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Fig. 4: Overview of neocortex E18 and quantiﬁcation of general tissue parameters. (A) control and (B) 
munc18-1 null-mutant neocortex. Layering and number of cells is similar in mutant and wild type (see also 
Verhage et al. 2000). (C) control (D) munc18-1 null-mutant marginal zone (layer I). Cortical plate neurons are to 
the left and pial to the right. Controls (C) and mutants (D) had few somata compared to axons (arrow heads) 
and dendrites (arrow). Immature neurons (N) were found scattered in the marginal zone. (E) The percentages 
of extracellular space (asterisks in A/B) were similar in both groups. (F) The numbers of cells per 1000µm2 of 
neocortical marginal zone were also similar. Bar: 6µm. (G) The number of LDCVs per 1000µm2.
ultra-structure of the mutant marginal zone at a low magniﬁcation in the electron 
microscope. The marginal zone is composed of few somata and many axons and 
dendrites (Fig. 4C,D). At E18, the marginal zone contained a similar number of cells in 
both the mutant and control brains (Cajal-Retzius cells and migrating or uncommitted 
neurons): control 3.5 ± 0.6 per 1000 µm2; mutant 3.8 ± 0.3 per 1000 µm2 (Fig. 4E; Table 
1). The percentage of extracellular space in the marginal zone was also similar (control 
19.6 ± 5.3 %; mutant 20.2 ± 3.5 %; n=4; Fig. 4F; Table 1). Thus, the overall organization of 
the mutant marginal zone was similar to control.
It was previously shown that in the absence of Munc18-1 protein and during 
overexpression of syntaxin-1A, the Golgi-complex and rough endoplasmic reticulum 
underwent deformation, and that expression of munc18-1 prevented such 
deformation. This suggests that the Syntaxin-1A protein in the absence of munc18-1 
may produce cellular abnormalities (Rowe et al., 1999). However, these abnormalities 
observed by Rowe et al. were not observed in the cortical plate cells of the munc18-1 
mutant (Fig. 4).
E16 E18
control mutant control mutant
tis
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ch
ar
ac
te
ris
tic
s
cells N.D. N.D. 3.5 ± 0.6 3.8 ± 0.3 per 1000 µm2
extracellular 
space
N.D. N.D. 20 ± 5 20 ± 4 %
LDCVs 34 ± 8 31 ± 5 55 ± 13 38 ± 5 per 1000 µm2
synapses 8.5 ± 2.1 3.1 ± 0.5 15.5 ± 2.3 3.6 ± 1.4 per 1000 µm2
with docked 
vesicle
5.1 ± 2.0 1.6 ± 0.5 8.6 ± 1.4 1.7 ± 0.9 per 1000 µm2
‘empty synapse’ 35 ± 5.1 13 ± 1.7 24.1 ± 2.6 8.1 ± 0.7 per 1000 µm2
multivesicular 
struct.
7.0 ± 1.9 6.6 ± 2.5 11.5 ± 3.5 22.2 ± 2.6 per 1000 µm2
  s
yn
ap
se
  c
ha
ra
ct
er
is
tic
s
diameter 0.68 ± 0.04 0.73 ± 0.09 0.58 ± 0.04 0.65 ± 0.02 µm
active zone 
length
0.26 ± 0.01 0.27 ± 0.02 0.29 ± 0.01 0.28 ± 0.01 µm
synaptic 
vesicles
4.5 ± 0.9 5.4 ± 1.6 9.8 ± 0.2 5.0 ± 0.8 per synapse
docked 
vesicles
1.2 ± 0.5 1.2 ± 0.4 2.1 ± 0.1 0.9 ± 0.5 per synapse
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Table 1: Quantiﬁcation of tissue and synaptic parameters in the marginal zone of the munc18-1 null-
mutant and control littermates at E16 and E18. Data represent means +/- SEMs, n=4 animals in each 
group. Statistical signiﬁcant differences between controls and mutants are indicated in bold + italic. N.D. = 
not determined.
We quantiﬁed the number of LDCV in the marginal zone. Both groups had similar 
numbers of LDCV at E16 (control 34 ± 8 per 1000 µm2; mutant 31 ± 5 per 1000 µm2; 
p=0.805) and at E18 (control 55 ± 13 per 1000 µm2; mutant 38 ± 5 per 1000 µm2; Fig. 
4G and Table 1).
At E16, synapse morphology is similar in controls and mutants
Scanning the marginal zone at high electron microscope magniﬁcation revealed 
that both control and mutant brains contained developing synapses (Fig. 5A-H, 
see also Verhage et al., 2000). We characterized synapse morphology by quantifying 
the presynapse proﬁle diameter, the active zone length and the numbers of 
morphologically apparently docked vesicles (<30 nm from the membrane). Control 
and mutant had similar presynapse proﬁle diameters (control 0.68 ± 0.04 µm; mutant 
0.73 ± 0.09 µm), active zone length (control 0.26 ± 0.01 µm, mutant 0.27 ± 0.02 µm) 
and total number of synaptic vesicles (control 4.5 ± 0.9; mutant 5.4 ± 1.6) and of 
docked synaptic vesicles (control 1.2 ± 0.5; mutant 1.2 ± 0.4) per synapse (Fig. 5K-M; 
Table 1). Thus, at E16 the synapse morphology of controls and mutants was similar.
At E18, synapse morphology differs between controls and mutants
At E18, presynapse proﬁle diameters (control 0.58 ± 0.04 µm, mutant 0.65 ± 0.02 µm) 
and active zone lengths (control 0.29 ± 0.01 µm, mutant 0.28 ± 0.01 µm) were similar 
in both groups. However, control animals showed two times more synaptic vesicles 
per synapse, while mutants had similar numbers as 2 days earlier (control: 9.8 ± 0.2 
vesicles per synapse; mutant 5.0 ± 0.8; p < 0.005). The amount of docked vesicles was 
also 2 times higher in control synapses, but the mutant contained similar numbers as 
at E16 (control 2.1 ± 0.1; mutant 0.9 ± 0.5, Fig. 5K-M and Table 1). Thus, whereas in the 
controls the numbers of docked and total vesicles per synapse doubled in two days, 
the synapse morphology in the mutant was still similar to that of two days before.  The 
staining for the synaptic proteins VAMP2 and Rab3 colocalized often with the small 
vesicles found in the synapses. This observation makes it even more likely that these 
vesicles are synaptic vesicles (Fig. 5D,E,I,J).
Synapses are less abundant in the mutant
In the marginal zone of the neocortex, the ﬁrst morphologically identiﬁable synapses 
were reported at E15 (König et al, 1975). At E16, we observed few synapses in the 
control (8.5 ± 2.1 per 1000 µm2). The mutant showed even fewer synapses (3.1 ± 0.5 
per 1000 µm2; p < 0.014), which is almost 3 times less than in controls (Fig. 5N; Table 
1). Two days later, controls showed almost twice as many synapses, while mutants had 
similar values as 2 days before (control 15.5 ± 2.3; mutant 3.6 ± 1.4; p < 0.005; Fig. 5N; 
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Fig. 5: Electron micrographs of marginal zone synapses in the munc18-1 null-mutant (F-H) and control 
littermates (A-C) at E18 and quantiﬁcation of synaptic parameters. Controls and mutants had similar 
developing synapses composed of a presynaptic element (pe) containing electron-lucent round and/or 
electron-lucent pleomorphic synaptic vesicles (sv), and a postsynaptic element (po). Immunogold labeling 
of VAMP/synaptobrevin (D,I)  and Rab3 (E,J). Quantiﬁcation of synaptic parameters and (K-O) the number of 
synapses in the marginal zone. * = P<0.05, ** = P< 0.01. Bars: 200 nm.
Table 1). Thus, at E18, controls had almost 4 times more synapses than mutants. At E16, 
43 synapses were counted and analyzed in the mutant, and 116 in controls; at E18, 50 
synapses in the mutant and 222 in control animals were analyzed. 
At both time points, approximately half of the synapses showed docked synaptic 
vesicles. Similar to the quantiﬁcation of all synapses (see above), we found that 
the number of synapses with docked vesicles almost doubled between E16 and 
E18 in controls, while the number of these synapses did not increase in the mutant. 
Consequently, synapses with docked vesicles were 3 times more abundant in controls 
at E16 (control 5.1 ± 2.0; mutant 1.6 ± 0.5; p < 0.060) and 5-fold at E18 (control 8.6 ± 
1.4; mutant 1.7 ± 0.9; p < 0.022; Fig. 5O; Table 1).
Thus at E16, controls and mutants had similar synapse morphology, but controls had 
many more synapses. Between E16 and E18, control synapses matured and increased 
in number, while the morphology and number of synapses in the mutant remained 
the same.
The mutant marginal zone contains fewer “empty synapses”
We observed that the membranes of certain axons and/or dendrites were connected 
by electron-dense material, denser than the rest of the membrane, and resembling the 
membrane specializations in synapses, but with no vesicles in the vicinity (Fig. 6). High 
osmolarity Karnovsky ﬁxative, which tends to shrinken embryonic tissue probably, 
caused a protein smear between the membranes (Fig. 6C). This suggests that speciﬁc 
proteins are present in this space. They may be involved in cell recognition or synapse 
formation. Such structures were also reported, for instance, in the rat embryo marginal 
zone and visual cortex and pontine nuclei of newborn rats, as well as in the chick 
embryo optic tectum (König et al., 1975; Panzica and Viglietti-Panzica, 1980; Blue and 
Parnavelas, 1983; Mihailoff and Bourell, 1986). They may represent either a synapse 
early in its development or a section through a part of the synapse that is devoid of 
vesicles, but they may also represent (in part) other forms of transitory intercellular 
junctions. Here, these structures are referred to as “empty synapses”. The lengths of 
their electron-dense membranes were similar between controls and mutants (E16: 
control 0.230 ± 0.004 µm; mutant 0.239 ± 0.008 µm; E18: control 0.245 ± 0.012 µm; 
mutant 0.226 ± 0.014 µm). However, the empty synapse incidence was signiﬁcantly 
different between the two groups. At E16, control animals had almost 3 times more 
empty synapses than mutants (control 35 ± 5.1; mutant 13 ± 1.7; p=0.002). The 
number of these empty synapses decreased between E16 and E18 in both groups, but 
remained signiﬁcantly different, controls having 3 times more, empty synapses than 
mutants (control 24.1 ± 2.6; mutant 8.1 ± 0.7; p=0.0004; Fig 6D-E; Table 1). Thus, the 
empty synapses, are a normal feature during development, are more regularly found 
at E16 than at E18 and less frequently observed in the mutants.
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The mutant contains more ‘multivesicular structures’ at E18
We observed that the membranes of two axons and/or dendrites were connected 
by electron dense material, and both sides contained round and/or pleomorphic 
vesicles (Fig. 7A,B,D). Such structures have been described in the developing brain, 
for instance, in the marginal zone (König et al., 1975), in the olfactory lobe (Pinching 
and Powell, 1971) and in the pontine nuclei (Mihailoff and Bourell, 1986) and may 
reﬂect the elimination of a synaptic contact or the degeneration of the entire axon 
and/or dendrite, starting a the synapse. We refer to these structures as ‘multivesicular 
structures’, because they have vesicles at both sides of the electron dense membrane.
The length of the electron-dense region of the membrane of the multivesicular 
structures was similar in controls and mutants (at E16: control 0.261 ± 0.006 µm; 
mutant 0.264 ± 0.027 µm; at E18: control 0.313 ± 0.025 µm; mutant 0.276 ± 0.017 µm). 
At E16, the incidence of multivesicular structures was similar in both groups (control 
7.0 ± 1.9 per 1000 µm2; mutant 6.6 ± 2.5 per 1000µm2), but at E18 it was 2 times more 
abundant in mutants (control 11.5 ± 3.5 per 1000 µm2; mutant 22.2 ± 2.6 per 1000µm2; 
p < 0.05; Fig. 7F,G; Table 1).
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Fig. 6:  Electron micrographs of electron dense membranes, ‘empty synapses’, in the marginal zone of 
the munc18-1 null-mutant (B,C) and control littermates (A) at E18 and quantiﬁcation. (A,B) Electron 
dense membrane (arrow) between axons and/or dendrites in tri-aldehyde ﬁxative and (C) the same structure 
in Karnovsky ﬁxative (see Experimental Procedures and Results sections). Notice in C the smear of proteins 
(arrows) between the two cell processes. Bar: 200 nm. (D,E) Quantiﬁcation. ** = p < 0.01, *** = p < 0.001.
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Fig. 7 : Electron micrographs of multivesicular structures in the marginal zone of the munc18-1 null-
mutant (D,E) and control littermates (B,C) at E18 and quantiﬁcation. (A) Cartoon of a synapse and a 
multivesicular structure, showing that the only difference is that vesicles (round or pleomorphic) are present 
at both sites of the membrane. (B,D) Multivesicular structures, i.e. two cell processes containing round and/
or pleomorphic vesicles (v) joined by an electron dense material. (B,D) Immunogold labeling of VAMP/
Synaptobrevin. Multivesicular structures were labeled in both groups. Bar: 200 nm. (E,F) Quantiﬁcation of 
multivesicular structures.
To assess the nature of the round and pleomorphic vesicles in the synapses and in 
the multivesicular structures, we performed immunogold labeling for two synaptic 
proteins on brain sections from mutants and controls at E18. Although the loose and 
immature tissue was difﬁcult to prepare and immunoreactivity for markers of the 
(mature) synapse was low, we observed signiﬁcant  VAMP/Synaptobrevin (Fig. 5D,I) 
and Rab3A immunoreactivity (Fig. 5E,J) at the vesicle membranes. In both groups, 
multivesicular structures round and pleomorphic electron-lucent vesicles were 
labeled with gold particles. Immunogold labeling also revealed that the multivesicular 
structures were immuno-positive for VAMP/Synaptobrevin in both groups (Fig. 7C,E).
DISCUSSION
In the present study we characterized and quantiﬁed synapse-formation and -
maintenance in the absence of presynaptic signaling, using the munc18-1 null-mutant 
as a model. We found that the overall organization of the neocortical marginal zone 
was normal. Proteins needed for synaptic function were expressed and targeted 
to the correct location. In the mutant, immature synapses had formed. Initially, the 
morphology of these synapses was similar to synapses in control littermates at the 
same age (E16), but controls had 3 times more synapses. Between E16 and E18, the 
number of control synapses increased  and the number of vesicles in the synapses 
also increased, while the morphology and number of secretion-deﬁcient synapses 
remained the same. Instead, the number of multivesicular structures increased in 
the mutants. Immunogold labeling indicated that both synapses and multivesicular 
structures of the mutants contained synaptic vesicle markers.
The lower amount of synapses is not the result of degeneration in 
other brain areas
In the munc18-1 null-mutant, massive degeneration takes place in lower brain regions 
between E16 and E18 (Verhage et al., 2000). However, this is unlikely to explain the 
lower density of synapses in the neocortex of the mutants. Most synapses found in 
the marginal zone are formed between two cortical neurons (see Marin-Padilla, 
1998; Miyashita-Lin et al., 1999). These neurons do not show signs of degeneration 
because they revealed neither apoptotic bodies (through standard histology) nor 
TUNEL staining (Verhage et al., 2000 and this manuscript). In addition, the levels of 
most synaptic proteins were not lower in the mutant relative to the control proteins, 
which would be expected if synapses of lower brain areas were an important input 
to the cortex. Furthermore, the distribution of the AMPA receptor was similar in 
mutant and wild type. Therefore, we conclude that the lower density of synapses is 
not a consequence of neuronal degeneration in other brain areas. The lower density 
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and failure to mature may rather be the primary consequence of deleting munc18-1 
expression and/or the resulting loss of presynaptic signaling.
Synaptic vesicles do not accumulate in the mutant
Despite the blockade of secretion in the munc18-1 null mutant we observed similar 
amounts of vesicles at E16 and at E18 in the secretion-deﬁcient synapses and fewer 
vesicles per synapse than in controls. Hence, vesicles do not accumulate after secretion 
was blocked. This suggests that the normal increase in the number of vesicles during 
synapse maturation depends primarily on local activity in the synapse than on supply 
from the cell body (independent of local activity). Alternatively, the munc18-1 gene 
may be required for targeting a normal number of precursor vesicles to the terminal. 
In any case, the lack of vesicle accumulation contrasts with the observation that 
mutation of a S. cerevisiae munc18 ortholog leads to vesicle accumulation at the target 
membrane (Novick and Schekman 1979).
Secretion-deﬁcient synapses may not mature and may transform to 
multivesicular structures instead
Between E16 and E18 both the number of synapses and the number of vesicles 
per synapse did not increase in the absence of presynaptic signaling, while these 
parameters approximately doubled over the same period in controls. This may 
be explained by assuming that after E16 no further synapses were formed in the 
mutant and that synapses formed earlier remained static for two days. However, since 
synapses are highly dynamic structures, we favor the explanation that synaptogenesis 
in itself is unimpaired, but that synapses do not mature in the mutant and disassemble 
instead after some time. Together with ongoing assembly of new immature synapses 
this disassembly can explain why we observed fewer and only immature synapses 
both at E16 and E18. Furthermore, the multivesicular structures that were frequently 
observed in the mutant at E18 may be the result of the disassembly of immature 
synapses observed at E16. The fact that these multivesicular structures were labeled 
with antisera for a synaptic vesicle marker strengthens the suggestion that they have a 
synaptic origin. In the munc18-1 mutant the multivesicular structures may be the ﬁrst 
step in a cascade of events that ultimately leads to general degeneration of the whole 
neuronal network as observed in lower brain areas (Verhage et al., 2000). The marginal 
zone contains a number of different classes of synapses. We cannot exclude that the 
difference in synapse density between controls and mutants is caused by a selective 
or disproportional loss of certain classes of synapses.
Interestingly, elimination of neuromuscular synapses depends on the activity of 
strong synapses, producing ‘punishment signals’ to weaker synapses (see for a 
review Lichtman and Colman, 2000). Since the neocortex in the munc18-1 null 
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mutant completely lacks neurotransmission, even spontaneous synaptic events, a 
different mechanism must cause this synaptic disassembly. Alternatively, the synaptic 
disassembly in the munc18-1 null-mutant and the appearance of many multivesicular 
structures maybe is initiated from the somata, which are devoid of neural inputs. It 
was previously shown that after silencing neuronal networks in culture, the ﬁrst signs 
of cell death are observed at the synapses (Williamson and Neale, 1998). In addition to 
the lack of synaptic input or output, the reduced Syntaxin levels may also contribute 
to the loss of synapses and the accumulation of multivesicular structures. However, 
albeit reduced, there is still considerable Syntaxin staining, also in the synaptic layers 
and in terminals of cultured null mutant neurons (Toonen et al, 2005). Furthermore, at 
E16 the organization of immature synapses is still normal in the mutant, while syntaxin 
levels are already reduced.
Synapse maturation may require the concerted effects of different 
presynaptic signals
In addition to the munc18-1 null mutant, a second mouse model was recently 
generated, the munc13-1/munc13-2 double null mutant (dko), that is also completely 
devoid of both spontaneous and evoked neurotransmitter release at least in 
cultured neurons of the hippocampus (Rosenmund et al., 2002; Varoqueaux et al., 
2002). In contrast to the munc18-1 null mutant, this mutant was found to produce 
normal, mature synapses in culture, and no conspicuous degeneration in the brain 
(Varoqueaux et al., 2002). It is not certain if as many neurons are silent in the munc13 
dko as in the munc18-1 mutant, has the same amount of synapses in vivo as in control 
animals and if multivesicular structures are also present in the former model. Still, 
these data suggest that the lack of evoked and spontaneous secretion of (classical) 
neurotransmitters does not prevent formation of normal, mature synapses. In line 
with this suggestion we observed that munc18-1 null mutant neurons cannot be 
rescued by co-culturing them with wildtype (transmitting) neurons or supplying 
exogenous neurotransmitters (Heeroma et al., 2004), indicating that additional defects 
in the munc18-1 null mutant are involved in the proposed instability of synapses 
and the eventual disassembly of neuronal networks. One candidate for such an 
additional defect is the defective secretion of neuromodulatory substances from 
large dense core vesicles (LDCVs) observed in munc18-1 null mutant chromafﬁn cells 
and pituitary (Voets et al., 2001, Korteweg et al., 2005). By contrast, in the munc13 dko 
chromafﬁn cells do not show impaired secretion of LDCVs (Ashery, Brose, personal 
communication). In conclusion, while presynaptic signaling is dispensible for the 
formation of initial immature synapses, the effects of classical neurotransmitters 
or neuromodulatory substances are probably required to form normal, mature 
synaptic networks. Alternatively, the proposed disassembly of synapses and the 
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neurodegeneration in the munc18-1 mutant may result from an intrinsic defect 
caused by the absence of the protein rather than from blocking presynaptic signaling. 
However, not all neurons degenerate in the munc18-1 mutant. For instance, primary 
sensory neurons normally express munc18-1 but do not degenerate in the null mutant. 
This argues against a cell-intrinsic defect as a primary cause for the observed effects 
reported in this study.
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DIFFERENTIAL GENE EXPRESSION IN THE 
DEVELOPING NEOCORTEX OF A MOUSE 
MODEL LACKING SYNAPTIC ACTIVITY

ABSTRACT
Neuronal activity has an important role in neuroplasticity, as activity can affect 
synaptic strength and morphology. Some of these effects are long-lasting and involve 
gene expression. We assessed the role of activity-dependent gene expression in 
the development of synapses. Thereto, a developmental transcript level proﬁle was 
generated using an oligonucleotide-microarray (7k) analysis, in which neocortical 
expression of munc18-1 null mutant mice, which are deprived of evoked and spontaneous 
neurotransmitter release, was compared to control animals. We hypothesized that 
genes induced by synaptic activity will have differences in transcript levels in mutants 
compared to controls. The RNA levels of most genes (>90%) were similar, including 
gene groups involved in cellular metabolism and apoptosis. At embryonic day 18, the 
mutant had a pronounced reduction in the RNA levels of a number of genes involved 
in neuronal transmission. However, these genes were unaffected earlier in embryonic 
life, when synaptic activity is not yet present. These data were validated using real-time 
quantitative PCR. Thus, during development synaptic activity increases the expression 
of several neuronal transmission compounds. 
INTRODUCTION
Synapses are dynamic structures and probably often exist transiently. Both their 
function and structure can be altered in response to various signals in developing and 
mature networks. The synergy of functional and morphological changes affects the 
strength of the synapse. Functional changes include changes in synaptic probability 
and the number of receptors in the postsynaptic membrane (Sheng and Kim, 2002). 
In addition, the shape of the synapse can be regulated, especially of the postsynaptic 
spine (Fischer et al., 1998; Majewska et al, 2003). These two types of changes can lead to 
short- or long-lasting strengthening or weakening of synaptic transmission. For some of 
the long-lasting effects, an increase of compounds involved in synaptic transmission is 
needed. This increase may involve regulation of transcription. For instance, adjusting the 
expression of genes involved in synapse function can be important for the maintenance 
phases of synaptic potentiation, and changes in the expression of structural genes may 
underlie morphological rearrangements. 
Activity regulates the expression of several synaptic genes, like cell adhesion molecules 
and synaptic release molecules. For instance, the expression of cell adhesion molecules 
is inﬂuenced by activity in some cases in a frequency dependent way. The RNA levels of 
cell adhesion molecule L1 are decreased by 0.1 Hz stimulation in mouse DRG neurons 
in vitro, while higher frequencies did not change the levels. In contrast the RNA levels 
of N-cadherin were lowered at both low and high frequencies (Itoh et al., 1997). In 
addition, the RNA levels of the cytoskeleton-associated protein, Arc are increased in 
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high frequency stimulated rat hippocampi and in cultured PC12 cells (Lyford et al., 1995). 
Synaptic activity can also increase the expression synaptic vesicle release genes (Sutton 
et al., 1999), neuropeptides (MacArthur and Eiden, 1996) and receptors (Hoffmann et al., 
2000). 
Effects of activity on the transcript levels of large numbers of genes were studied using 
microarray technology. The effect of NMDA-receptor activation on RNA levels, was 
measured using microarray hybridization. Especially the RNA levels of genes involved 
in intracellular structure and vesicular trafﬁcking were increased (Hong et al., 2004). In 
addition, application of kainate, an agonist of non-NMDA-glutamate receptors, to the 
hippocampal dentate gyrus increases the mRNA levels of genes encoding transcription 
factors and vesicle- and synapse related proteins (Nedivi et al., 1993). These data show 
that the expression of particular synaptic proteins is regulated by activity. The increase 
in synaptic proteins most likely underlies the increase in synaptic strength that occurs 
during development. 
Until now, effects of synaptic activity on gene expression are mainly studied by massive 
over-stimulation of neurons. We now took a novel approach by exploiting activity-
dependent changes in transcript levels in the munc18-1 null mutant, which is devoid of 
activity. In the munc18-1 null mutant all studied synapses are deprived of evoked and 
spontaneous release of classical neurotransmitters, and have a reduced secretion from 
large dense core vesicles (Verhage et al., 2000; Voets et al., 2001). We used this mouse 
model to perform an open screen using microarray technology, and compared RNA 
levels with wild type littermates in the neocortex during late embryonic development. 
In addition to synaptic activity also munc18-1 itself may be responsible for differential 
expression of genes in this mutant. Therefore, we examined the transcript levels before 
(E14), during (E16) and after (E18) the ﬁrst synapses had formed to distinguish effects 
induced by activity and by expression of munc18-1. For instance, at E14 synapses 
have not yet formed in the neocortex, but munc18-1 is already expressed in wild type 
animals. Therefore, at this stage only genes that are regulated by Munc18-1 will be 
differentially expressed. While at E18, genes will be regulated both by synaptic release 
and by expression of Munc18-1. Strikingly, especially the transcrip levels of genes 
involved in neuronal transmission were lower in the mutant at E18 and not earlier in 
development.
EXPERIMENTAL PROCEDURES
Laboratory animals
Munc18-1 deﬁcient mice were generated as described before (Verhage, et al., 2000). 
Mouse embryos were obtained by caesarean section of pregnant females from timed 
heterozygous matings. The day a vaginal plug was observed was considered to be 
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embryonic day 0 (E0). Embryos were harvested from mothers rapidly sacriﬁced after 
timed matings at E14 E16 and E18. Experimental procedures were carried out with local 
regulatory approval for animal experimentation, according to the Dutch law for animal 
welfare.
RNA isolation
RNA was isolated from mutant and wild type animals (for qPCR and microarray RNA 
from different animals was used) by using the Trizol method (Invitrogen, San Diego, 
USA). The amount of RNA was measured with a spectrophotometer and a Bioanalyzer 
(Agilent technologies, Palo Alto, USA), and similar amounts of RNA was used in the 
cDNA reactions or loaded on a Northern gel. Genomic DNA was removed by a DNAse 
I treatment (1 U, Invitrogen), which was apparently sufﬁcient since genomic primers 
developed to detect an HPRT intron did not result in a PCR product.
Microarrays
Custom slides
Microarray expression analysis was carried out as described by Buermans et al. (2005), 
with minor changes. Microarrays were produced by spotting mouse oligonucleotides 
(65 base-pairs C6-modiﬁed; 7524 set Sigma/Compugen, Jamesburg, USA). cDNA 
synthesis was performed on total RNA (60-75 µg per sample) with aminoallyl-dUTP 
(Ambion, Austin, Texas, USA). RNA was removed by hydrolysis (0.03 M NaOH) and 
non-incorporated nucleotides were removed using a Microcon YM-30 ﬁlter (Millipore, 
Billerica, MA, USA). Each mutant sample was coupled to either Cy3 or Cy5, whereas 
control RNA was pooled and separated into two before dye coupling, one tube for Cy3 
and one for Cy5. Uncoupled dye was removed using a PCR puriﬁcation column (Qiagen, 
Hilden, Germany). For each slide labeled cDNA (mutant and pooled control) was mixed 
with Cot-1 DNA (30 µg), tRNA (75 µg) and poly-A (15 µg) and ethanol-precipitated. 
Labeled DNA was dissolved in hybridization mix (460 µl) to achieve a ﬁnal composition 
of 50% formamide, 10% dextran sulphate, 2 X SSC, 2% SDS, 8% glycerol and 10 µg of 
tRNA. The arrays were analyzed with Imagene 5.0 standard settings (10% lower and 
5% upper cut-off in signal and background, threshold value 0.55, empty spots setting 
2.4). At E14 and E18 spots were also manually ﬂagged, if dust was on the spot area or if 
circles were placed outside the printed area. Local or general background subtraction 
was performed (no difference in results) and the values were 2log-transformed and 
duplicate spots were averaged. Normalization was performed to the average signal of 
non-ﬂagged spots in the channel (Cy3 and Cy5 separately). The data were analyzed 
with a Student’s t-test, α=5% and also in SAM (Signiﬁcance Analysis of Microarrays; 23). 
Genes were counted as measurable if they were non-ﬂagged in at least 75% of the 
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arrays. A transcript was deﬁned as regulated if the levels were signiﬁcantly different 
(Student’s t-test; α= 5%) in the mutant compared to control animals. The genes were 
grouped according to Gene Ontology assignments (Van der Wiel et al., 2005). We have 
adhered to this classiﬁcation throughout the manuscript. Genes were clustered using 
the programs Cluster and Treeview http://rana.lbl.gov/EisenSoftware.htm). 
Microarray setup 
For the E14 micro-array experiment 6 mutant and 6 control animals were used and 
hybridized to 6 microarray slides (n=6), for E16 n=4, and for E18 n=11 (Fig. 1). For each 
developmental stage, the control material was used as common reference. Therefore, 
it was pooled not only after the RNA isolation but also after the cDNA reaction. A 
dye-swap was performed by labeling half of the RNA of the mutant animals with Cy3 
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KO1 KO2 KO3 KO4 KO5 KO6
gWT
WT1 WT2 WT3 WT4 WT5 WT6
Grouped WT cDNA
              (gWT)
Hybridization
cDNA synthesis
cDNA synthesis
Dye coupling
Dye coupling
Mutant RNA
Control RNA
KO1 KO2 KO3 KO4 KO5 KO6
cy3
cy5
gWT gWT gWT gWT gWT
Figure 1: Scheme showing the procedure used for the microarray performed on E14, E16 and E18 
mutant and control animals. In this example of the experimental set-up 6 mutant (KO) and 6 control (gWT) 
animals are indicated. RNA of control animals (n=6 for E14, n=4 for E16 and n=11 for E18) was pooled. Half of 
the control material was labeled with Cy3 and half of it with Cy5. The mutants were kept separately and half 
of there numbers were labeled with Cy3 and the other half with Cy5. Then the hybridization with 1 mutant 
and a part of the control material was performed.
and half with Cy5, and of the control material the other way around. We performed 
a control experiment using munc18-1 heterozygote material (n=2). We hybridized 
two aliquots of one heterozygote cortex, one labeled with Cy3 and one with Cy5, to 
the same array. The data showed a normal distribution and no relation between the 
abundance of the transcript and the Cy3/Cy5 ratio (Fig. 2), indicating the absence of 
dye-bias and reproducibility of the procedure for high and low abundant transcripts. 
The normal distribution had a standard deviation of 0.1 and 72% of the data are within 
this standard deviation. Original data ﬁles for all arrays were uploaded in MIAME format 
for expression arrays at GEO, http://www.ncbi.nlm.nih.gov/geo/ accession numbers 
GSE3637, GSE3538 and GSE3639.
qPCR
Oligonucleotide primers were designed to amplify a 80-120 bp amplicon. HPRT was 
chosen as an internal standard. Primers were designed using Primer Express software 
1.0 (PE Applied Biosystems, Foster City, CA, USA).  PCR reactions (20 µl) were set up and 
run as described by the manufacturer, shortly the reactions contained 10 µl SYBR Green 
PCR Core Kit (PE Applied Biosystems, Foster City, CA, USA), 20 pmol of each primer 
(Sigma or Eurogentec, Seraing, Belgium); and 3 µl of cDNA template (equivalent to 1 
ng RNA). Ampliﬁcation, data acquisition, and data analysis were carried out in the ABI 
7700 Prism Sequence Detector (once at 2 min, 50° C; 10 min, 95° C; and 40 cycles at 
95° C, 15 s; 59° C, 1 min). The calculated cycle threshold values (Ct) were exported to 
Microsoft Excel for analysis using the ∆∆Ct method (Spijker et al., 2004a). Dissociation 
curves (Dissociation Curves 1.0 f. software, PE Applied Biosystems, Foster City, CA, USA) 
of PCR products were run to verify ampliﬁcation of the correct product. As negative 
control primers were chosen in the region of munc18-1 that is removed in the mutant. 
In another study we showed that qPCR has the selectivity to detect transcripts over a 
dynamic range of 5 orders of magnitude, including the very low-abundant transcripts. 
In addition, we showed that it has the resolution to discriminate subtle changes in RNA 
levels signiﬁcantly if they are larger then 1.4 fold (Spijker et al., 2004a). 
RESULTS
To address the relation between synaptic activity and gene expression during synapse 
development, we studied the RNA levels in the munc18-1 null mutant at embryonic day 
14, 16 and 18 relative to the levels in control littermates, using DNA array technology 
and quantitative real-time PCR. 
We performed two control experiments using munc18-1 heterozygote material. We 
hybridized two aliquots of one heterozygote cortex, one labeled with Cy3 and one with 
Cy5, to the same array (Fig. 2A). The data showed a normal distribution (Fig. 2B) and no 
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relation between the abundance of the transcript and the Cy3/Cy5 ratio, indicating that 
the procedure is reproducible for high and low abundant genes and transcripts are 
not binding to one of the colors speciﬁcally. The normal distribution had a standard 
deviation of 0.1 and 72% of the data lay within this standard deviation.
The expression of a few genes is altered in the mutant animal
To identify activity-dependent gene expression, we compared the RNA levels in cortices 
from control and munc18-1 deﬁcient mice at E14 (n=6), E16 (n=4) and E18 (n=11). 
Cortices of E18 null mutant animals were somewhat smaller than the cortices of wild 
type littermates, while no difference was observed at E14 and E16. At E18, the RNA 
yield of null mutants was also lower; about 70% of control levels. The microarray data 
were standardized to the average background on the total array. The normalized raw 
data of the mutant of the six separate E14, four E16 and eleven E18 experiments were 
hierarchically clustered. The mutant data of the three embryonic days clustered in 
separate groups (Fig. 3). This indicates that the gene proﬁles of experiments within a 
certain embryonic age were more similar than between ages. The E14 mutant data 
were the most separate relative to the E16 and E18 data. Of 7524 printed transcripts, our 
assay detected expression of 66.5% (5010 transcripts) in the neocortex at E14, 77.4% at 
5756
Chapter 3 Activity-dependent gene expression
All genes All genes self hybridizationB.
0
10
20
30
40
%
 o
f e
xp
re
ss
ed
 g
en
es
wt>ko ko>wt
<1
/2
signal ratio
1/
1.
8
1/
1.
6
1/
1.
4
1/
1.
2
1.
0 1.
2 1.
4 1.
6
-2
-3
-2
-1
0
1
2
3
-4 0 2 4 6
A.
Standardized abundance
Ra
tio
 c
y3
/c
y5
self-self hybridization
wt/ko hybridization
Figure 2: Relation between abundance of a transcript and its regulation. A: The standardized intensity 
of the spot is indicated on the x-axis and the Cy3/Cy5 ratio on the y-axis. All expressed genes measured in 
two control hybridizations with heterozygote material are shown. One aliquot of the heterozygote RNA was 
labeled with Cy3 and a second aliquot of the same material with Cy5 (in grey and in black a E18 experiment 
with a mutant and wild type sample). B: For each group, all expressed genes were classiﬁed into signal intensity 
difference intervals (0.1 bins) according to their Cy3/Cy5 signal ratio. Transcripts in the “1” bins had identical 
Cy5 versus Cy3 signal intensity ratio and were thus not regulated. Positive values indicate that the levels 
are higher in mutants (ko), while negative values indicate higher levels in control animals (wt). The y-axis 
shows the percentage of genes in a certain bin. The black bars indicate the distribution of all expressed genes 
across eleven comparisons of mutant and control animals. Grey bars denote the percentage of expressed 
genes in a certain bin across two control hybridizations with heterozygote material. Per array, one aliquot 
of heterozygote material was labeled with Cy3 and a second aliquot of the same heterozygote mRNA was 
labeled with Cy5 and hybridized to an array.
E16 (5831) and 74.2% at E18 (5586). 
At the early embryonic ages there were virtually no differences in RNA levels between 
the mutant and wild type, at E14 30 genes (0.6%) and at E16 129 genes (2.2%, p<0.05) 
had different RNA levels. However, many more transcripts levels were different at E18 
comparing the mutant and control animals (505 transcripts (9.0%), p<0.05) (Table1). 
Number
measurable
Percentage
measurable
Number
changed
Percentage
changed
# higher 
in control
# higher 
in mutant
E14 5010 66.5 30 0.6 8 22
E16 5831 77.4 129 2.2 377 69
E18 5586 74.2 504 9.0 271 233
 
Analysis of the data with SAM (Signiﬁcance Analysis of Microarrays; Tusher et al., 2001), which 
is a Student’s t-test extended with a multiple testing correction, gave a more stringent view: 
only 2 genes were signiﬁcantly regulated at E14 (FDR < 5 %) and E16 (FDR < 5 %) and at E18 
175 genes were signiﬁcantly regulated (FDR < 5 %). 
The most upregulated transcripts in the mutant at E18 were glial ﬁbrillary acidic protein, 
lysosomal-associated protein transmembrane 5, and secreted phosphoprotein 1 (Fig 4). 
Tachykinin 1, and somatostatin were within the most downregulated transcripts in 
the mutant. The difference in their transcript levels was in the range of munc18-1, the 
deleted gene. Residual hybridization for munc18-1 in the mutant can be explained by 
the truncated RNA for this gene (Verhage et al., 2000) or by binding of munc18-2 or 
munc18-3. In conclusion, only at E18 a signiﬁcant amount of transcripts had different 
levels, consistent with the idea that synaptic activity inﬂuences gene expression. 
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Figure 3: Clustering of separate arrays. Standardized mutant intensity levels of the changed genes were 
clustered. The arrays with samples of the same embryonic age cluster together. The distance between the E14 
cluster and the E16 and E18 cluster is larger then the distance between the E16 and E18 cluster.
Table 1: Quantiﬁcation of genes that are measurable or changed on the array of mutant and control 
mice.  Table 1 shows the quantiﬁcation of genes measurable in numbers and percentage relative to the total 
amount of genes printed (7524) on the array at E14, E16 and E18. The table also shows the number (#) of 
changed genes on the array at the different time points.
Genes that were found to have differences in transcript levels (according to the Student’s t-
test) with a similar function were grouped according to Gene Ontology (GO) assignments. 
The three organizing classes of GO are biological process (Fig. 5), molecular function and 
cellular component (Fig. 6). Within these classes, groups of genes are deﬁned based on 
their common properties. This organization is not speciﬁcally developed for the nervous 
system and has redundancy in class-assignments. An overrepresentation-analysis, which 
indicates that the function or process in which the group is involved can be viewed as 
affected by our experiments, was performed using the biological process class as it was the 
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1/4 1/3 1/2 1 432
Tachykinin1 (Substance P)
Munc18-1
Somatostatin
Calbindin-28K
Cellular retinoic acid binding protein 1
Testican-3
Huntingtin-associated protein 1
G-protein signaling 4
Glutamic acid decarboxylase 1
Vesicular inhibitory amino acid transporter
Purkinje cell protein 4
Dynamin 19
Guanine nucleotide binding protein gamma
Copine 6
Regulated endocrine-specific protein 18
Endothelin converting enzym-like 1
Secretogranin II
GABA-A receptor alpha 5 subunit 
Pre B-cell leukemia transcription factor 1
Mevalonate kinase
Synuclein alpha
Reelin
NAD(P) dependent steroid dehydrogenase-like
Striatum-specific G protein-coupled receptor
Nociceptin/orphanin FQ
Dentatorubral pallidoluysian atrophy
Poliovirus receptor-related 1
Sialyltransferase 4
Complement component 1q subcomponent alpha
Gap junction membrane channel protein beta 6
Emr 1
Granulin
Neuropeptide receptor 1
Pleckstrin
Mpv17
Transferrin segment 4
Transferrin segment 3
Growth arrest specific 7
Cathepsin S
ATP-binding cassette sub-family A
 Complement component 1 q subcomponent c
Upregulated by 125-dihydroxyvitamin D-3
Hexosaminidase B
Putative transmembrane glycoprotein
Apolipoprotein E
Lysosomal-associated protein transmembrane 5
CD68 antigen
Contactin 2
Glial fibrillary acidic protein
 Secreted phosphoprotein 1 
Figure 4: Most extreme regulated genes. Expression levels of the 5% highest and lowest regulated genes 
at E18 are shown relative to control animals (average ± SEM). Half of the genes are high expressed in the 
mutant, half of them high in control animals. Some of the genes that have a relative low expression in mutant 
animals are involved in synapse function. Some genes high expressed in the mutant are involved in immune 
response.
 most suitable for neurons. Within this class, 4 groups were relatively enriched at E14, 
18 at E16 and 52 groups were enriched at E18 (Fig. 5 and Table 2). For all ages, the RNA 
levels of genes involved in basal cell function were hardly affected. For instance, cellular 
metabolism was not enriched at any of the embryonic ages. This suggests that the 
expression of only speciﬁc gene groups is affected in the munc18-1 mutant.
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Figure 5: DAG (directed asymmetric diagram) view E14, E16, E18 for Biological process. Overview over 
the regulated GO groups in Biological process (bold-italic) and their relation. A: E14, B: E16 and C: E18 (see 
page 60).
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Figure 6: DAG view E18 Molecular function (A) and cellular component (B). Overview over the regulated 
GO groups (bold-italic) and their relation at E18.
Gene groups involved in neuronal transmission have high numbers 
of differentially expressed genes
More detailed analysis of gene groups indicated by the overrepresentation analysis 
showed that most gene groups were not enriched in the mutant. Of the groups 
containing more than 10 differentially expressed genes those involved in (regulation) 
of transcription were the most enriched groups at E14 and E16. At E18, groups involved 
in regulation of action potential, tachykinin signaling pathway, sterol transport and 
cholesterol transport were the only groups that were more than 6 times enriched 
(Table 2). However these groups only contained a low number of genes (2-3 genes). 
In biological process Observed Expected R P
E14 regulation of cell migration 2 0.15 13.33 0.0094
regulation of cell motility 2 0.15 13.33 0.0094
regulation of transcription\. DNA-
dependent
11 5.25 2.1 0.0087
transcription\. DNA-dependent 11 5.32 2.07 0.0096
regulation of cellular physiological 
process
14 7.55 1.85 0.0072
regulation of cellular process 14 7.73 1.81 0.0090
regulation of physiological process 14 7.68 1.82 0.0084
regulation of biological process 15 8.17 1.84 0.0053
E16 adult behavior 2 0.16 12.5 0.0097
nucleobase\, nucleoside\, nucleotide 
and nucleic acid metabolism
41 26.33 1.56 0.0009
regulation of nucleobase\, nucleoside\, 
nucleotide and nucleic acid metabolism
34 18.42 1.85 0.0001
positive regulation of transcription\, 
DNA-dependent
5 1.08 4.63 0.0041
positive regulation of transcription from 
RNA polymerase II promoter
4 0.85 4.71 0.0099
regulation of transcription 34 18.26 1.86 0.0001
regulation of transcription\, DNA-
dependent
33 17.93 1.84 0.0002
transcription 34 18.74 1.81 0.0002
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Table 2. Enriched GO groups at E14, E16 and E18. The changed genes (according the Student’s t-test) are 
grouped by the biological process, molecular function and cellular component. Indicated are the numbers 
of genes that are regulated in those groups (Observed) and the numbers that was expected in that group 
(Expected). The enrichment of the group is indicated (R) and the signiﬁcance of this enrichment (P).
transcription\, DNA-dependent 33 18.13 1.82 0.0002
transcription from RNA polymerase II 
promoter
8 2.81 2.85 0.0066
transcription initiation from RNA 
polymerase II promoter
2 0.09 22.22 0.0029
transcription initiation 2 0.16 12.5 0.0097
regulation of cellular metabolism 34 19.43 1.75 0.0004
regulation of cellular physiological 
process
41 26.06 1.57 0.0007
endocytosis 7 1.53 4.58 0.0007
synaptic vesicle endocytosis 2 0.09 22.22 0.0029
regulation of cellular process 41 26.89 1.52 0.0013
regulation of metabolism 34 19.86 1.71 0.0005
regulation of physiological process 43 26.84 1.6 0.0003
regulation of biological process 44 28.73 1.53 0.0007
E18 cell-cell signaling 24 9.58 2.51 0.0000
transmission of nerve impulse 18 6.71 2.68 0.0000
regulation of action potential 3 0.32 9.38 0.0017
synaptic transmission 15 6.23 2.41 0.0005
G-protein coupled receptor protein 
signaling pathway
32 21.08 1.52 0.0075
neuropeptide signaling pathway 10 3.19 3.13 0.0004
tachykinin signaling pathway 2 0 NA 0.0000
sterol metabolism 12 3.19 3.76 0.0000
cholesterol metabolism 11 3.03 3.63 0.0000
cholesterol biosynthesis 7 1.28 5.47 0.0000
sterol biosynthesis 8 1.44 5.56 0.0000
regulation of cytokine biosynthesis 4 0.8 5 0.0028
steroid biosynthesis 9 2.56 3.52 0.0002
steroid metabolism 15 4.47 3.36 0.0000
regulation of nucleic acid metabolism 63 33.86 1.86 0.0000
positive regulation of nucleic acid 
metabolism
9 2.4 3.75 0.0001
positive regulation of transcription 9 2.4 3.75 0.0001
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positive regulation of transcription\, 
DNA-dependent
6 1.76 3.41 0.0036
regulation of transcription 63 33.06 1.91 0.0000
regulation of transcription\, DNA-
dependent
62 31.79 1.95 0.0000
transcription 65 34.02 1.91 0.0000
transcription\, DNA-dependent 63 32.42 1.94 0.0000
regulation of cellular metabolism 70 37.38 1.87 0.0000
positive regulation of cellular 
metabolism
12 3.35 3.58 0.0000
regulation of cellular physiological 
process
95 73.47 1.29 0.0019
positive regulation of cellular 
physiological process
22 11.98 1.84 0.0023
potassium ion transport 8 3.19 2.51 0.0084
sterol transport 2 0 NA 0.0000
cholesterol transport 2 0 NA 0.0000
secretory pathway 10 4.31 2.32 0.0063
regulation of cellular process 97 76.99 1.26 0.0041
positive regulation of cellular process 23 13.26 1.73 0.0040
biomineral formation 6 1.92 3.13 0.0063
ossiﬁcation 6 1.92 3.13 0.0063
skeletal development 8 3.19 2.51 0.0084
determination of symmetry 4 0.96 4.17 0.0074
determination of bilateral symmetry 4 0.96 4.17 0.0074
determination of left/right symmetry 4 0.96 4.17 0.0074
positive regulation of biosynthesis 4 0.8 5 0.0028
regulation of metabolism 73 40.09 1.82 0.0000
positive regulation of metabolism 13 3.83 3.39 0.0000
organismal physiological process 62 42.65 1.45 0.0007
bone remodeling 7 2.08 3.37 0.0018
regulation of cytokine production 4 0.8 5 0.0028
neurophysiological process 28 14.85 1.89 0.0004
regulation of physiological process 100 76.83 1.3 0.0011
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positive regulation of physiological 
process
22 12.46 1.77 0.0039
regulation of biological process 108 85.93 1.26 0.0025
In molecular function
E14
E16 nucleic acid binding 40 26.42 1.51 0.0022
DNA binding 35 21.02 1.67 0.0009
enzyme activator activity 5 1.24 4.03 0.0076
transcription regulator activity 22 12.92 1.7 0.0078
E18 polysaccharide binding 11 5.15 2.14 0.0085
heparin binding 9 3.7 2.43 0.0065
cation binding 67 48.72 1.38 0.0021
calcium ion binding 39 26.69 1.46 0.0066
phospholipid binding 7 2.25 3.11 0.0032
calcium-dependent phospholipid 
binding
5 1.45 3.45 0.0075
DNA binding 69 46.95 1.47 0.0002
transcription factor activity 30 12.22 2.45 0.0000
opioid peptide activity 3 0.32 9.38 0.0017
steroid binding 4 0.64 6.25 0.0007
carbonate dehydratase activity 2 0 NA 0.0000
guanylate kinase activity 2 0 NA 0.0000
signal transducer activity 91 72.52 1.25 0.0065
ligand-dependent nuclear receptor 
activity 5 0.16 31.25 0.0000
steroid hormone receptor activity 5 0.16 31.25 0.0000
transcription regulator activity 39 17.04 2.29 0.0000
transporter activity 68 47.27 1.44 0.0005
auxiliary transport protein activity 3 0.32 9.38 0.0017
channel regulator activity 3 0.32 9.38 0.0017
calcium channel regulator activity 3 0.32 9.38 0.0017
potassium channel activity 6 1.77 3.39 0.0037
6564
Chapter 3 Activity-dependent gene expression
voltage-gated potassium channel 
activity 4 0.96 4.17 0.0075
In cellular component
E14
E16 chromosome 9 2.67 3.37 0.0013
chromatin 5 1.32 3.79 0.0099
nucleoplasm 15 6.86 2.19 0.0030
transcription factor complex 13 5.77 2.25 0.0045
E18 synaptic vesicle 8 1.47 5.44 0.0000
synaptic vesicle membrane 3 0.49 6.12 0.0046
vacuole 14 5.4 2.59 0.0003
lytic vacuole 14 4.91 2.85 0.0001
lysosome 14 4.91 2.85 0.0001
nucleoplasm 21 8.84 2.38 0.0001
transcription factor complex 17 5.4 3.15 0.0000
heterotrimeric G-protein complex 5 1.31 3.82 0.0042
integral to plasma membrane 37 24.57 1.51 0.0047
voltage-gated potassium channel 
complex 3 0.33 9.09 0.0018
intrinsic to plasma membrane 37 24.57 1.51 0.0047
plasma membrane 78 59.95 1.3 0.0045
extracellular region 142 115.8 1.23 0.0012
extracellular space 128 105.64 1.21 0.0040
 
Of the gene groups containing 15 or more genes with different RNA levels the most 
enriched (more than 2 times) groups were synaptic transmission (Fig. 5), steroid 
metabolism, transmission of nerve impulse, and cell-cell signaling (Table 2). The groups 
synaptic transmission and transmission of nerve impulse are subgroups of the group 
cell-cell signaling (Fig. 1c). None of these groups were enriched at E14 or E16. Most of 
the genes involved in synaptic transmission and the neuropeptide genes had lower 
transcript levels  in the mutant (Fig. 7)
The groups cell-cell signaling, secretory pathway and neurotransmitter transport contain 
synapse speciﬁc genes. In the cell-cell signaling group many genes had similar transcript 
levels, including 33 neurotransmitter receptors. The enriched group secretory pathway 
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contained several genes involved in synaptic vesicle release, like synaptotagmin1 
and SNAP25, which had similar transcript levels. In this group also DOC2A (a binding 
partner of Munc18-1) was present, for which we found that the RNA levels were lower 
in the mutant. This group included several molecules of the CASK/Lin2-Veli/Lin7-Mint1/
Lin10 complex, some of these were affected in the mutant, like veli, neurexin II and 
neurexin III. The group neurotransmitter transport, including the munc18-1 binding 
partner syntaxin1A (which was signiﬁcantly changed), was not signiﬁcantly enriched. 
In this group 9 neurotransmitters carriers were present, of which only the transcript of 
the GABA carriers were different. All these genes were signiﬁcantly different as well if 
tested using SAM. 
In the GO-enriched gene group cell-cell signaling, several genes were coding for 
neuropeptides. RNA levels of all neuropeptide genes (6) on the array were higher in 
controls than in the mutants (signiﬁcant both in Student’s t-test and in SAM) and those 
genes were among the most severally differentially expressed genes (Fig. 7). The RNA 
levels of the somatostatin and substance P genes showed the largest differences (see 
chapter 4 of this thesis). Transcript levels of the dynorphin and enkephalin gene were 
1.5 fold higher in the controls and cholecystokinin levels were also signiﬁcantly higher 
(1.2 fold). The transcript levels of other secreted substances were lower in the mutant 
as well, for instance the neurotrophic gene BDNF (1.5 fold), FGF1 (1.5 fold) and Reelin 
(1.8 fold). 
6766
Chapter 3 Activity-dependent gene expression
0
10
20
30
%
 o
f e
xp
re
ss
ed
 g
en
es
wt>ko ko>wtsignal ratio
All genes (n=5586) Neuropeptide (n=28)
40
<1
/2
1/
1.
8
1/
1.
6
1/
1.
4
1/
1.
2
1.
0 1.
2
1.
4
1.
6
B.
0
10
20
30
40
wt>ko ko>wtsignal ratio
All genes (n=5586) Synaptic transmission (n=62)
%
 o
f e
xp
re
ss
ed
 g
en
es
A.
<1
/2
1/
1.
8
1/
1.
6
1/
14
1/
1.
2
1.
0
1.
2
1.
4
1.
6
Figure 2
Figure 7: Distribution of gene expression differences for all genes and in certain gene groups. A: For 
each group, all expressed genes were classiﬁed into signal intensity difference intervals (0.1 bins) according 
to their Cy3/Cy5 signal ratio. Transcripts in the “1” bins had identical Cy5 versus Cy3 signal intensities and were 
thus not regulated. Positive values indicate that the levels are higher in mutants (ko), while negative values 
indicate higher levels in control animals (wt). The y-axis shows the percentage of genes in a certain bin. In 
all the panels, the black bars indicate the distribution of all expressed genes across eleven comparisons of 
mutant and control animals. Grey bars denote distribution of expressed genes in the synaptic transmission 
group, B: neuropeptide group.
Immune or glial genes are higher expressed in the mutant at E18 
Although gene groups with high numbers of genes with different RNA levels contained 
mainly genes with lower RNA levels in the mutant, in general as many genes had 
higher as had lower transcript levels in the mutant (Fig. 4). Genes that had a more than 
2 times higher levels in the mutant were; secreted phosphoprotein 1 (ossiﬁcation), 
macrophage-speciﬁc gene (steroid metabolism), P lysozyme structural (signal 
transduction), glial ﬁbrillary acidic protein (cytoskeleton organization and biogenesis), 
contactin 2 (cell adhesion), CD68 antigen (cell adhesion), and lysosomal-associated 
protein transmembrane 5 (vacuolar transport). Most of the genes that had higher 
RNA levels in the mutant have a function in glial cells, immune cells or lysosomes. The 
group regulation of cytokine production was enriched (Fig. 5). This may indicate that 
an immune response occurred in the mutant. This may explain not only the increase in 
immune response genes, but also the increase in glial and lysosomal genes.
Quantitative PCR validates differential expression
To validate the differences in transcript levels, we studied other RNA samples with qPCR. 
We studied to most affected genes in the array experiment and several post-synaptic 
genes and cell-adhesion molecules that were not printed on the array, because the 
literature shows that these genes may be affected by synaptic activity. Several synaptic 
structure and function genes, like ion-channels, proteins of the post-synaptic density, 
cell adhesion molecules, and proteins of the active zone were studied in the munc18-1 
null mutant at embryonic day 18. 
The RNA levels of two ion-channels, six post-synaptic density proteins, thirteen cell 
adhesion molecules, two active zone proteins, and some other proteins were measured 
using both qPCR (n=3) and array analysis (n=11). The levels were measured relative 
to hypoxanthine phosphoribosyl transferase (HPRT). Many of the tested genes had 
similar transcript levels in the mutant compared to control animals (Student’s t-test 
α=5%), which was shown both by qPCR and microarray hybridization (Fig. 8). The RNA 
levels of the genes coding for acetylcholinesterase, NSE and Kif-17 were lower in the 
mutant. The levels of NSE were also lower in the mutant if using microarray analysis. The 
levels of acetylcholinesterase were too low to detect using microarray hybridization. 
A few synaptic structure transcripts had different RNA levels, but only if measured 
by microarray analysis; the RNA levels contactin 2, and contactin3 were higher in the 
mutant, whereas the levels of DsCAM, Necdin, NeurexinII and NeurexinIII were lower. 
However, the differences in transcript levels were very small. In general the measured 
transcript levels using array technology or qPCR were similar, only for a few transcripts 
the two methods gave different results.
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Figure 8: Quantiﬁcation of RNA levels of in control and munc18-1 mutant mice at E18 by qPCR and 
array. RNA levels of E18 embryos of both control and mutant mice were measured using both qPCR and 
array for transcripts that have a function in apoptosis, ion-channels, post-synaptic density, cell adhesion, 
active zone and some others. First column: Group. Second column: Name of the transcript. Third column: 
Measured using qPCR or microarray analysis. Asterisks indicate a signiﬁcant change (Student’s t-test; α=5%). 
Fourth column: Amount of transcript present in the mutant relative to control as measured with qPCR (black) 
and array (gray). For each transcript the amount was standardized to HPRT (qPCR) or to the total signal 
(microarray). Data represent mean ± SEM of 3 animals (qPCR) or 11 animals (microarray)  per transcript. The 
SEM are asymmetric for the qPCR data, because the log scale qPCR data are transposed to the linear fold 
change scale. For proprotein convertases and secretory protein 6 animals per sample (qPCR) were used.
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The expression of apoptotic genes is not different in the mutant
To test whether apoptosis was induced in the cortex E18 mutants, we analyzed the 
transcript levels of genes involved in apoptosis. 
The transcript levels of three apoptotic genes were measured using both qPCR (n=3) 
and array analysis (n=11). In the qPCR, the RNA levels were measured relative to HPRT 
(Fig. 8). Of the 88 printed apoptotic transcripts were 63 detectable in the array. The 
highest abundant transcript was caspase3, whereas BAD had the lowest RNA levels. The 
levels for the tree apoptotic genes that were measured using qPCR were equal in the 
mutant compared to control mice (Student’s t-test α=5%) in the qPCR and microarray 
analysis. Of the other apoptotic genes present on the array only 10% was changed 
at E18 and none of these were changed at E14. Because the apoptotic gene group is 
affected in the mutant to a low extend, no additional apoptosis occurs in the mutant 
neocortex relative to control animals.
DISCUSSION 
In this paper we studied the effect of synaptic activity on gene expression in the 
developing brain. Therefore we analyzed transcript levels in the munc18-1 null mutant, 
which is deprived of evoked and spontaneous release of classical neurotransmitters and 
has a reduced secretion from large dense core vesicles, relative to control littermates 
using microarray analysis and quantitative PCR. The transcript levels of many genes 
and gene groups, especially of genes that have a basal function, were not different 
in the mutant. In addition, we found minor changes in the levels of a few apoptotic 
genes. Several genes that have a function in glial cells, immune cells or lysosomes had 
higher transcript levels in the mutant. Gene groups containing high numbers of genes 
with affected RNA levels were synaptic transmission, steroid metabolism, transmission 
of nerve impulse, and cell-cell signaling. At E14 and E16, when synapses are not yet 
functional in the cortex, these gene groups were not enriched. These results were 
conﬁrmed using qPCR.
Model and methods are well controlled
Measuring the RNA levels using qPCR and microarray analysis showed comparable 
results. Both methods showed differences in transcript levels for several genes and 
many genes were shown to have similar levels in the mutant compared to control 
animals using both methods. However, for several cell adhesion molecules a small 
difference in the transcript levels were detectable using microarray analysis, but qPCR 
did not conﬁrm these differences. In addition, the differences were often larger when 
measured by qPCR than when measured by microarray analysis, as was observed by 
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others (see for instance: Musatov et al., 2004 and McMullen et al., 2004). This may be a 
result of the overlapping spectra of Cy3 and Cy5 or by auto-ﬂuorescence of the spotted 
probes. The transcript levels of acetylcholinesterase were measurable using qPCR, but 
was too low to be detected by microarray analysis. In conclusion, both methods gave 
very similar results, however qPCR is a more sensitive method. 
A thorough previous analysis at the cellular level suggests that at E14 mutants have no 
detectable phenotype in the brain (Verhage, et al., 2000). The changes in RNA levels at 
this stage of development may be considered for that reason as non-speciﬁc effects 
or may be caused by transcription regulation of Munc18-1 and will not be caused by 
synaptic activity. For this reason we used this E14 animals as control for effects other 
than caused by activity. The amount of genes with differences in RNA levels at E14 is 
much smaller compared to the other embryonic days and no synaptic function genes 
had different RNA levels at this time point. Therefore, comparing the transcript levels in 
mutant and control animals at E14 is a good control for effects that are not caused by 
activity in the mutant.
The lower expression level for synapse function proteins is not the 
result of apoptosis
In the munc18-1 null-mutant, massive degeneration was observed in lower (non-
cortical) brain areas between E16 and E18 (Verhage et al., 2000). However, it is unlikely 
that this degeneration affects the analyses in the neocortex described here. First, the 
array data showed no signiﬁcant change in the RNA levels of gene groups involved in 
apoptosis and the qPCR measurements showed not signiﬁcant change in BAD, BCL-2 
or caspase 3 (Fig. 8) in the neocortex. Second, no morphological signs of degeneration 
were observed in a detailed analysis of the neocortex (chapter 2). Third, if cell death 
would be involved, RNA levels of other synaptic and non-synaptic genes is expected 
to be affected equally, which was not observed. Finally, lower innervation, and thus 
synaptic input, of the neocortex from degenerating brain areas is unlikely to affect the 
observed differences because the embryonic neocortex is poorly innervated by neurons 
in other areas and most synapses are corto-cortical connections. Again, also in this 
scenario the transcript levels of all genes should be affected equally. However although 
several synaptic genes were affected in the mutant, several synaptic proteins were not 
had similar transcript levels in the mutant, like SNAP25, VAMP2 and synaptotagmin 1. 
Therefore the regulation of some synaptic transcripts is not caused by apoptosis of a 
speciﬁc part or a changed innervation of the cortex. In conclusion, apoptosis in the 
mutant brain cannot explain the differences in transcript levels in the mutant cortex.
Genes expressed in immune and glial cells and genes with a lysosomal function had 
relatively high RNA levels in the mutant at E18. Some of these transcripts are similar 
in neurons (Holness et al., 1993; Schafer et al., 2000). These transcripts may have higher 
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levels in the mutant as a result of inﬁltration of the brain by immune cells to remove 
the apoptotic cells in the lower brain areas. Therefore, the increase in some immune 
response transcripts may be an indirect effect of the synaptic defects.
Expression of synapse function genes is regulated by synaptic 
release
Groups of genes involved in synapse function contained the highest amount of 
regulated genes and most pronounced affected genes. Most of these transcripts were 
lower in the mutant at E18, but their levels were similar at E14 and E16, when synapses 
are not yet functional in the cortex (Konig, et al., 1975).  For instance, the levels for Doc2, 
syntaxin 1a (both Munc18-1 binding proteins), syntaxin 3A and synaptogyrin 3 were 
lower in the mutant at E18 (see chapter 5). A plausible explanation for these observations 
is that normally synaptic release increases the RNA levels of genes involved in synapse 
function, but is not increased in the munc18-1 mutant that lacks synaptic release. Other 
studies have shown a regulation by activity of these synaptic genes (Sutton et al., 1999; 
Davis et al.,, 1998 ; Belizaire et al., 2004). However, in this study the expression of these 
genes may also be reduced as a direct effect of the low levels of their binding partners. 
In addition, dark-rearing postnatal mice leads to changes in the expression of synaptic 
proteins (Tropea et al., 2006). However, this study especially showed an increase in 
the expression of receptor subunits, this in in contrast to our results. In the group 
secretory pathway also veli, neurexin II and neurexin III had different transcript levels 
in the mutant. Munc18-1 is connected to the CASK/Veli/Mint complex via binding to 
Mint1, this complex is hypothesized to have a role in synapse formation (Scheiffele, 
2003). However, these differences in RNA levels could not be conﬁrmed using qPCR and 
therefore might be a false positive of the array (see chapter 5). 
The gene group cell mobility is another group containing a high number of regulated 
genes. The increase in the levels of cell mobility genes, like cytoskeleton genes, may be 
necessary in control animals for the morphological changes that occur during synapse 
maturation. Some cytoskeletal genes have been shown to be regulated by synaptic 
release (Lyford et al. 1995) and some have been shown to be essential for spine mobility 
(Ackermann and Matus, 2003; Meng et al., 2003). However, in the munc18-1 mutant the 
affected cell mobility genes were mainly involved in synapse function, like calbindin-
28K, and calretinin. This observation provides more proof that especially synapse 
function expression is affected in the mutant.  
In this study genes involved in synaptic function had mainly lower RNA levels in the 
mutant, whereas genes involved in cell adhesion had both higher and lower levels. This 
difference may occur because cell adhesion molecules have a very diverse role in the 
brain. Cell adhesion molecules are not only important in neurons, but also in glial cells 
and immune cells, whereas synapse function molecules have a more speciﬁc role.
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Synapse instability is not inﬂuenced on gene expression level
At E16 and E18 less synapses are present in the cortex of the mutant (chapter 2), possibly 
because synapses cannot be preserved without synaptic activity. In control animals, 
activity may increase the expression of several genes. This increase may be essential for 
the maturation of synapses. Without activity, such as in the mutant, the expression of 
these genes will not be increased and synapses may be eliminated. Candidate genes, 
involved in this phenomenon, may have a function in synapse structure, such as cell 
adhesion molecules or PSD-molecules. However, the transcript levels of these genes 
are not severely reduced in the mutant. Thus, the instability of synapses in the mutant is 
probably caused by an intrinsic effect of the deletion of munc18-1 (see also Heeroma et 
al., 2004). On the other hand, the reduction in the RNA levels of several genes involved 
in cell-cell signaling is most likely regulated by synaptic release, because the expression 
of these genes was similar in mutant and control animals at E14 and E16. In control 
animals this synaptic activity-dependent increase in neuronal secretion genes may be 
essential for the formation of mature synapses.
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REDUCED EXPRESSION OF NEUROPEPTIDE
GENES IN A MOUSE MODEL
LACKING SYNAPTIC ACTIVITY

ABSTRACT
Activity-dependent changes in synapses rely on functional changes in resident 
proteins and on gene expression. We addressed the relation between synapse activity 
and the expression of synaptic genes by comparing RNA levels in the neocortex 
of normal mice versus synaptically silent munc18-1 null mutants, using microarray 
analysis, quantitative PCR and Northern blotting. We hypothesized that RNA levels of 
synaptically released compounds will be reduced in mutants, relatively to controls. 
We found that all neuropeptide genes detectable on the microarray had different 
transcript levels, being 3-20 fold higher in control cortex. Transcript levels for genes 
encoding for their receptors and most other synaptic components were similar in the 
mutant. Differences in the transcript levels of neuropeptide genes were conﬁrmed 
by qPCR analysis. In situ hybridization indicated that the difference in neuropeptide 
expression was uniform and not due to the loss of speciﬁc cells in the mutant. In 
primary sensory neurons, which do not depend on synaptic activity for their input, the 
differences in neuropeptide transcript levels were not observed. These data reveal no 
simple relation between activity of synapses and expression of their resident proteins, 
but identiﬁed a unique feature of neuropeptide gene expression, which appears to 
depend on synaptic activity.
INTRODUCTION
The strength of synaptic coupling between neurons is regulated by a number of 
different mechanisms acting on different time scales both during development 
and in mature networks. Most of the short-term changes probably depend on local, 
activity dependent changes in resident proteins, e.g. translocation, phosphorylation 
etc. Long-term changes probably involve changes in protein composition of the 
synapses involved. Indeed, gene expression is essential for some forms of synaptic 
plasticity (see for instance (Nguyen et al., 2002). Several lines of evidence suggest a link 
between synapse use and the supply of synaptic components via activity dependent 
gene expression. Firstly, interference with sensory input decreased the expression 
of synaptic genes (Munoz et al., 1998). Secondly, pharmacological interference with 
action potential propagation or synaptic activity decreased the expression of synaptic 
genes (Missias et al., 1996; Corriveau et al., 1998; Hoffmann et al., 2000; Loeb et al., 2002). 
Conversely, agents that induce synaptic activity also induced the expression of several 
synaptic components (Nedivi, 1999; Lou and Bixby, 1995; Plunkett et al., 1998).
In addition to genes encoding resident synaptic proteins, synaptic activity may also 
inﬂuence the expression of synaptic ‘consumables’, like secreted neuropeptides, 
neurotrophins and their co-factors. For instance, BDNF RNA levels are regulated by LTP 
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and injury (Hughes et al., 1999) and BDNF immunoreactivity was reduced after visual 
deprivation in retinal ganglion cells (Seki et al., 2003). Lesions in the cortex decreased 
VGF RNA levels in the ipsilateral cortex (Snyder et al., 1998) but increased the RNA 
levels of cholecystokinin, neuropeptide Y, and somatostatin (Jacobs et al., 1994). 
Furthermore, intraocular tetrodotoxin injection rapidly decreased the levels of VGF 
in the geniculate nucleus (Snyder et al., 1998) and the depolarizing agent veratridine 
increased the RNA and protein levels of somatostatin in cortical cultures (Tolon et al., 
1996).
Together these lines of evidence identify a relationship between neuronal activity 
or synapse use and the expression of certain synaptic components and secreted 
factors. Such a coupling may be a general principle that contributes to the proper 
establishment of functional synapses during brain development and to various long-
term changes in synaptic coupling in the adult brain. However, it is currently unclear 
how such principles may operate, whether expression of all synaptic components is 
regulated in a concerted manner, when synapses have just formed and in the adult 
brain, and whether expression is primarily coupled to the activity of the whole neuron 
or directly to the activity of its synapses.
To get a better insight into these issues, we examined the effect of synaptic activity on 
the RNA levels in vivo in a mouse model devoid of synaptic activity. The munc18-1 null 
mutant mice are characterized by the complete loss of both evoked and spontaneous 
release events from both inhibitory and excitatory neurons in the brain, but do 
show spontaneous action potentials in individual cells and morphologically normal 
synapses (Verhage et al., 2000; Bouwman et al., 2004; Heeroma et al., 2003). The release 
from large dense cored vesicles is also severely impaired (Voets et al., 2001, Korteweg 
et al., 2005). Consequently, these mutants will also fail to induce expression of genes 
that are normally induced by synaptic activity in normal animals. By comparing RNA 
levels between wildtypes and mutants at the time when synapses become active, 
such activity dependent genes can be identiﬁed. For this purpose we performed 
an open microarray screen and found that few genes were differentially expressed 
between mutants and wildtypes. However, striking differences in the expression of 
neuropeptide genes were observed, but not of their receptors, neurotransmitter 
producing enzymes and neurotransmitter-receptors. We investigated this further by 
real-time quantitative PCR and Northern blot analysis and used in situ hybridization 
to exclude that the loss of speciﬁc cells accounted for the differences in neuropeptide 
mRNAs between mutants and controls.
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EXPERIMENTAL PROCEDURES
Laboratory animals
Munc18-1 deﬁcient mice were generated as described before (Verhage et al., 2000). 
Mouse embryos were obtained by caesarean section of pregnant females from timed 
heterozygous matings. The day a vaginal plug was observed was considered to be 
embryonic day 0 (E0). Embryos were harvested from mothers rapidly sacriﬁced after 
timed matings at E14, E16 and E18. Experimental procedures were carried out with 
local regulatory approval for animal experimentation, according to the Dutch law for 
animal welfare.
RNA isolation
See chapter 3.
Microarrays
See chapter 3.
Northern
Total RNA was isolated from brains of E18 embryos by using Trizol (Invitrogen, San 
Diego, USA). The RNA (10 µg/lane) was subjected to electrophoresis (1.0% agarose, 
0.04 M 3-[N-morpholino]propanesulfonic acid (pH 7.0), and 1.75% formaldehyde), 
transferred to a charged nylon membrane (Amersham, Uppsala, Sweden) and UV 
cross-linked (3 min). Sequential hybridizations were performed to cDNA probes 
for enkephalin and GAPDH, respectively. After prehybridization (65° C, 30 min, 0.5 
M NaHPO4 pH 7.0, 1% BSA, 1 mM EDTA, 7% SDS) hybridizations were performed 
overnight at 65°C in the same buffer now containing 0.2 × 106 cpm/ml probe, labeled 
with α-32P dCTP to a speciﬁc activity of 2 × 109 cpm/µg, using the Random Primers 
DNA Labeling System (Roche, Basel, Switzerland). After hybridization, the membrane 
was washed twice in hybriwash 5 (65° C, 5 min, 40 mM NaHPO4 pH 7.2, 1 mM EDTA, 
5% SDS) and twice in hybriwash 1 (65° C, 15 min, 40 mM NaHPO4 pH 7.2, 1 mM EDTA, 
1% SDS) and then exposed up to 48 hr in a PhosphoImager screen (Fuji, Tokyo, Japan). 
Signals were analyzed with Aida 3.0 software. 
qPCR
See chapter 3.
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In situ hybridization
In situ hybridization was carried out as described by Schaeren-Wiemers and 
Gerﬁn-Moser (Schaeren-Wiemers and Gerﬁn-Moser, 1993), with minor changes. 
Cryostat sections of the whole brain, cut at 16 µm thickness, were thaw-mounted 
onto poly-L-lysine coated slides, dried and ﬁxed for 10 minutes in freshly made 
4% paraformaldehyde in phosphate-buffered saline (PBS). After washing with 
PBS sections were acetylated for 10 minutes in a solution containing 245 ml H2O, 
0.013% triethanolamine, 438 µl HCl (37%) and 625 µl acetic anhydride. Sections 
were then washed with PBS and prehybridized for 2 hours at room temperature in 
a hybridization solution (50% deionidized formamide, 5X SSC (20X SSC: 3 M sodium 
chloride, 0.3 M sodium citrate), 0.1% Ficoll 400, 01% polyvinylpyrrolidone, 0.1% bovine 
serum albumine, 250 µg/ml baker’s yeast RNA and 500 µg/ml herring sperm DNA). 
Hybridization was performed overnight at 72° C with 300-1300 ng/ml digoxygenin-
labeled RNA probe in 150 µl hybridization buffer. Sections were then washed shortly 
with 2X SSC and washed for 2 hours in 0.2X SSC at 72° C. Preincubation with 1 ml 
buffer 1 (100 mM Tris-HCl pH 7.4; 150 mM NaCl) with 10% heat inactivated fetal 
calf serum (hiFCS) was performed for 1 hour at room temperature in a humidiﬁed 
chamber. The sections were then incubated overnight at 4° C with alkaline 
phosphatase-conjugated mouse anti-digoxygenin Fab fragment (Roche, Basel, 
Switzerland), 1:5000 diluted in buffer 1 with 1% hiFCS. Following washing with buffer 1 
and equilibration with buffer 2 (100 mM Tris-HCl, pH 9.5; 50 mM MgCl2; 100 mM NaCl), 
the color reaction was performed in the dark for 24 hours at room temperature with 
200 µl NBT/BCIP solution (Roche, Basel, Switzerland) and 2.4 mg levamisole in buffer 2.
Extraction of Substance P from brain
Brains or cortices were solubilized with a tissue homogenizer and were then sonicated 
on ice (3 x 10 sec) in 10 mM Hepes (pH 7.4) with proteinase inhibitors (Roche, Basel, 
Switzerland). Then NaCl and Triton-X100 were added (ﬁnal concentration: 150 mM 
and 1%, respectively) and the samples were rotated at 4°C for 1 h. Homogenates were 
centrifugated for 5 min at 16,100g. 
Reverse-phase columns (1.0 ml C18) were activated with methanol, followed by rinsing 
with TFA (triﬂuoroacetic acid; 7.5 mM). Samples (supernatant of homogenate) were 
loaded on columns and the columns were washed two times with TFA. Substance P 
was eluted from the columns with 1 ml of 60% acetonitrile in 7.5 mM TFA. The samples 
were dried in a speed-vac until 10 µl was left and 100 µl EIA buffer was added (Cayman 
Chemical Co., Ann Arbor, MI, USA). Solubilized peptides in the sample were quantiﬁed 
using a BCA protein assay (Pierce, Rockford, Illinois, USA).
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Figure 1: Quantiﬁcation of expression levels in control and mutant animals by array, qPCR 
and Northern blot. A: Quantiﬁcation of RNA levels using microarray technology. Control RNA was 
labeled with Cy3 (green) and mutant with Cy5 (red). Levels were standardized to the total level in the 
channel (green or red). Each picture represents a certain gene in duplicate with the surrounding spots 
on the array. Green: higher in control. Red: higher in mutant. Yellow: equal expression. The intensity 
of the spot indicates the abundance of the transcript. For results see ﬁgure 2. B: Raw data of a qPCR 
experiment on wild type and mutant for substance P and HPRT. X-axis: PCR cycles numbers, Y-axis: 
ﬂuorescence. If the curve passes the threshold the number of cycles that the PCR has performed at 
that point is the read-out for the abundance of the transcript. C: Comparison of qPCR data and array 
data for neuropeptide genes, indicating that the results from the qPCR and array experiments are 
similar. An important observation is that the array experiment gives less pronounced differences than 
the qPCR. Dark gray bars represent qPCR regulation data and lighter gray bars represent array data. 
Error bars indicate the SEM.
Quantiﬁcation of substance P; enzyme immunoassay
The quantiﬁcation of Substance P in brain samples was accomplished by an antigen 
competition enzyme immunoassay (EIA) (Cayman Chemical Co., Ann Arbor, MI, USA). 
In the assay substance P coupled to acetylcholinesterase and substance P in the lysed 
brain sample compete. The acetylcholinesterase hydrolyzes acetylthiocholine to 
thiocholine and this in turn reacts with 5,5’-dithio-bis-2-nitrobenzoic acid, producing 
a 5-thio-2-nitrobenzoic acid absorbing at 412 nm. To the wells, which are pre-coated 
with monoclonal anti-rabbit antibody, 50 µl of the lysed brain sample was added. Then 
50 µl of the acetylcholinesterase-conjucated substance P and 50 µl of rabbit anti-
substance P was added, except to the non-speciﬁc binding wells, in which buffer was 
added. The plates were then incubated at 4° C overnight and washed for 5 times with 
wash buffer. Then, 50 µl of the enzyme substrate was added and incubated for 1 hour 
at room temperature, in the dark with rotation. The absorbance was measured at 405 
nm in a microplate reader (Biorad, Hercules, CA, USA). We calculated the net optical 
density (OD) dividing the sample values by the non-speciﬁc binding values. The OD 
values were divided by the amount of peptide in the sample (that was measured with 
the BCA) and compared between mutant and control. The results were standardized 
to synaptobrevin and GDI levels, which were quantiﬁed by Western blot.
RESULTS
Microarray analysis identiﬁes neuropeptide genes as the main 
differentially expressed gene group.
To address the relation between synaptic activity and neuropeptide expression, we 
compared the RNA levels between munc18-1 null mutant and control neocortex 
at embryonic day (E) 14, 16 and 18. We analyzed the neocortex because some other 
brain areas suffer from degeneration at E18 in the null mutant, but the neocortex 
shows no signs of impaired viability or aberrant organization (chapter 2). Comparisons 
were made at this late embryonic stage because the number of synapses in the 
neocortex was previously found to increase 3 fold between E16 and E18 (chapter 2) 
and synaptic secretion events were readily observed in control neocortical slices at 
this stage (Verhage et al., 2000). Hence, there is a suitable time window of massive 
synaptogenesis during prenatal development to study induction of synaptic gene 
expression in lethal mutants.
We analyzed the transcript levels using microarray analysis of a 7k oligonucleotide 
library (Fig. 1A). More than 90% of the detected mRNAs showed no differences 
between the mutant and controls. Genes which were affected in the mutant with 
a similar function were grouped according to Gene Ontology (GO) assignments 
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Figure 2: Quantiﬁcation of RNA levels in control and munc18-1 mutant mice at E18 by qPCR 
and array. A: RNA levels of E18 embryos of both control and mutant mice were measured using 
both qPCR and microarrays. First column: Name of the transcript and group to which the transcript 
belongs. Second column: Expression data from literature, whether or not the transcript is expressed 
in the mouse cortex (? = not found in literature, +/- = medium expression levels, + = high expressed, 
++ = very high expressed, +++ = extremely high expression levels). Third column: First detected 
time point in embryonic development of expression of the transcript in literature (? = not found in 
literature). Fourth column: RNA levels of several transcript were measured by microarray. Indicated 
is the relative difference (fold regulation) in expression in mutant as compared to control animals. 
Data are averages, n = 11 (N.A. is not analyzed, N.D. is not detectable). Only the neuropeptides 
cholecystokinin, dynorphin, enkephalin, neuropeptide Y, somatostatin and substance P and BDNF, 
neuropeptide-Y receptor 1 and the GABA-A receptor subunit α5 were signiﬁcantly different in the 
mutant relative to control mice (*, α = 5%). Fifth column: RNA levels were measured by qPCR and 
standardized to hypoxanthine phosphoribosyl transferase (HPRT). Indicated is how many times the 
transcript is more expressed in mutant relative to control (n = 3 except for proprotein convertases and 
secretory protein: n = 6: N.A. is not present in oligoset). Between brackets the standard error of the 
mean (SEM). Only Dynorphin, Enkephalin, Somatostatin, Substance P, BDNF, Tyrosine hydroxylase 
and the Serotonin receptor 1B differed signiﬁcantly between mutant and control (*, α = 5%). Sixth 
column: A estimate of the abundance of a certain transcript is obtained by the difference between the 
cycle threshold of HPRT and the speciﬁc transcript (∆Ct value) of the qPCR: very low: ∆Ct > 4, low: 
(see chapter 3). Of the gene groups containing 15 or more affected genes the most 
enriched (more than 2 times) groups were synaptic transmission, steroid metabolism, 
transmission of nerve impulse, and cell-cell signaling. The group cell-cell signaling 
included a large number of gene encoding neuropeptides. For a full description of 
these data see chapter 3 of this thesis. Here we report on an analysis and validation of 
the remarkable differences in neuropeptide gene expression.
RNA levels of neuropeptide genes were always higher in controls than in the mutants 
(Fig. 2). In the microarray analysis, levels of the somatostatin and substance P genes 
showed the largest differences (3 fold higher in the controls, Fig. 1A and 2). RNA 
levels of the dynorphin and enkephalin gene were 1.5 fold higher in the controls 
and cholecystokinin levels were also signiﬁcantly higher (1.2 fold). The transcript 
levels of the neurotrophic gene BDNF were 1.5 fold higher. In contrast to the secreted 
neuropeptides, other synaptic signaling genes were not unaffected(Fig. 2). The only 
(minor) differences were observed for the genes encoding the neuropeptide-Y-
receptor-1 (1.6 fold) and the GABAA receptor subunit α5 (1.8 times). Thus, 5 out of 5 
neuropeptides showed marked differences in transcript levels, while 2 out of 22 other 
genes that have a role in synaptic signaling showed slight change in RNA levels.
qPCR conﬁrms the differential expression of neuropeptide genes 
For independent proof, we analyzed the transcript levels of the synaptic signaling 
genes also using quantitative PCR. The levels were measured relative to hypoxanthine 
phosphoribosyl transferase (HPRT, Fig. 1B). The cycle-threshold of a transcript relative 
to the control gene HPRT is an estimate of the relative amount of RNA in the cortex. 
Most neuropeptides had different RNA levels in the mutant, in a similar way as found 
on the microarray, although the absolute differences varied (Fig 1C). The transcript 
levels of dynorphin were 4 fold higher in the controls, the levels of enkephalin 2 fold 
and that of somatostatin and substance P 3 and 24 fold higher respectively (n=3). 
In contrast to the neuropeptides, the RNA levels for the corresponding receptors 
proprotein-convertases, most classical transmitter-receptors and classical transmitter 
synthesizing enzymes were not affected (Fig 2).
We also analyzed the RNA levels of enkephalin, dynorphin and substance P (data 
not shown) independently using Northern blotting, and conﬁrmed their difference 
1<∆Ct<4, medium: -1 < ∆Ct < 1, high: -4 < ∆Ct < -1, very high: ∆Ct <-4. Graph: Amount of transcript 
present in the mutant relative to control as measured with qPCR. For each transcript the amount was 
standardized to HPRT. Data represent mean ± SEM of 3 animals per transcript, but for proprotein 
convertases and secretory protein 6 animals per sample. (1(Alvarez-Bolado et al., 1990) (rat), 2(Rius 
et al., 1991) (mouse), 3(Burgunder, 1994) (rat), 4(Ni and Jonakait, 1988) (mouse), 5(Thoss et al., 1995) 
(rat), 6(Lobo and Parnavelas, 1988) (rat), 7(Gambarana et al., 1990) (rat), 8(Van Eden et al., 1995) 
(rat), 9(Poulter et al., 1992) (rat), 10(Laurie et al., 1992) (rat), 11(Luo et al., 1996), 12(Wenzel et al., 1997), 
13(Martin et al., 1998), 14(Marcinkiewicz et al., 1994), 15(Han and Morgan, 1999), 16(Burgunder and 
Young, 1990). 
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in transcript levels. In conclusion, microarray analysis, qPCR and Northern blotting 
showed that neuropeptide genes had differences in transcript levels at E18, while 
almost all other synaptic signaling genes were not.
Selective loss of neuropeptide expressing cells cannot explain 
different mRNA levels.
The observed differences in neuropeptide mRNA levels in the neocortex might be 
caused by a selective loss or dysgenesis of certain neuropeptide expressing neurons. 
Therefore, we performed in situ hybridization on mutant and control animals at E18 
for neuropeptide Y, somatostatin and somatostatin receptor 1 mRNAs (Fig. 3). The 
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Figure 3. Distribution of neuropeptides and neuropeptide receptors in control and mutant mice. 
In situ hybridization on E18 control (ﬁrst column) and mutant (second column) mice with probes against 
Somatostatin, Somatostatin receptor, and Neuropeptide Y. Control stainings with sense probes were empty 
(data not shown). Caudate putamen (CP), Hypothalamus (H), Lateral ventrical (LV), Neocortex (NC), and 
Thalamus (T). Staining for both neuropeptides (Somatostatin and Neuropeptide Y) was especially strong in 
the cortex; some staining for the neuropeptide receptors (Somatostatin receptor and Neuropeptide receptor 
(data not shown)) was also seen in the cortex. The localization of the staining in control and mutant mice is 
comparable.
expression patterns of these mRNAs were similar in mutants and controls and in 
line with earlier studies (Alcantara et al., 1998; Burgunder, 1994; Tong et al., 1997; 
Wulfsen et al., 1993). Somatostatin hybridization was present in the neocortex, but 
also highly expressed in the olfactory tubercle. Almost no expression was detected 
in the thalamus and hypothalamus. Hybridization for neuropeptide Y was detected 
in especially the cortex, but also in the olfactory tubercle and the caudate putamen. 
No hybridization signal was present in the thalamus and hypothalamus. For the 
somatostatin receptor low expression was found only in the neocortex. The sense 
probes did not produce signal on the sections for neither the neuropeptide nor the 
receptor transcripts (data not shown). These data indicate that a selective loss or 
dysgenesis of certain neuropeptide expressing neurons in the cortex cannot explain 
the lower levels of neuropeptide mRNAs in the mutant.
Neuropeptide genes are not differentially expressed at earlier 
stages
Genes regulated by synaptic activity should not be differentially expressed in the 
neocortex before E18, because few synapses have formed and no synaptic activity 
was detected before this stage (Konig et al., 1975; Verhage et al., 2000). To test this, we 
analyzed the transcript levels at E14 and E16 in the cortex of mutants and controls 
by qPCR (Fig. 4). Indeed, at E14 and E16 the transcript levels of tested neuropeptide 
were similar (n=3), although all transcripts were detectable at both these earlier 
stages. Hence, no differences in neuropeptide levels were detected in stages when no 
functional synapses are present.
In comparison to E18 (see also Fig. 1-2), the expression of all neuropeptide genes was 
lower at E14-16 (Fig. 4, left column) in controls. Therefore, it can be concluded that 
neuropeptide gene expression is induced between E14 and E18 in normal murine 
cortex, but this induction did not occur in the mutant. In contrast, differences in RNA 
levels of the munc18-1 itself were observed independent of embryonic age (Fig. 4).
Neuropeptide genes are not differentially expressed in sensory 
neurons
In contrast to other neurons, many sensory neurons do not depend on synapses to 
be activated, but are directly activated by the sensory receptors. Therefore, sensory 
neurons are expected to receive normal input in the munc18-1 mutant. If synaptic 
input determines neuropeptide expression, the neuropeptide transcript levels 
should be similar in sensory neurons. To test this, we investigated the RNA levels of 
neuropeptides in the sensory neurons of the dorsal root ganglia (Fig. 5) at E18. In 
contrast to the neocortex, substance P transcript levels were similar in these ganglia 
and galanin and enkephalin had even higher levels in the mutant. The mRNA levels for 
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the control gene, GAPDH, were similar and munc18-1 mRNA was not detected in the 
mutant, as expected. Thus, differences in transcript levels of neuropeptides were not 
observed in neurons that are expected to have normal activity. 
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Figure 4: RNA expression at E14, E16 and E18 in mutant relative to control mice. RNA levels were 
quantiﬁed in mutant and control animals of embryonic day 14, 16 and 18. Each bar represents the average 
regulation in mutant relative to controls ± SEM (n=3). Signiﬁcant differences (*) are calculated by Student’s 
t-test (α=5%). An estimate of the abundance of a certain transcript (qPCR) is expressed as the difference 
between the cycle threshold of HPRT and the speciﬁc transcript (∆Ct value); very low: ∆Ct > 4, low: 1<∆Ct<4, 
medium: -1 < ∆Ct < 1, high: -4 < ∆Ct < -1, very high: ∆Ct < -4. Only the levels of the neuropeptides, dynorphin, 
enkephalin, somatostatin and substance P is signiﬁcantly different at E18. Munc18-1 is differentially expressed 
at all developmental stages.
Substance P protein levels are unaffected
We determined whether the protein levels of substance P, the most affected 
neuropeptide on RNA level, were also affected in the mutant using ELISA (enzyme 
immunoassay). Substance P levels were measured in the cortex (n=3) and in the whole 
brain, including the cortex (n=3). The substance P levels measured were standardized 
to the amount of Synaptobrevin 2 and GTP dissociation inhibitor (GDI) in the sample. 
These proteins were chosen because they have a low molecular weight and are still 
present after puriﬁcation, and their protein levels were shown to be similar in the 
mutant compared to control animals (chapter 2). The peptide levels of Substance P in 
control and mutants were similar in both cortex and whole brain (Fig. 6), even with a 
trend to higher levels in the mutant animals.
In addition, we performed a Western blot for Substance P and Somatostatin (data 
not shown), which showed similar proteins levels in mutant and control animals for 
both neuropeptides. Thus, the protein levels for substance P and somatostatin are not 
affected in the mutant.
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Figure 5. Relative RNA levels of mutant dorsal root ganglia to control DRGs. Quantiﬁcation of RNA levels 
of several transcripts in dorsal root ganglia (DRG) at E18 by qPCR. Bars represent the average expression level 
in four mutant animals compared to four control animals ± SEM (of every animal several DRGs were pooled). 
Black bars represent signiﬁcant and gray bars represent non-signiﬁcant changes. Signiﬁcant differences are 
calculated by Student’s t-test (*, α = 5%). The levels of the neuropeptides enkephalin and galanin in the dorsal 
root ganglia is higher in mutant compared to control mice, while substance P and GAPDH are not changed. 
DISCUSSION
In this paper we demonstrate differences in RNA levels of neuropeptide genes, but not 
neuropeptide receptors, neurotransmitter-producing enzymes, and neurotransmitter-
receptors in a comparison at embryonic day 18 between normal mice and mutant 
mice that lack synaptic activity. These differences were not observed at earlier time 
points, E14 and E16, when functional synapses are rare, and also not in primary sensory 
neurons, which are expected to have a normal synaptic activity in the mutants. In situ 
hybridization indicated that the lower neuropeptide mRNA levels cannot be explained 
by a selective absence of neuropeptide expressing neurons in the mutant. 
 
Methodological errors and apoptosis cannot explain the 
differential expression of neuropeptides
In this study, we used both microarray analysis and qPCR to analyze RNA levels of 
neuropeptides and differences were typically detected with both methods. The 
differences in transcript levels between mutant and control animals as measured by 
qPCR were usually larger than when measured by microarray analysis (see chapter 3 of 
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Figure 6. Protein quantiﬁcation for the neuropeptide Substance P. Substance P levels in the cortex and 
whole brain were quantiﬁed using an enzyme immunoassay, the results were standardized to Synaptobrevin 
and GDI levels, which were quantiﬁed by Western blot (Bars indicate means ± SEM (n=3)). The protein levels 
in cortex and whole brain were not signiﬁcantly different (α=5%).
this thesis). In addition, qPCR was more sensitive than the microarray analysis, thereby 
generating a larger dynamic range to measure differences in transcript levels. For 
instance, the Arg-vasopressin receptor 1A, the substance P receptor and the serotonin 
receptor 1B were only detected by qPCR.
As descripted in chapter 3 of this thesis apoptosis cannot explain the speciﬁc changes 
in neuropeptide RNA levels. Moreover, imprecise dissection of the neocortex is also 
an unlikely explanation for differences in neuropeptide transcripts, because some 
of these genes are expressed mostly (>80 %) within the neocortex and not in the 
surrounding tissue, e.g. neuropeptide Y and somatostatin (see Fig 3). In conclusion, 
apoptosis and imprecise sampling in the mutant brain is not likely to explain the 
selective reduction in neuropeptide transcripts in the neocortex.
Neuropeptide gene expression is regulated by synaptic activity
Groups of genes involved in cell-cell signaling included the highest number of 
regulated genes, many of which coded for neuropeptides. In normal mice, the 
expression of many of these genes is induced around the time that the ﬁrst functional 
synapses develop. In comparison, this increase does not occur in mutants, which 
do establish morphologically similar synapses, however, which do not transmit. A 
plausible explanation for these observations is that synaptic release does increase 
expression of neuropeptides between E16 and E18 but not in the silent munc18-
1 mutant. The observation that neuropeptide transcript levels in sensory neurons 
of the wild type and mutant are similar is in line with a synaptic activity-dependent 
induction of neuropeptide gene expression. Induction of neuropeptide expression 
is also observed in models for nerve injury (Ma and Bisby, 1998; Ma and Bisby, 1999) 
or hyperexcitation (Reibel et al., 2000). This induction may be explained by increased 
synaptic activity in both cases. An alternative explanation for the differences in 
neuropeptide transcrips in our mutant is that Munc18-1 itself acts as a transcriptional 
regulator. However, this is unlikely because of Munc18-1’s subcellular localization, 
lack of DNA-binding motifs and currently available literature, which does not provide 
evidence in this direction.
Transcripts coding for synaptic released proteins were lower in the mutant, such as 
neuropeptides, BDNF and reelin. When the peptides are not released, protein levels 
in the cell may increase, which may feed backward and downregulate its expression. 
However, the expression may also only be increased when synaptic release occurs. 
The low reelin levels may cause the reduced maturation of synapses in the mutant 
(Bouwman et al., 2004). 
In contrast to the RNA level, the protein levels of the neuropeptide substance P 
were not signiﬁcantly affected in the mutant. This observation may be explained by 
a different time course for the production of protein and RNA levels. Alternatively, 
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neuropeptide levels may remain high because they are not released in the mutant. 
The number of LDCVs in the mutant is about 70% of the number in control animals. 
However, the number of synapses is much lower in the mutant (25%; chapter 2). This 
indicates that synapses contain more LDCVs in the mutant. The lower release of LDCV 
in the mutant may lead to more LDCVs in the synapses. When vesicles are not used, 
a feedback mechanism on the transcription may reduce the expression of signaling 
molecules, but their protein levels will be relatively stable in the vesicles. 
Transcript levels of neuropeptide receptors and prohormone convertases were not 
different in the mutant (Fig. 2). This may indicate that neuropeptide receptor gene 
expression does not depend on synaptic activity in a similar way as the neuropeptides. 
On the other hand, expression of neuropeptide receptors may lag behind expression 
of the neuropeptides and their induction may be part of a later phase. Proprotein 
convertases (PC1, and PC2), which cleave prohormones into the functional 
neuropeptides and are usually secreted together with the peptides, were unaffected 
in the mutant. This is in contrast with earlier research in the snail, Lymnaea stagnalis 
(Spijker et al., 2004b), where expression of neuropeptides and proprotein convertases 
is coupled upon physiological stimulation.
We anticipated that the expression of many synaptic genes would be altered 
in mutants that are unable to use their synapses. In contrast, most of the genes 
measured were unaffected and genes encoding neuropeptide receptors, classical 
transmitter receptors and converting enzymes were unaffected as well. Hence, the 
current results suggest that different biological principles exist to regulate expression 
of synaptic signaling genes. Whereas expression of neuropeptide genes appears to 
depend directly on the (abundance and) activity of synapses, other synaptic genes are 
regulated independent of this. Further genomic research is necessary to unravel the 
mechanisms behind these different principles. It can be expected that different control 
regions and transcriptional regulators orchestrate the induction of neuropeptide 
genes and of other synaptic genes. Such studies may also shed light on the question 
what the evolutionary advantage may be of the speciﬁc coupling between synaptic 
activity and neuropeptide gene expression.
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APPENDIX -Chapter 2
Fig. 3: Localization of pre- and postsynaptic proteins in neurons. Immunostaining for AMPA-receptor 
GluR2/3 shows receptors are targeted similar in wild type (B) and mutant (E). Staining for VAMP2 indicates 
that the localization of presynaptic proteins is unaffected in mutant (D) compared to wild type(A). The overlay 
of these two stainings (C,F) shows adjacent staining for the pre- and postsynaptic marker. The scheme to 
the side (Uylings et al., 1990) showed what part of the cortex is represented in the pictures. Abbreviations: V, 
ventricular zone; SV, subventricular zone; IZ, intermediate zone; SP, subplate; CP, cortical plate; MZ, marginal 
zone.
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REDUCED SYNTAXIN1 PROTEIN 
AND TRANSCRIPT LEVELS IN BRAINS OF 
MUNC18-1 NULL MUTANT MICE

ABSTRACT
It is known that Munc18-1 binds to the SNARE-complex member Syntaxin1 with high 
afﬁnity. This interaction may have a role in synaptic release. In addition, this interaction 
enhances the stability of Syntaxin1. Here we show that Syntaxin1 protein levels in the 
munc18-1 null mutant neocortex, which lacks synaptic release, were reduced to 30% 
of control levels. However, the protein levels for several other synaptic proteins were 
unaltered, including the SNARE-complex members SNAP25 and Synaptobrevin2. 
Moreover, syntaxin1 transcript levels were reduced to 60% of control levels, whereas 
the transcript levels of other synaptic genes were unaltered. In primary sensory neurons, 
which do not depend on synaptic release for their input, Syntaxin1 protein levels were 
lower in the munc18-1 mutant as well. However, transcript levels were unaffected in 
these neurons. Expression of munc18-1 in HEK-293 cells did not change the expression 
of any of the tested synaptic proteins, including Syntaxin1.
We conclude that syntaxin1 is the only core complex member of which transcript levels 
are regulated by input activity. This effect will reduce the syntaxin1 protein levels in 
the munc18-1 mutant. The protein levels in this mutant are further reduced by a direct 
effect of the loss of munc18-1. 
INTRODUCTION
Neurotransmitter secretion from synaptic vesicles in the mammalian brain depends on 
many interacting proteins. For this process the SNARE-complex, which is composed of 
three strongly interacting proteins (SNAP25, Synaptobrevin and Syntaxin1), is required. 
Several proteins have been implicated in the assembly and regulation of this SNARE-
complex. Munc18-1, for instance, binds with high afﬁnity to Syntaxin1 (Hata et al., 1993) 
and is thought to regulate secretion via this interaction. 
In addition to regulation by binding partners, Syntaxin1 levels have also been shown 
to be regulated by activity. For instance, prenatal sound stimulation increases the 
protein levels of syntaxin1 in the chick brainstem (Alladi et al., 2002). A similar increase 
in syntaxin1 RNA levels was observed in the hippocampus after a working memory task 
by using in situ hybridization (Davis et al, 1998). In these papers only the expression of 
syntaxin1 was studied. Therefore, the effect on gene expression may be a more general 
effect. The levels of all synaptic proteins may be raised by an increase in the number 
of synapses. In addition, the stimulation protocols that were used in these papers may 
affect other processes than activity. As was shown in chapter 3 and 4 of this thesis 
often several genes of a functional group are regulated simultaneously. However, gene 
expression of syntaxin1 but not of other SNARE-complex members are affected by 
activity. For instance, the expression of syntaxin1 can be induced by overexpression 
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of P/Q-type calcium channels or ionomycin treatment of HEK-293 cells (Sutton et al., 
1999), whereas SNAP25 and synaptobrevin were unaffected. A similar effect was seen 
by induction of long-term potentiation in the dentate gyrus: syntaxin1 transcript levels 
increased, while the levels of other SNARE complex member were unaltered (Hicks et 
al., 1997). These studies all show that the expression of syntaxin1 is very dynamic and 
enhanced activity showed an increase in syntaxin1 levels. 
In the munc18-1 mutant, which is severely impaired in all components of synaptic release 
(Verhage et al., 2000; Voets et al., 2002), Syntaxin1 protein levels are reduced to 30% of 
the amount present in control animals, while the levels of the other SNARE-complex 
members are unchanged. Munc18-1 was shown to stabilize Syntaxin1 protein levels, as 
was shown by pulse-chase analysis of syntaxin levels in munc18-1 overexpressing HEK-
293 cells (Toonen et al., 2005). In the munc18-1 null mutant Syntaxin1 is less stable in 
the absence of its binding partner Munc18-1. This reduction in Syntaxin1 protein levels 
however, may also be an effect of the lack of synaptic release in the mutant. Activity 
may, for instance, regulate syntaxin1 transcription. 
This study aims to get insight into the role of synaptic release and the Munc18-1/ 
Syntaxin interaction in syntaxin1 mRNA and protein expression. We measured protein 
and transcript levels of syntaxin1 in the munc18-1 null mutant neocortex. This mutant 
is devoid of all synaptic activity and munc18-1, but has spontaneous action potentials. 
In order to make a distinction between effects of Munc18-1 and synaptic activity we 
measured syntaxin1 levels in mutant dorsal root ganglia (DRG). In contrast to mutant 
CNS neurons, mutant DRG neurons probably get input from the sensory cells, but both 
lack munc18-1. Protein levels were reduced in both the neocortex and the sensory 
DRG neurons. However, transcript levels were only reduced in the neocortex and not in 
the DRG neurons. These data suggest that synaptic release can adjust syntaxin1 gene 
expression. To test whether Munc18-1 can affect syntaxin1 gene expression as well, we 
overexpressed munc18-1 in HEK-293 cells. No signiﬁcant effect of this overexpression 
was found on syntaxin RNA levels. Therefore, gene expression of syntaxin1 most likely 
depends on input activity and Munc18-1 is mainly involved in stabilization of Syntaxin1 
proteins levels. Both effects will contribute to the reduced syntaxin1 protein levels in 
the munc18-1 null mutant.
EXPERIMENTAL PROCEDURES
Laboratory animals
Munc18-1 deﬁcient mice were generated as described before (Verhage, et al., 2000). 
Mouse embryos were obtained by caesarean section of pregnant females from timed 
heterozygous matings. The day a vaginal plug was observed was considered to be 
embryonic day 0 (E0). Embryos were harvested from mothers and rapidly sacriﬁced 
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after timed matings at E16 and E18. Experimental procedures were carried out with 
local regulatory approval for animal experimentation, according to the Dutch law for 
animal welfare.
RNA isolation
RNA was isolated from mutant and wild type animals by using the Trizol 
method (Invitrogen, San Diego, USA). The amount of RNA was measured using 
a spectrophotometer and Bioanalyzer (Agilent technologies, Palo Alto, USA). 
Approximately similar amounts of RNA were used in cDNA reactions or on a Northern 
gel. Genomic DNA was removed by a DNAse I treatment, which was apparently 
sufﬁcient since genomic primers developed to detect an HPRT intron did not result in 
a PCR product.
qPCR
See chapter 3.
Northern
Total RNA was isolated from brains of E18 embryos by using Trizol (Invitrogen, San Diego, 
USA). The RNA (10 µg/lane) was subjected to electrophoresis (1.0% agarose, 0.04 M 3-
[N-morpholino]propanesulfonic acid (pH 7.0), and 1.75% formaldehyde), transferred to 
a charged nylon membrane (Amersham, Uppsala, Sweden) and UV cross-linked (3 min). 
Sequential hybridizations were performed to cDNA probes for syntaxin1 and GAPDH, 
respectively. After prehybridization (at 65°C for 30 min; 0.5 M NaHPO4 pH 7.0, 1 % BSA, 
1 mM EDTA, 7 % SDS) hybridizations were performed overnight at 65°C in the same 
buffer now containing 0.2 × 106 cpm/ml probe, labeled with α-32P dCTP to a speciﬁc 
activity of 2 × 109 cpm/µg, using the Random Primers DNA Labeling System (Roche, 
Basel, Switzerland). After hybridization, the membrane was washed twice in hybriwash 
5 (at 65°C  for 5 min; 40 mM NaHPO4 pH 7.2, 1 mM EDTA, 5% SDS) and twice in hybriwash 
1 (at 65°C for 15 min; 40 mM NaHPO4 pH 7.2, 1 mM EDTA, 1% SDS)
 and then exposed up 
to 48 hr in a PhosphoImager screen (Fuji, Tokyo, Japan). Signals were analyzed with Aida 
3.0 software.
Cortical cultures
Cortices were dissected from embryonic day 18 mice and collected in Hanks Buffered 
Salts Solution (HBSS) (Sigma, St. Louis, USA), buffered with 7 mM Hepes. After removal of 
the meninges, the cortices were incubated for 30 minutes in trypsinated HBSS at 37 °C. 
After washing the neurons were triturated with ﬁre polished Pasteur pipettes, counted 
with a hemacytometer and plated in Neurobasal medium (Invitrogen, Carlsbad, USA) 
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supplemented with 2 % B-27 (Invitrogen), 1.8 % Hepes, 1 % glutamax (Invitrogen), 1 
% Pen/Strep (Invitrogen) and 0.2 % β-mercaptoethanol. Low-density cultures were 
plated on poly-L-lysin coated glass coverslips at 25,000 cells/cm2. For island cultures, 
neurons were plated at 6,000 cells/cm2 on islands of rat glia. Glial islands were obtained 
by spraying a 0.25 mg/ml rat tail collagen solution (BD Biosciences, Bedford, USA) on 
glass coverslips. After drying and UV sterilization glial cells were plated at 600/cm2. 
Munc18-1 wild-type linked to enhanced green ﬂuorescent protein (EGFP) via an internal 
ribosomal entry site (IRES) subcloned into pLenti-vectors and neurons were transduced 
as described  (Naldini et al., 1996), as control a vector with CRE linked to EGFP was used. 
The transduction efﬁciency was analyzed by counting ﬂuorescent cells.
Electrophoresis and Immunoblotting
DRGs were collected at E18 and homogenized in SDS-PAGE loading buffer (66 mM 
Tris/HCl, pH 6.8, 3 % [w/v] SDS, 5 % [v/v] glycerol, 2 % [v/v] β-mercaptoethanol, and 
0.001 % [w/v] bromophenol blue). Cortices were isolated for brains for E18 animals, 
homogenized and SDS-PAGE loading buffer was added. SDS-PAGE was performed 
with all DRGs of one embryo per lane, 10µg protein of cortex-material, using gradient 
gels (6-15 %) in Tris-glycine electrophoresis buffer. Proteins were transferred to PVDF 
membranes at 100 V for 1 hr and detected with either secondary antibodies coupled 
to horseradish peroxidase and enhanced chemiluminescense or alkaline phosphatase-
conjugated secondary antibodies and enhanced chemiﬂuorescence. Quantiﬁcation 
was performed on a Fluor S MultiImager (BIO-RAD, Tokyo, Japan).
Antibodies
Monoclonal antibody against munc18-1 was purchased from Transduction Laboratories 
(Lexington, KY). The monoclonal anti-syntaxin-1A/B (HPC-1) was purchased from Sigma 
(St. Louis, MO). The polyclonal anti-VCP (K331; Sugita and Sudhof, 2000) was as described 
previously. The horseradish peroxidase-conjugated secondary antibody against mouse 
IgG was purchased from Jackson Immuno Research Laboratories, Inc. (West Grove, 
PA), and the peroxidase-conjugated secondary anti-rabbit IgG from Sigma. The ECL-
substrate (Super Signal West Dura Extended) was purchased from Pierce (Rockford, IL). 
The alkaline phosphatase-conjugated secondary mouse and rabbit IgG and IgM and 
ECF-substrate were purchased from Amersham (Buckinghamshire, UK).
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RESULTS
Syntaxin1 protein levels are reduced in the neocortex of the 
munc18-1 null mutant
Syntaxin1 levels are reduced with 70% in the whole brain of the munc18-1 null mutant 
compared to control animals (Toonen et al., 2005). To analyze the role of synaptic 
activity and the Munc18-1/Syntaxin1 interaction on syntaxin1 expression, we examined 
the protein levels of Syntaxin in the neocortex of munc18-1 null mutant mice, because 
other brain areas but the neocortex are degenerated at E18 in the mutant. Syntaxin1A 
and Syntaxin1B levels were approximately 70% lower in the mutant neocortex, while 
the levels of the other SNARE-complex proteins, Synaptobrevin/VAMP2 and SNAP25, 
and other presynaptic proteins, like Synaptotagmin and VCP were unaffected (Figure 
1 and chapter 2 of this thesis). In conclusion, Syntaxin1 is the only SNARE-complex 
member of which protein levels are reduced.
Syntaxin1 mRNA expression is lower in mutant mice
To test whether a lower mRNA expression causes the observed changes in Syntaxin1 
protein levels, we analyzed syntaxin1 transcript levels in the cortex of control and 
munc18-1 null mutant mice by using quantitative PCR (qPCR) at several embryonic 
stages. Syntaxin1 levels were 1.7 times lower at E18 in the mutant compared to control 
animals, whereas the transcript levels of other pre- and postsynaptic proteins, like 
DOC2a/b, NARP, SNAP25, stargazin, synapsin2, synaptotagmin1, VAMP2 and VCP, were 
not signiﬁcantly changed (Figure 2A; α=5%). The lower syntaxin1 expression in the 
mutant relative to control animals was conﬁrmed using Northern blotting (Figure 2B) 
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Figure 1: Reduced syntaxin-1 protein levels in the neocortex from munc18-1-deﬁcient mice. 
Quantiﬁcation of immunoblot analyses with speciﬁc antibodies against Syntaxin1 (monoclonal), Munc18-1 
(monoclonal) and SCAMP (polyclonal) of protein levels in control (+/+) and mutant (-/-) mice in the cortex 
of E18 embryos. Results are represented as mean percentage of control levels ± SEM (n=3). Example blots 
are also shown (top). Differences were analyzed using a Student’s t-test (α=5%). The protein levels of both 
Munc18-1 and Syntaxin1 were signiﬁcantly different (*).
and microarray analysis (chapter 3 of this thesis). The transcript levels of rabphilin3A 
another presynaptic gene were 1.6 times lower in the mutant. 
Earlier in development, at E14 and E16, none of the synaptic protein transcripts, 
including syntaxin1, were differentially expressed. 
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Figure 2: Quantiﬁcation of expression levels of synaptic proteins in control and mutant mice. A: RNA 
levels were quantiﬁed in mutant and control animals of embryonic day 14, 16 and 18. Each bar represents 
the average regulation in mutant relative to controls ± SEM (n=3). Whether the differences are signiﬁcant is 
tested by the Student’s t-test (*, α=5%). An estimate of the abundance of a certain transcript is obtained by 
the difference between the cycle threshold of HPRT and the speciﬁc transcript (∆Ct value) of the qPCR: very 
low: ∆Ct>4, low: 1<∆Ct<4, medium:-1<∆Ct <1, high:-4<∆Ct<-1, very high: ∆Ct <-4. Transcript levels increase 
during development. The expression of only syntaxin1A and rabphilin3A is signiﬁcantly different at E18. 
Munc18-1 is differentially expressed at all developmental stages. B: Northern blot analysis of the RNA levels 
of syntaxin1 and GAPDH in control (+/+) and mutant mice (-/-) at embryonic day 18 (per lane approximately 
10 µg was loaded). Using northern blot, the same expression level is seen as in qPCR (n=2). 
+/+ +/+-/- -/-
Syntaxin1 GAPDH
1.9kb
Syntaxin1 protein levels are lower in mutant sensory neurons 
The lower protein amount of Syntaxin1 in the munc18-1 mutant may be the direct result 
of the absence of munc18-1 or the consequence of the complete absence of synaptic 
activity in these animals. Therefore, we tested protein and transcript levels of syntaxin1 
in sensory neurons. Unlike cortical neurons, these neurons most likely have normal 
input, because they are activated by sensory receptors on their peripheral ends and 
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Figure 3: Quantiﬁcation of syntaxin-1 protein and RNA levels in DRG’s of munc18-1-deﬁcient mice. 
Immunoblot analyses with speciﬁc antibodies against Syntaxin1 (monoclonal) and VCP (polyclonal) shows 
the protein levels in control (+/+) and mutant (-/-) mice in the cortex of E18 embryos (per lane all DRG of 1 
animal was loaded). B: RNA levels of SNARE complex proteins were quantiﬁed in DRGs of E18 mutant and 
control animals. Each bar represents the average regulation in mutant relative to controls ± SEM (n=3). 
Signiﬁcant differences are calculated by Student’s t-test (α=5%). Black bars indicate signiﬁcant different RNA 
levels (*) and gray bars represent non-signiﬁcant changes.
thus do not depend on synaptic release. These neurons, like cortical neurons, cannot 
secrete neurotransmitter on their postsynaptic cells, because they lack munc18-1. We 
measured protein levels and mRNA levels in dorsal root ganglia (DRG) at E18. Syntaxin1 
protein levels were much lower in mutant DRG (Figure 3A), similar to the neocortex. The 
transcript levels of syntaxin however were not signiﬁcantly different, as were the levels 
of VAMP2 and GAPDH mRNA. In conclusion, in DRG neurons only Syntaxin1 protein 
levels are reduced, whereas the transcript levels are similar in mutant and control 
animals. 
Activity and munc18-1 expression do not increase syntaxin1 
expression in HEK-293 cells
To examine whether syntaxin1 expression is regulated by munc18 directly, HEK-293 
were transfected with munc18 and syntaxin1. The syntaxin1 transcript and proteins 
levels were undetectable in HEK-293 cells (Figure 4), indicating that Munc18-1 cannot 
induce endogenous syntaxin1 gene expression in HEK-293 cells. However, the regulatory 
machinery that can induce syntaxin1 expression in neurons may not be present in 
HEK-293 cells. Therefore, a better experiment would be to transduce neurons of control 
animals with munc18-1. We performed a pilot experiment, where munc18-1 was co-
expressed with EGFP via an internal ribosomal entry site. Transcript levels of syntaxin1, 
VAMP2, SNAP25 and GAPDH were not different as compared to control neurons (data 
not shown). However, from this experiment no conclusions can be drawn, because only 
about 5% of the cells had detectable EGFP levels. Using qPCR, differences as small as 
1.4 times can be measured, which means that syntaxin1 levels in the 5% transfected 
neurons should be upregulated 28 times to be detectable. 
In addition, to test whether syntaxin1 is regulated by activity, we treated HEK-293 cells 
with ionomycin, to stimulate calcium inﬂux. Using PCR or Northern blot to analyze 
syntaxin1 transcript levels, syntaxin1 transcript levels in stimulated or unstimulated 
HEK-293 cells were undetectable. Sutton et al (1999) showed an induction of syntaxin1A 
transcription in HEK-293 cells after ionomycin stimulation, however we are unable to 
reproduce their results. 
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DISCUSSION
In this paper we studied the role of synaptic release and interaction between Munc18-
1 and Syntaxin1, in the regulation of syntaxin1 expression. We made use of munc18-1 
null mutant mice that lacks synaptic release and are therefore synaptically silent. We 
found lower syntaxin1 RNA and protein levels at E18, whereas the expression of several 
other synaptic proteins was unaffected. At earlier time points, when synapses are not 
yet functional in the cortex, no difference was detected. Lower Syntaxin1 protein levels 
were also observed in mutant sensory neurons, which do not depend on synaptic 
activity for their input. Differential transcription levels of syntaxin1 were not observed in 
these neurons. In cortical cultures containing low percentage of munc18-1 transfected 
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Figure 4: Quantiﬁcation of syntaxin1 RNA and protein levels in HEK293 cells overexpressed with 
munc18-1. HEK293 cells were transfected with syntaxin1 and munc18-1. The transfection was successful, 
because the transfected samples contained RNA and protein of the transfected gene. A: Northern blot analysis 
of transcript levels in HEK293 cells. Only GAPDH was endogenously expressed in HEK293 cells. Expression of 
syntaxin1 or munc18-1 did not induce expression of the other gene. B: Western blot showing that expression 
of syntaxin1 or munc18-1 does not effect the expression of the other protein. 
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cells, syntaxin1 transcript levels were not signiﬁcantly increased. Transfection of HEK-
293 cells with munc18-1 did not inﬂuence syntaxin1 gene expression.
Syntaxin1 is the only SNARE-complex member regulated by 
activity
In this paper, protein and transcript levels for all three SNARE-complex members 
were studied under several conditions. In these experiments only transcript levels of 
syntaxin1 were altered, and SNAP25 and VAMP levels were unaffected. This is in line 
with some other publications in which syntaxin1 was reported to be affected by an 
increase in activity, whereas the other SNARE-complex members were unaltered (Hicks 
et al., 1997; Sutton et al., 1999). Since all three SNARE-complex members are needed 
for synaptic release, the amount of Syntaxin1 may be rate-limiting when the amount 
of syntaxin1 is lower than the levels of the other core complex members. In the qPCR 
experiment transcript levels of syntaxin1 were shown to be lower than the other SNARE-
complex members. Therefore, the reduction in syntaxin1 levels may contribute to the 
abolishment of synaptic release in the munc18-1 mutant and be a way for neuronal 
networks to regulate secretion capacity in a use-dependent manner.
The role of synaptic release and munc18-1 in the regulation of 
syntaxin1 expression
The lower Syntaxin1 protein levels in mutant mice may in part result from decreased 
stability in absence of its binding partner Munc18-1 (Toonen et al., 2005). However, 
we show here that the lower protein levels may partly be an effect of reduced gene 
expression. Synaptic release may cause this change in syntaxin1 gene expression, 
because syntaxin1 was only differentially expressed at E18, when synapses are 
functional, and not earlier in development. In addition, in sensory neurons, which are 
probably active in the mutant, no effect on transcript levels was observed. Expression of 
munc18-1 in HEK 293 cells did not induce syntaxin1 transcript levels. These four ﬁndings 
indicate that synaptic release may regulate the transcription of syntaxin1 via the inﬂux 
of calcium (see Sutton et al., 1999). Syntaxin1 RNA levels are most likely not affected 
by Munc18-1 directly, because syntaxin1 transcript levels were similar in mutant and 
control sensory neurons, which do not depend on synaptic release for their activity. 
Moreover, munc18-1 overexpression in neurons and expression in HEK-293 cells did not 
change the expression of syntaxin1, although these data were not conclusive.
In conclusion, syntaxin1 gene expression is most likely regulated by input activity, this 
effect will reduce the protein levels in the munc18-1 mutant. In addition, the protein 
levels of syntaxin1 are further reduced by a direct effect of the loss of munc18-1, because 
Munc18-1 enhances the stability of Syntaxin1.
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GENERAL DISCUSSION

DISCUSSION
The aim of the studies described in this thesis was to elucidate the role of synaptic 
transmitter release in the development of the nervous system. Three main questions 
were investigated: First, how does synaptic activity inﬂuence initial brain development 
and synapse formation. Second, which genes are (dis-)regulated under different 
conditions of  synaptic release during development. Third, is the supply of synaptic 
proteins dependent on synaptic transmission? This chapter brieﬂy summarizes our 
main ﬁndings and discusses the results obtained.
Using the munc18-1 null mutant mouse, which is severely impaired in all forms of 
synaptic release, we were able to analyze the role of synaptic release in development 
(chapter 2). We found no differences in overall cortical structure, and no changes in 
synaptic protein levels and munc18 targeting in these animals. In addition, immature 
synapses were found both in the mutant and control animals from developmental day 
E16 on. However, the number of synapses was lower in the mutant at E16. The number 
of synapses increased in the control animals, but did not increase over time in mutant 
mice. In addition to synapses, synapse-like structures (with vesicles present on both 
sites of the electron dense stained membrane) were observed by EM in the neocortex of 
mutant and control mice. These ‘multivesicular structures’ were present at similar levels 
in E16 mutant and control animals, but at E18 their number was higher in the mutant 
compared to control animals. These results imply, that immature synapses do form 
without synaptic release, but cannot mature and therefore may form multivesicular 
structures instead.
The regulation of RNA levels under conditions of defective synaptic release was studied 
in chapter 3. In the munc18-1 null mutant, gene expression was studied using micro-
array analysis and quantitative PCR. Generally, the expression of most genes was 
unaffected in the mutant. At E18, genes with higher transcript levels in the mutant are 
of speciﬁc functional classes and may have a function in glial cells, immune cells or 
lysosomes. Most genes having lower levels in the mutant were assigned to a function 
in neuronal transmission, and were not regulated at E14 and E16. These data indicate 
that synaptic release is necessary to increase the expression of several components 
required for synaptic transmission. In Chapter 4 the relation between the usage of 
the synapse and the expression of synaptic proteins was studied. Neuropeptides were 
found to have lower RNA levels at E18, when comparing the munc18-1 null mutant 
versus control, whereas the levels of several synaptic release-related genes, such as 
neuropeptide receptors, were unaffected. At earlier time points E14, E16, when synapses 
are not yet functional in the cortex, no difference was detected in the transcript levels of 
the neuropeptide genes. RNA levels of neuropeptides were similar in primary sensory 
neurons, which are probably active in the munc18-1 mutant. Thus, these data strongly 
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support the idea that synaptic release is involved in the regulation of the expression of 
neuropeptide genes.
The regulation of the expression of the Munc18-1 binding partner syntaxin1 was 
studied in chapter 5. Previously, Syntaxin1 protein levels were shown to be lower in 
whole brain isolations of munc18-1 mutant relative to controls. We found lower levels 
of syntaxin1 mRNA and protein at E18 in the neocortex of the munc18 null mutant 
when synaptic release is absent. However, at earlier time points in embryonic life, 
no difference was observed. In sensory neurons, which do not need Munc18-1 to be 
active, Syntaxin1 protein levels were lower in the mutant compared to control animals. 
However, transcript levels were unaffected in these sensory neurons. This indicates that 
syntaxin1 expression can be regulated by input-activity-dependent gene expression 
and that Syntaxin protein levels may be stabilized by Munc18-1. 
1 - The role of synaptic release in neuro-development and gene 
expression
Deletion of synaptic release initially leads to normal brain development. Neurons can 
migrate to the correct location and are able to form axons, dendrites and synapses with 
normal structure in the absence of synaptic release. However, the number of synapses 
is lower in the munc18-1 mutant. Therefore, synaptic release may play a role in synapse 
maturation and/or stabilization, which is one of the ﬁnal steps of the development of 
neuronal connections. In this thesis, we have shown that during synapse development 
some proteins with a synaptic function are regulated by activity. This activity-dependent 
increase of synaptic proteins may be involved in functional maturation of the synapse. 
Both the increase in synapse number and the increase in synaptic proteins may either 
be caused by input or output activity, because almost every neuron is both pre-and 
postsynaptic. The DRG data in chapter 4 indicate that the expression of neuropeptides 
may be regulated by input activity. 
Besides increasing the number of synapses during embryonic development, after birth 
activity may act as a limiting factor, as was indicated in a recent article (Flavell et al., 
2006). 
In addition to genomic effects, activity may inﬂuence processes such as translation, 
protein localization and posttranslational modiﬁcation. These processes may be 
important for network development as well. Examples of these are Synaptic vesicle 
protein 2 (SV2) and Rab3A that are ﬁrst localized in neurites. Later, these proteins 
appear in nerve terminals (Confaloni et al., 1997; Stettler et al., 1994). In addition, NCAM 
is recruited to the cell surface in an activity-dependent manner (Kiss et al., 1994) and 
eye opening induces a rapid dendritic localization of PSD-95 in central visual neurons 
(Yoshii et al., 2003). Moreover, incorporation of receptors in the post-synaptic membrane 
depends on activity (see for review Barish et al., 1998). Also translation can be regulated 
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in an activity-dependent way. Some synaptic transcripts are polyadenylated in response 
to activity and this will most likely lead to an increase in translation rates (Du and 
Richter, 2006). All these effects are consistent with the idea that only active synapses 
will become reinforced. 
A - Processes involved in the activity-dependent regulation of genes
Which processes underlie activity-dependent regulation of gene expression is not 
completely understood, although there are some clues. During early development, 
neurons express basal levels of several activity-dependent proteins, such as receptors 
and synaptic vesicle proteins. The synapse may only be consolidated when gene 
expression of both pre- and post-synaptic are coordinated. The frequency of synaptic 
release in the growth cones may be one of the factors that deﬁne whether a synapse 
should be formed. A certain frequency may increase the expression of speciﬁc genes 
in one cell but not in another; this frequency-dependent regulation of gene expression 
has been shown for cell adhesion molecules (Itoh et al., 1997). 
The inﬂux of calcium as a result of synaptic release, has been shown to be an important 
second-messenger for activity-dependent gene expression (see for review Barish et al., 
1998). The activity-dependent effects of calcium may require the activation of a large 
variety of Ca2+/CaM-dependent effector molecules, like Ca2+/CaM-dependent protein 
kinases (see for review Bito, 1998). These kinases may, for instance, phosphorylate CREB, 
which will lead to CRE-dependent transcription. In addition, calcineurin is required for 
the activity-dependent transcription via CREB (Hahm et al., 2003). Calcineurin is less 
expressed in the munc18-1 mutant than in control animals (chapter 3) and this reduction 
may be responsible for some of the differentially expressed genes in the mutant. Impey 
et al. studied which genes are a target for CREB (2004). Some of the CREB targets found 
in the article were affected in the mutant, for instance the levels of VGF, synaptotagmin 
7, shank and cyclin G were changed. However, also some CREB targets were unaffected 
in the mutant like VAMP2, GKAP and ephrin A5.
In addition to CREB-dependent regulation of expression, several other pathways may 
be involved in this process, for instance the MAPK-pathway, which is essential for the 
translational (Kelleher et al., 2004) and transcriptional component of LTP (Davis et al., 
2000).  In conclusion, most likely several pathways are involved in the regulation of 
transcription and a central role for calcium seems plausible.
B - Differences in synaptic release-dependent gene expression during 
development and adult plasticity
Several genes were differentially expressed during both development and synaptic 
plasticity (See for review Lynch, 2004). However, some differentially expressed genes 
during synaptic plasticity were not affected in our study on developing neurons, 
113112
Chapter 6 Discussion
including cell adhesion molecules and neurotransmitter-receptors. For instance, 
LTP induced by BDNF leads to an induction of other transcripts then we have seen. 
Following BDNF-LTP the transcript levels of Narp, neuritin, CARP, TIEG and ARL4L are co-
upregulated with Arc (Wibrand et al., 2006). In the munc18-1 mutant we have analyzed 
the RNA levels of NARP, TIEG and ARL4 relative to control animals, all were unchanged. 
In addition, we did not ﬁnd a difference in the expression of NMDA receptors subunits in 
the munc18-1 mutant, whereas it has been shown that the expression is affected during 
synaptic plasticity as well as in other studies on developmental expression of the NMDA 
receptor (Williams et al., 1993; Roberts and Ramoa, 1999). However, the developmental 
NMDA subunit switch may occur at a later embryonic age than we performed this 
experiment. In general, some of the activity-dependent gene expression may occur only 
after birth, because the expression of some genes may depend on the higher activity 
levels that occur only after birth. Immature synapses only receive a low frequency 
of action potentials. This low frequency ﬁring may stimulate the expression of some 
proteins and in this way may strengthen the synapse. High frequency and phasic ﬁring 
is correlated with consolidation of terminals, synapse stabilization, and myelination (see 
Itoh et al., 1997). High frequency ﬁring may lead to substantial gene expression. Indeed 
the largest change in transcription is seen after birth (Stead et al., 2006), conﬁrming 
the idea that the higher activity levels after birth may lead to larger changes. Firing 
frequency may explain the differences in the expression during development and 
plasticity as well. In the mutant the expression of neuropeptides was lower relative to 
control animals, whereas the expression of the neuropeptide receptors was similar. This 
difference may be explained by the fact that the pre-synapse is established earlier than 
the post-synapse. In conclusion, the difference in activity-dependent expression during 
development and plasticity may be a matter of precise moment of development and a 
difference in robustness in action potential ﬁring. 
2 - The role and regulation of LDCV release in brain development 
A – The importance of LDCV release for normal and munc18-1 mutant brain 
development
Several studies have shown that neurotrophins may strengthen the synaptic transmission 
in the CNS (see Vicario-Abejón, et al., 1998; Martínez et al., 1998). For instance, in the late 
phase of LTP neurotrophins are involved, as has been shown by pretreating brain slices 
with a TrkB-IgG (Kang et al., 1997). Furthermore, for this LTP phase, gene expression is 
required. This gene expression may in turn be regulated by neurotrophins, since they 
are known to be involved in activity-dependent gene expression (Frey et al., 1998; 
Messaoudi et al., 2002). The gene expression induction by NGF was studied in PC12 
cells (Lee et al., 2005). This study shows some overlap with our study (cytochrome P450 
and ATPase are changed in both studies), however no change in neuropeptide and 
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synaptic release proteins expression is seen in the PC12 cells. In our mutant still the 
reduction in other neurotrophins (especially BDNF) may be responsible for the changes 
in transcription.
In conclusion, in the munc18-1 mutant activity-dependent reduction in neurotrophins, 
may be the cause of the lower expression of synaptic compounds, since the gene 
expression of some neurotrophins is decreased. 
B – The role of synaptic activity on the expression of genes involved in release 
of LDCVs and synaptic vesicles 
In the munc18-1 null mutant we found a reduced expression of several genes involved 
in synaptic release. In particular, genes involved in LDCV release were regulated, some 
of these genes are involved in synaptic vesicle release as well. However, none of these 
genes were solely involved in synaptic vesicle release. For instance, synaptotagmin7, 
SNAP23 and Doc2 levels were differentially expressed in the munc18-1 mutant 
compared to control animals and are only involved in LDCV release (Shin et al., 2002; 
Chen et al., 2000; Charvin et al., 1999). RNA levels of syntaxin1 that is involved in both 
synaptic vesicle release and LDCV release (Foran et al., 1996) are lower in the mutant. 
In contrast, the levels of SNAP25 and synapsin1, which are only involved in synaptic 
vesicle release but not in LDCV release (Foran et al., 1996; Navone et al., 1984), were 
similarly expressed in mutant and control animals. In conclusion, only genes involved in 
LDCV release were found affected in the munc18 mutant, whereas genes, which have a 
function in synaptic vesicle release only are unaltered. In conclusion, particularly genes 
involved in LDCV release are susceptible to regulation, in contrast to genes that are 
involved in synaptic vesicle release.
3 – Other effects of munc18-1 deletion 
In chapter 2 we describe that for the maintenance of neuronal networks, synaptic activity 
may be essential. Because neuronal networks in the mutant cannot be maintained, 
lower brain areas go into apoptosis. However, recent data show that deleting munc18-1 
in Purkinje cells leads to apoptosis of these neurons (Heeroma et al., 2004). Therefore, 
the degeneration of brain areas other than the cortex, may be a direct effect of deletion 
of munc18-1 and not of synaptic activity. 
The proposed relation between secretion and neuronal maintenance was tested 
in low-density cultures, organotypic cultures and in vivo, by conditional, cell-speciﬁc 
inactivation of the munc18-1 gene (Heeroma et al., 2004). This study shows ﬁrst, the 
lack of synaptic activity cannot explain the degeneration in munc18-1 mutants. Second, 
trophic support delays but cannot prevent degeneration, and ﬁnally, a cell-intrinsic, yet 
unknown function of Munc18-1 is essential for prolonged survival.
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4 - Future directions
This thesis focused on the role of activity in the development of neuronal networks 
and the regulation of gene expression by secretory activity. Some questions remain to 
be answered. For instance, the question what the role of activity is in neuronal network 
formation, has not been completely answered. Using the synaptic silent munc18-1 
mutant we made some progress. However, it now has been shown that the degradation 
of the lower brain area is caused by a cell-intrinsic yet unknown function of Munc18-1 
and not only by lack of activity. Therefore, other synaptic vesicle release devoid mouse 
models, like the munc13-1/2 double mutant, should be used to study this question 
further. However, this model has drawbacks as well, since most likely not all neurons in 
this mutant are silent and LDCV release is not impaired. LDCV release is another form of 
activity that has most likely a substantial role in network development, especially via the 
release of neurotrophins. The role of LDCV release in developing and mature networks 
could be studied in inducible mutants for certain genes, like for instance an inducible 
SNAP23 mutant. As SNAP23 is important for LDCV release, this form of synaptic release 
is most likely impaired in this mutant. Comparing control animals with the SNAP23 
mutant at RNA and morphological level may reveal the role of LDCV release on gene 
expression and network formation. 
Another question discussed in this thesis is, which genes are regulated by activity. 
From the munc18-1 mutant data we have many candidate genes, which are probably 
regulated by activity. Other models lacking activity, like the munc13-1/2 double mutant 
and the inducible munc18-1 mutant may be used to validate the activity-dependent 
expression of these genes. In addition, the sensory neurons of the DRG, which do not 
depend on synaptic release for their activity but lack munc18-1, can be analyzed by 
microarray technology. The analysis of DRGs will reveal which genes are regulated 
directly by the removal of munc18-1 and not by activity. In the current study we might 
have missed some of the genes regulated by activity. First, in this thesis we studied the 
gene expression differences in the total cortex, which is composed of several cell types. 
Second, we only analyzed the expression of approximately 25 % of genes coded in 
the mouse genome. Studying single cell cultures may reveal other activity-dependent 
genes, for instance munc18-1 mutant cell cultures and a more extended microarray may 
be used to analyze the expression of more genes. In addition, the question should be 
answered whether activity regulates gene expression at other levels than transcription, 
for instance by inﬂuencing translation or posttranslational modiﬁcation. Therefore, the 
munc18-1 mutant cortical protein levels should be analyzed.
To conclude, we have shown that immature synapses can form without synaptic 
release and that synaptic release is necessary to increase the expression of several 
neuronal transmission related genes. Using several mutants and proteomics analysis of 
the release machinery we can shed more light on the function of synaptic release and 
LDCV release in brain development. 
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ABBREVIATIONS 
 
 ACh: Achetylcholine
 Arc: Activity-regulated cytoskeleton protein 
 ARL: ADP-ribosylation factor-like protein
 AMPA α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid
BDNF:  Brain-Derived Neurotrophic growth Factor
CAMK:  Calmodulin-dependent protein kinase 
CARP:  Cbl-related protein 
ChAT:  Choline-acetyltransferase
 DRG: Dorsal root ganglia
 EDTA: EthyleneDiamineTetraacetic Acid 
 Elisa: Enzyme immunoassay
 E16: Embryonic day 16
 E18: Embryonic day 18
 GDI: GDP dissociation inhibitor
 GABA: Gamma-aminobutyric acid
 GAD: Glutamic acid decarboxylase 
 GAPDH: Glyceraldehyde-3-phosphospate dehydrogenase 
 GO: Gene orthology
 HPRT: hypoxanthine phosphoribosyl transferase 
 LDCV: Large dense-core vesicle
 LGN: Lateral geniculate nucleus 
LTP:  Long-Term Potentiation
MAPK:  Mitogen-activated protein kinase 
 Munc18-1 Mammalian homologue of Caenorhabditis elegans UNCoordinated 
locomotion-18
 NARP: Neuronal activity-regulated pentraxin
 NCAM: Neural cell adhesion molecule 
 NGF: Nerve growth factor
 NMDA: N-methyl-D-aspartatic acid
 NO: Nitric oxide
 NOS: Nitric oxide synthase
 NPY: Neuropeptide Y
 NT: Neurotrophin
 PBS: Phosphate Buffered Saline
 PC: Proprotein convertase
 qPCR: Real-time quantitative PCR
 SAM: Signiﬁcance Analysis of Microarrays 
 SCAMP Secretory carrier membrane protein
 SDS: Sodium Dodecyl Sulfate 
 SEM: Standard error of the mean
 SSC: Sodium chloride Sodium Citrate 
 SNAP-25: synaptosomal associated protein of 25 kD
 SNARE: Soluble N-ethylmaleimide-sensitive fusion (NSF) protein
  attachment protein (SNAP) receptors)
 SV: Synaptic vesicle protein
 TIEG: TGF-beta-induced immediate early gene-1
 Trk: Tyrosine kinase
 TTX: Tetrodotoxin
 VAMP: Vesicle-associated membrane protein 
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NEDERLANDSE SAMENVATTING
Studies naar de rol van synaps activiteit in synaps ontwikkeling en gen 
expressie
Onze hersenen worden geïnformeerd over vele processen in en buiten ons lichaam 
en sturen vele andere processen aan. Voor veel van deze processen zijn speciﬁeke 
gebieden (centra) in de hersenen aanwezig. Tussen deze hersencentra bevinden zich 
verbindingen om informatie samen te brengen en om activiteiten van het lichaam 
op elkaar af te stemmen. Zo regelt een bepaald centrum in de hersenen tijdens het 
spreken de bewegingen van de mond en de tong. Een ander hersengebied bepaalt 
welke woorden je moet (of wilt) uitspreken. In weer een ander deel komt de informatie 
binnen die meldt dat de tong beweegt of die aangeeft dat de thee zoet is. Het lichaam 
is in staat goed te functioneren, omdat hersencentra onderling verbonden zijn en dus 
nauwkeurig met elkaar samenwerken.
Binnen zo’n centrum is een heel netwerk van zenuwcellen (neuronen) verantwoordelijk 
voor de totstandkoming van een bepaald proces. De verbindingen tussen de 
zenuwcellen binnen een hersencentrum, maar ook tussen hersencentra onderling, 
worden gevormd door uitlopers van de cellen. Als je je realiseert dat de hersenen 
bestaan uit 100 miljard zenuwcellen en dat iedere cel vele uitlopers heeft, dan is 
duidelijk dat hier sprake is van een immens netwerk. 
Zenuwcellen kunnen met elkaar communiceren door het afgeven van bepaalde 
signaalstoffen (ﬁguur 1). De afgifte van deze signaalstoffen gebeurt in daarvoor 
gespecialiseerde delen van de uitlopers, de zgn. synapsen, waarvan we er 60 biljoen 
hebben. 
Figuur 1. Zenuwcellen kunnen signaalstoffen afgeven, die worden herkend door de doelwitcel.
 
(Afgevende) Zenuwcel
 
(Doelwit) Zenuwcel
Uitloper Synaps
Signaalstof
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Om de juiste zenuwcellen en centra met elkaar te verbinden, moet de ontwikkeling 
van het zenuwstelsel strak worden gereguleerd. Bijvoorbeeld moeten de afgevende 
cel en de doelwitcel elkaar kunnen herkennen. Hoe daarvoor wordt gezorgd is nog niet 
helemaal duidelijk. Wel weten we dat dit een zeer complex proces is. Een proces dat 
niet alleen voor de geboorte plaatsvindt, maar ook daarna. In dit proefschrift proberen 
we antwoord te geven op de vraag hoe deze stap in de ontwikkeling van de hersenen 
verloopt. 
Al vroeg in de ontwikkeling geven zenuwcellen signaalstoffen af. Er werd altijd 
aangenomen dat deze signaalstoffen ervoor zorgen dat de uitlopers hun weg vinden 
naar de juiste zenuwcel en dat signaalstoffen zorgen voor het aanmaken van de 
juiste synapsen. Echter, uit ons onderzoek blijkt dat de signaalstofafgifte bij geen 
van deze processen een rol speelt. In dit onderzoek hebben we gebruik gemaakt van 
een genetisch gemodiﬁceerde muis die deze signaalstoffen niet afgeeft. In deze zgn. 
mutante muis vinden de uitlopers gewoon hun weg en worden synapsen gevormd. 
Wel speelt de signaalstof een rol bij de functie van de synaps; zonder signaalstof is er 
geen communicatie tussen de zenuwcellen.
Het vormen van synapsen is één belangrijke stap, maar het behoud ervan is minstens 
zo belangrijk. Vele synapsen moeten namelijk jaren mee, sommige zelfs ons hele leven. 
De afgifte van signaalstoffen zou door zenuwcellen gebruikt kunnen worden om elkaar 
als partners te herkennen en daarmee de juiste synapsen te vormen. Als synapsen 
worden gevormd tussen verkeerde cellen, zijn deze instabiel en gaan verloren. De 
vraag of signaalstofafgifte betrokken is bij synaps-stabilisatie  hebben we beantwoord 
in dit proefschrift (Hoofdstuk 2). In hoofdstuk 2 laten we zien dat in een mutante muis 
zonder signaalstofafgifte minder synapsen en synapsen met een rare vorm aanwezig 
zijn. De rare vorm van de synapsen, die we vinden in de mutant zijn waarschijnlijk 
synapsen die worden opgeruimd. Deze gegevens suggereren dat signaalstofafgifte 
inderdaad een stabiliserende werking op de synaps heeft.
Vervolgens hebben we de vraag gesteld waardoor stabilisatie afhankelijk is van de 
afgifte van signaalstoffen. Het zou kunnen dat de afgifte van signaalstoffen ervoor 
zorgt dat de doelwitcel de synaps in stand houdt, bijvoorbeeld door een bepaald 
stabiliserend eiwit gaan maken als hij meer signaalstof krijgt van de afgevende cel. 
Zenuwcellen moeten zich aanpassen aan verschillende omstandigheden, zoals het 
hart zich aanpast aan hoe actief je bent. Als je hardloopt, hebt je een hogere hartslag 
dan wanneer je slaapt. De afgifte van signaalstoffen in de hersenen zou voor deze 
aanpassing en de synaps-stabilisatie belangrijk kunnen zijn. 
De informatie hoe een bepaald eiwit gemaakt moet worden ligt op het DNA, in de 
celkern. Als er veel van dat eiwit nodig is, wordt de informatie op het DNA vaker 
afgelezen (ﬁguur 2). De betreffende informatie van het DNA wordt tijdens het aﬂezen 
gekopieerd op een drager, het zogenaamde boodschapper RNA. Dit RNA wordt van 
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de celkern naar de rest van de cel gebracht en wordt daar gebruikt om eiwit te maken. 
De hoeveelheid boodschapper RNA voor een bepaald eiwit is dus een maat voor de 
hoeveelheid eiwit die op dat moment wordt gemaakt. 
Figuur 2. Informatie hoe een eiwit gemaakt wordt ligt op het DNA. Voor ieder eiwit is er een gen op het 
DNA. Dit gen wordt afgelezen en er wordt RNA gemaakt. Voor ieder eiwit is er dus ook een speciﬁek RNA. De 
informatie op het RNA wordt vervolgens gebruikt om een eiwit te maken.
In hoofdstuk 3 hebben we gekeken hoe de hoeveelheid RNA voor bepaalde eiwitten 
verandert als er geen sprake is van afgifte van signaalstoffen. Hiervoor hebben we de 
hoeveelheid RNA in cellen van onze mutante muis vergeleken met die van een normale 
muis. We laten zien dat vooral de hoeveelheid RNA van eiwitten die een rol spelen in 
de synapsvorming verandert. Dit bevestigt de hypothese dat afgifte van een bepaalde 
signaalstof er tijdens de hersenontwikkeling voor zorgt dat de juiste eiwitten worden 
gemaakt en dat die op hun beurt de betrokken synapsen stabiliseren. 
In hoofdstuk 4 hebben we onderzocht wat het effect is van de afgifte van signaalstoffen 
op hun eigen aanmaak. Vooral de hoeveelheid RNA van één groep van signaalstoffen 
in de hersenen, de neuropeptiden, is lager als er geen afgifte is van deze of andere 
signaalstoffen. In zenuwcellen die geen afgifte van signaalstoffen nodig hebben om toch 
actief te kunnen zijn, vinden we deze verlaging in neuropeptide hoeveelheden niet. Dit 
duidt erop dat de afgifte van signaalstoffen inderdaad de hoeveelheid neuropeptide 
RNA reguleert. Dit effect is ook nog behoorlijk speciﬁek, want de RNA hoeveelheden 
van andere groepen signaalstoffen zijn dan niet of nauwelijks veranderd. 
In hoofdstuk 5 hebben we gekeken naar drie andere eiwitten die in de synaps aanwezig 
Signaalstof
Het DNA wordt afgelezen en de 
informatie wordt gebruikt 
om RNA te maken
De informatie op het RNA 
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zijn. Deze eiwitten zijn betrokken bij het afgeven van signaalstoffen. Van maar één van 
deze eiwitten, Syntaxin1, zijn RNA hoeveelheden verlaagd in de mutant terwijl de andere 
twee onveranderd zijn. Vervolgens hebben we gekeken of ook de eiwit hoeveelheden 
van Syntaxin1 veranderd zijn in de mutante muis. Aangezien RNA wordt gebruikt om 
eiwitten te maken verwacht je dat als er minder RNA is er ook minder eiwit is. Inderdaad 
waren ook de eiwit hoeveelheden lager. Dat zou kunnen betekenen dat ook de Syntaxin1 
hoeveelheden worden gereguleerd door signaalstofafgifte. Dat is echter waarschijnlijk 
maar voor een deel waar. Als we namelijk in de mutant kijken naar zenuwcellen die wel 
actief zijn (ook zonder afgifte van signaalstoffen) dan zijn de RNA hoeveelheden van 
Syntaxin1 hetzelfde als in normale muizen, maar de eiwit hoeveelheden zijn wel lager. 
Dit komt waarschijnlijk door het eiwit (munc18-1) dat weggehaald is in de mutante 
muis. Syntaxin1 kan aan dit eiwit binden. Als munc18-1 niet aanwezig is zoals in de 
mutant, dan zou Syntaxin1 makkelijker door enzymen kunnen worden afgebroken. In 
de cel zijn altijd enzymen aanwezig die eiwitten afbreken, zo worden oude eiwitten 
weer opgeruimd. Als een eiwit in zijn eentje door de cel zwerft kunnen de enzymen 
het makkelijker afbreken. Dit laat zien dat de veranderingen die we zien in de mutant 
niet alleen komen doordat er geen signaalstofafgifte is, maar dat de afwezigheid van 
Munc18-1 ook veranderingen in eiwit en RNA hoeveelheden geeft. 
Een belangrijke conclusie uit mijn proefschrift is dat het ontbreken van de afgifte van 
signaalstoffen de hoeveelheden RNA en eiwitten kan beïnvloeden. Signaalstofafgifte 
is dus is naar alle waarschijnlijkheid via vele andere moleculen betrokken bij de 
ontwikkeling van functionele synapsen in de hersenen.
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EN UITERAARD DEED IK DIT NIET ALLEEN.....
Afgelopen jaren heb ik van velen praktische en/of emotionele steun gekregen. Mijn 
promotor Matthijs, bedankt dat je mij hebt geholpen een zelfstandig onderzoeker 
te worden. Alhoewel ik jouw werkschema niet zou kunnen volhouden, was het zeker 
een stimulerend voorbeeld. Je enthousiasme voor wetenschap werkte aanstekelijk. 
Ik hoop dat ik inmiddels jouw manier van data op een duidelijke manier presenteren 
goed heb afgekeken. Guus, dank je dat je op het juiste moment mijn onderzoek een zet 
in de goede richting hebt gegeven. Daarnaast hartelijk dank voor de gastvrijheid op 
jouw lab, waarvan ik nog steeds met veel plezier gebruik van maak. Mijn co-promotor 
Sabine, ik denk nog met veel plezier terug aan het kliederen met lijm om dammetjes 
te bouwen voor de array-kleuringen. Iets minder ﬁjn vanwege de kou, maar zeker niet 
minder leerzaam waren de dagen tussen kerst en nieuwjaar, toen je me inwijdde in de 
wereld van de quantitative PCR.
De eerste OIO-jaren heb ik doorgebracht op het RMI. De sfeer was er altijd erg goed. 
Vooral de vrijdag-middagen waren echt een begrip. Bij deze wil ik met name Peter, 
Marten, Rea, Leo, Joke, Ceriel, Niki, Julia, Marjan, Patrick, Johanneke, Wouter, Dorien, 
Hikke, Robert, Anita, Tom, Ria, Joost, Wout en Bert bedanken voor de hulp en/of mentale 
steun. Tineke, dank je voor de nuttige snoeptripjes en niet alleen omdat ze eindigden 
met een lekkernij.
Ik denk met veel plezier terug aan de gemeenschappelijke lunches op het MaV-lab, 
deze maakten de groep een stuk hechter. Sander, ﬁjn dat ik, zelfs als het eens laat werd, 
nog steeds input van je kon krijgen. Ruud, dank je voor het meedenken en ik hoop 
dat we hoofdstuk 5 snel kunnen publiceren. Maia and Paola, thanks for the fruitful 
cooperation for chapter 2. Betty thanks for the nice work and collaboration. Mijn 
kamergenoten Roland, Linda, Chris, en K.J. wil ik bedanken voor een goede werksfeer 
en de broodnodige aﬂeiding. Robbert en Joost Ho, ik ben echt blij dat ik niet zelf al die 
staarten heb hoeven genotyperen en het was echt groen en gezellig. Desirée, dank je 
voor de mooie in situ’s en de goeie feesten bij jou thuis. Elisabeth, kamer- en lotgenoot, 
ik ben blij voor je dat je een leuke werkplek hebt gevonden. Jan, heel veel succes met 
jouw laatste loodjes. Als je vier en half jaar samen op een kamer werkt, dan maakt je ook 
alle pieken en dalen van elkaar mee. Joost, dank je dat ik altijd op je steun kon rekenen 
en ik hoop dat er nog vele van onze oeverloze kofﬁekamer- discussies mogen volgen. 
Tina wat een planning, net voor jouw grote dag is het toch gelukt om de layout van dit 
boekje klaar te krijgen, het is echt schitterend geworden. Tatjana en Tina ﬁjn dat ik altijd 
even mocht klagen tijdens onze etentjes. De laatste twee jaar hebben mijn huidige 
collega’s van de afdeling moleculaire celfysiologie mij met enige regelmaat een hart 
onder de riem gestoken. Die steun heb ik zeker gewaardeerd.
Ontspanning is toch minstens zo belangrijk als je deze berg beklimt. Zo werkte ik met 
enige regelmaat met Daniëlle aan mijn stapel kleren, ik hoop dat er nog vele winkel 
135134
Dankwoord Dankwoord
uitstapjes mogen volgen. Daniëlle dank je voor de mooie omslag. Maar uiteraard ook 
dat je mijn paranimf wilde zijn en voor alle steun en toeverlaat. Jeroen, dank je voor alle 
gezellige etentjes. Afra, Arnoud, Arjen, Marten en Juriaan, even mijn zinnen verzetten 
was heel belangrijk, de klimavondjes, tochten en avondjes uit waren een welkome 
afwisseling.
De juiste nurture en nature heb je nodig om genoeg doorzettingsvermogen, 
leergierigheid en handigheid te hebben om een biologisch proefschrift tot een goed 
einde te brengen. Mijn opa wil ik bedanken voor het goede voorbeeld. Ik hoop dat ik op 
uw leeftijd nog steeds zo nieuwsgierig ben. En uiteraard wil ik mijn ouders bedanken, 
twee biologen als voorbeeld, wat wil je nog meer. Jan en Jacomine, dank jullie voor mijn 
genen, het feit dat jullie mij het wetenschappelijk denken met de paplepel hebben 
ingegoten, voor jullie steun en enthousiasme. Tialda, het is ﬁjn wanneer je zus je 
frustraties zo goed begrijpt. Ik heb aan je begrip veel steun gehad.
En de onvermoeibare steun thuis, lieve Frank, je wist me altijd weer goede moed in te 
praten. Ongelofelijk met welk geduld je je iedere keer weer, gewapend met een rode 
pen, door de teksten heen wist te slaan.
P.S. Uiteraard is er altijd de mogelijkheid dat je iemand gaat vergeten. Bij deze wil ik 
iedereen bedanken die op welke manier dan ook deze afgelopen jaren geholpen heeft 
mijn proefschrift tot een goed einde te brengen!
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